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Chapter 1      
 General introduction and outline of the thesis 
 
 
 
 
 
 
 
 
 
 
 
 
General Introduction 
 Coronary atherosclerosis is a worldwide pandemic disease and accounts for almost 17 million deaths annually (1). Common systemic risk factors for atherosclerosis include high cholesterol levels, hypertension, smoking, obesity, diabetes mellitus and family history for coronary artery disease. Furthermore, in patients with an atherogenic profile, plaque does not develop evenly across the entire coronary tree, but shows a predilection for sites where the laminar blood flow gets disturbed, such as the vicinity of coronary artery bifurcations (2).  The detection and accurate quantification of coronary plaque may potentially improve individualized risk stratification and allow the monitoring of patient’s response to pharmacological treatment. Although quantitative coronary angiography (QCA) has been used in the past to study the extent and progression of the disease (3), this technique can only depict the contrast-enhanced lumen, whereas atherosclerotic disease of the arterial wall does not necessarily result in narrowing of the vessel lumen. Currently, the preferred method to study atherosclerosis is by intracoronary, cross-sectional imaging methods, such as intravascular ultrasound (IVUS) (4).  However, both QCA and IVUS are expensive, invasive and involve certain, albeit minimal risks, thus they are unsuitable for preventive plaque detection in asymptomatic individuals or routine serial assessment of atherosclerosis.   Computed tomography coronary angiography (CTCA) has rapidly emerged as a noninvasive imaging modality for visualisation of the coronary arteries. Following the advances in multidetector CT technology and the improvement of spatial and temporal resolution with the introduction of 64-slice CT scanners, numerous studies have confirmed the ability of the technique to reliably detect and exclude significant coronary disease against invasive angiography (5-7). Similarly to IVUS, CTCA goes beyond lumenography and enables the assessment of atherosclerotic plaque burden, remodeling, eccentricity, and calcified and noncalcified plaque in both stable and unstable patients (8-10).   
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It is envisioned that the ability of CTCA to provide information not currently available from invasive angiography (i.e. plaque burden and calcium score) may change the way patients with atherosclerotic cardiovascular disease are stratified and managed (11). IVUS studies (12) have demonstrated that there is a direct association between the burden of coronary atherosclerosis, its progression and the presence of clinical events at follow-up. The use of CTCA to non-invasively quantify and monitor atherosclerotic plaque could contribute to the potential development of prediction models based on atherosclerotic plaque burden.  Moreover, the complex three-dimensional (3D) geometry of coronary artery bifurcations can be better visualized by means of CTCA which can provide a 3D reconstruction of the bifurcation, without the limitations of vessel foreshortening and overlap that exist in conventional angiography. Percutaneous treatment of coronary bifurcation lesions has been associated with worse acute and late outcomes due to higher restenosis and stent thrombosis rates (13-15). Comprehensive pre-interventional assessment of atherosclerosis at coronary bifurcation sites may be important to better plan a percutaneous treatment strategy.  Similar to any other imaging modality, CTCA has certain inherent limitations. Extensive coronary calcifications create blooming artifacts and still hamper the accurate evaluation of coronary vessels. Insufficient spatial resolution does not yet allow for precise detection of very small plaques and discrimination of the atherosclerotic plaque components. Presence of arrhythmias remains a contraindication for CTCA. The radiation exposure during CTCA is still an issue, although current scan protocols can considerably decrease the radiation dose. Anatomical information derived by CTCA can not accurately predict the hemodynamic significance of coronary lesions; however there is extensive research ongoing towards the direction of non-invasive functional assessment.        
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Outline of the thesis 
 In Part 2, the potential of CTCA to assess coronary atherosclerotic disease is discussed. The ability of 64-slice CTCA to detect and quantify coronary atherosclerotic plaque using intravascular ultrasound as a reference standard is evaluated (Chapter 2). The reproducibility of CTCA data analysis using semiautomatic plaque quantification software is investigated and the implications for the design of longitudinal studies are discussed (Chapter 3).  The natural history of coronary atherosclerosis in patients receiving contemporary medical treatment was studied by CTCA and the serial changes in coronary plaque burden, lumen dimensions and arterial remodeling were assessed (Chapter 4). Also, the potential of CTCA derived cross-sectional parameters to predict functional significance of lesions as indicated by fractional flow reserve was examined (Chapter 5).  Two manuscripts are provided in Part 3 which describe the ability of CTCA to comprehensively assess coronary bifurcations. Using CTCA and intravascular ultrasound-virtual histology, the distribution and composition of atherosclerotic plaques at bifurcations in relation to the bifurcation angle were evaluated (Chapter 6). In the following chapter, a novel CT-Medina classification for bifurcation lesions combining lumen narrowing and plaque distribution is proposed (Chapter 7).   In Part 4, the use of CT coronary angiography for risk stratification of coronary atherosclerotic disease is discussed. The feasibility and reproducibility of a CTCA derived SYNTAX Score compared to the widely used conventional angiography SYNTAX Score was investigated (Chapter 8).   The diagnostic performance of CTCA to detect high risk (3-vessel and/or left main) coronary artery disease was evaluated (Chapter 9). The CTCA accuracy was further studied in women and men at low to intermediate risk of coronary artery disease (Chapter 10). Finally, the influence of gender on the diagnostic accuracy of CTCA was investigated (Chapter 11).      
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a b s t r a c t
Objective: We evaluated the ability of 64-slice multidetector computed tomography (MDCT)-derived
plaque parameters to detect and quantify coronary atherosclerosis, using intravascular ultrasound (IVUS)
as the reference standard.
Methods: In 32 patients, IVUS and 64-MDCT was performed. The MDCT and IVUS datasets of 44 coronary
arteries were co-registered using a newly developed fusion technique and quantitative parameters were
derived from both imaging modalities. The threshold of >0.5mm of maximum wall thickness was used
to establish plaque presence on MDCT and IVUS.
Results:Weanalyzed1364 coregistered1-mmcoronary cross-sections and255 segments of 5-mm length.
Comparedwith IVUS, 64-MDCTenabled correct detection in 957of 1109 cross-sections containingplaque
(sensitivity 86%). In 180 of 255 cross-sections atherosclerosis was correctly excluded (speciﬁcity 71%).
On the segmental level, MDCT detected 213 of 220 segments with any atherosclerotic plaque (sensitivity
96%), whereas the presence of any plaque was correctly ruled out in 28 of 32 segments (speciﬁcity
88%). Interobserver agreement for the detection of atherosclerotic cross-sections wasmoderate (Cohen’s
kappa coefﬁcient K=0.51), but excellent for the atherosclerotic segments (K=1.0). Pearson’s correlation
coefﬁcient for vessel plaque volumesmeasured byMDCT and IVUSwas r=0.91 (p<0.001). Bland–Altman
analysis showed a slight non-signiﬁcant underestimation of any plaque volume by MDCT (p=0.5), with
a trend to underestimate noncalciﬁed and overestimate mixed/calciﬁed plaque volumes (p=0.22 and
p=0.87 respectively).
Conclusion: MDCT is able to detect and quantify atherosclerotic plaque. Further improvement in CT
resolution is necessary for more reliable assessment of very small and distal coronary plaques.
© 2011 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
The detection and accurate quantiﬁcation of coronary plaque
maypotentially improve individualized risk stratiﬁcationandallow
the monitoring of patient’s response to pharmacological treat-
ment. Currently, intravascular ultrasound (IVUS) is considered the
∗ Corresponding author at: Erasmus Medical Center, Departments of Radiol-
ogy and Cardiology, Room Ca 207, ‘s-Gravendijkwal 230, 3015 CE Rotterdam, The
Netherlands. Tel.: +31 623726545; fax: +31 107035482.
E-mail address: elpa98@gmail.com (S.-L. Papadopoulou).
1 Present address: Division of Cardiology, Department of Medicine, Showa Uni-
versity School ofMedicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.
reference method to quantify coronary atherosclerosis [1]. How-
ever, the method is expensive, invasive and involves certain, albeit
minimal risks, which makes it unsuitable for preventive plaque
detection in asymptomatic individuals or routine serial assess-
ment of atherosclerosis. Consequently, the ideal alternative to IVUS
would be a non-invasive method of coronary imaging that enables
accurate assessment of atherosclerotic plaque. Multidetector com-
puted tomography (MDCT) has rapidly emerged as a noninvasive
imaging modality for visualisation of the coronary arteries. Fol-
lowing the advances in MDCT technology and the improvement
of spatial and temporal resolutionwith the introduction of 64-slice
MDCT scanners, numerous studies have conﬁrmed the ability of
the technique to reliably detect and exclude signiﬁcant coronary
disease against invasive angiography [2–7]. The accuracy of detec-
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tion and quantiﬁcation of coronary plaque using MDCT compared
to IVUS has been less extensively investigated and has been based
mainly on qualitative visual plaque detection on MDCT. The aim
of this study was to evaluate the ability of 64-slice CT to detect
and quantify coronary atherosclerosis compared to IVUS, using
similar quantitative parameters on MDCT and IVUS. For this sys-
tematic approachweapplieda fusion technique recentlydeveloped
in our institution [8],which allows us to co-register IVUS andMDCT
images such that cross-sectional images can be compared head-to-
head.
2. Materials and methods
2.1. Patients
Our study comprised patients who were treated in our insti-
tution for acute coronary syndromes between May 2005 and
January 2006. Acute coronary syndrome (ACS) was deﬁned as ST
segment elevation myocardial infarction, non-ST-segment eleva-
tion myocardial infarction (troponin positive) or unstable angina
(troponin negative). Immediately after initial management of the
culprit lesions, thesepatientswereasked toparticipate in theMDCT
study. They were considered for inclusion only if an IVUS pull-
back was performed in one ormore of their coronary arteries other
than the treated vessel, if they had a heart rate lower than 70bpm
during the MDCT acquisition and had no prior coronary bypass
surgery. Exclusion criteria included renal dysfunction (serum cre-
atinine >120mmol/L), contrast allergy and irregular heart rhythm.
The institutional review board of our hospital approved the study,
and all patients provided written informed consent before study
participation.
2.2. MDCT acquisition
All patients underwent CT coronary angiographywith a 64-slice
scanner (Sensation 64, Siemens, Forchheim, Germany), according
to a previously published protocol [4]. Because patients having an
ACSwere already treatedwith intravenous nitrates and b-blockers,
additional medication prior to CT scan was not necessary. Scan
parameters were: gantry rotation time of 0.33 s; 32×2 slices per
rotation; 0.6mm detector collimation; table feed of 3.8mm per
rotation; tube voltage of 120kV; and tube current of 900mAs.
Prospective X-ray tube modulation was not applied. A bolus of
100mL of contrast material (400mgI/mL; Iomeron, Bracco, Milan,
Italy) was injected intravenously at ﬂow rate of 5mL/s. The ini-
tiation of the scan was synchronized to the arrival of contrast
in the coronary arteries by a bolus-tracking technique (threshold
of 100Hounsﬁeld units). The estimated mean effective radiation
dose was 17.0±1.1mSv, using the dose-length product and the
conversion factor k (0.017mSv/mGy/cm). Axial CT images were
reconstructed with a slice thickness of 0.75mm and 0.4mm incre-
ments using a retrospectively ECG gating algorithm to obtain
optimal, motion-free image quality, resulting in a temporal reso-
lution of approximately 165ms and a spatial resolution of 0.4mm.
Optimal data sets with the best image quality were reconstructed
mainly in themid- to end-diastolic phase, using amedium-smooth
convolution kernel, andwere uploaded to anMDCT Picture Archiv-
ing and Communication System.
2.3. IVUS acquisition
The IVUS was performed using standard methodology. One
or more of the coronary arteries of these patients were imaged
by IVUS with commercially available catheter (40MHz, Atlantis
SR Pro, Boston Scientiﬁc, Boston, Massachusetts). After the intra-
coronary administration of 100–200g of nitroglycerine, IVUS
images were acquired using automatic mechanical pullback
devices operating at a continuous pullback speed of 0.5mm/s
[1]. Data were stored on DVD, transformed into the Digi-
tal Imaging and Communication in Medicine image standard,
and archived for ofﬂine analysis with retrospective image-based
gating [9] (axial spacing of gated IVUS images approximately
0.5mm).
2.4. MDCT and IVUS co-registration
Datasets were transferred to an ofﬂine workstation for
further analysis using an in-house developed tool, based
on MeVisLab software (MeVisLab, Mevis, Bremen, Germany,
http://www.mevislab.de). The registration procedure was per-
formed by an independent investigator not involved in the later
comparative analysis, and has been previously described in detail
[8]. Brieﬂy, the process was performed as follows: for each ves-
sel of interest, the stack of ECG-gated IVUS images (axial distance
of approximately 0.5mm) was examined to identify bifurcations,
which were used as landmarks. In order to register the MDCT to
the IVUS images, a vessel centreline was manually drawn in the
MDCT dataset starting from the ostium. Cross-sectional images,
perpendicular to the centreline, were equidistantly generated at
every 0.2mm. The corresponding IVUS-derived landmarks were
identiﬁed on this MDCT image set. After manual registration of the
side branches, cross-sectional MDCT images perpendicular to the
centreline were generated again, but now such that the number
of MDCT images between the landmarks was equal to the number
of IVUS images between the landmarks. For each IVUS image the
position and rotation of the corresponding MDCT image between
the manually registered side branches was determined by linear
interpolation. Therefore, only vessels with at least two bifurcations
identiﬁable on both imaging modalities were co-registered. The
goal of the registration process was to reconstruct cross-sectional
MDCT images of the coronary artery at the same axial position
where the IVUS images were obtained, enabling a head-to-head
comparison between these images.
2.5. MDCT image analysis
For each vessel, the co-registered region of interest (ROI) was
considered for plaque analysis. Both the inner lumen and the outer
vessel boundaries were identiﬁed and manually annotated follow-
ing a stepwise approach. Multiplanar reformatted images were
generated and the lumen and vessel borders were traced longi-
tudinally on at least 3 different vessel views; the intersections
between these longitudinal contours and cross-sectional images
at 1mm intervals were calculated in order to create cross-sectional
contours, which were examined and, if necessary, adjusted by an
experienced observer. The settings for window level and width
were previously optimized by an independent investigator and
ﬁxed at 740HU and 220HU respectively [10] (RengoM., et al. Opti-
mization of window-level settings in CT coronary angiography for
the quantiﬁcation of coronary lumen and plaque; submitted for
publication). The annotation of lumen and the vessel wall bound-
aries was also facilitated by gradient magnitude images, which are
derived from the MDCT images (Fig. 1A and B). They represent the
magnitude of the image intensity gradient vector; the amount of
local change in image intensity. The transition from high intensity
lumen to the low intensity epicardial tissue is depicted in these
images as a bright ridge. The plaque area was calculated by sub-
tracting lumen area from vessel area. Plaques in which ≥50% of
the plaque area was occupied by calciﬁed tissue (in the respective
cross-section) were classiﬁed as calciﬁed, plaques with calciﬁed
tissue occupying <50% as mixed and plaques without any calcium
as non-calciﬁed. Typical example of non-calciﬁed plaque visu-
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Fig. 1. Example of generated cross-sectional MDCT images (1mm interval). Panel (A): in the normal MDCT image, the vessel lumen is brightly enhanced (asterisk), and
a non-calciﬁed, eccentric plaque is visible (arrow). Panel (B): in the gradient MDCT image, the bigger change in image intensity is depicted brighter, which facilitates the
discrimination of borders between tissues with different intensities. Panels (C and D): analyzed normal and gradient image respectively; panel (E): corresponding IVUS
cross-section; panel (F): longitudinal vessel view.
alised by MDCT and IVUS is shown in Fig. 1(C–F). The threshold
of >0.5mmplaque thickness onMDCTwas used to consider plaque
present, similarly to IVUS. Plaque area and % plaque burden (plaque
area/vessel area)measured byMDCTwere also examined as poten-
tial quantitative parameters to detect plaque. A second investigator
also blinded to the IVUS results, performed the same analysis inde-
pendently on 22 randomly selected ROIs.
2.6. IVUS image analysis
IVUS analysis was performed off-line by an experienced car-
diologist, blinded to the MDCT scans. Lumen and external elastic
membrane (EEM) contours were manually traced to determine
lumen area and vessel area using dedicated software (QCU-CMS,
version 4.5, Leiden, the Netherlands). The measurements were
performed according to the American College of Cardiology rec-
ommendations [1] and atherosclerotic plaques were deﬁned as
structures located between the media and the intima with a thick-
ness of at least 0.5mm.
2.7. Comparison between IVUS and 64-MDCT
The MDCT and IVUS annotated contours on the co-registered
ROIs were compared at corresponding positions. The software
determined the lumen area, vessel area and maximum wall thick-
ness for the annotated MDCT contours at 1mm increments and for
the corresponding IVUS contours, whichwere obtained by interpo-
lating the IVUS contours with cubic B-spline interpolation, at the
position derived from the registration. Plaque volumes on MDCT
and IVUS were calculated for the entire ROI by adding plaque vol-
umes of all respective cross-sections, according to Simpson’s rule.
The co-registered ROIs were further divided into 5-mm segments
for the purpose of evaluating diagnostic accuracy ofMDCT to detect
plaque on a segmental level, apart from the cross-sectional level.
2.8. Statistical analysis
Continuous variableswere presented asmeans± standard devi-
ation, unless otherwise indicated, and categorical variables were
reported as frequencies. Differences in baseline characteristics
between patients included in the study and patients excludedwere
evaluated using chi-square test, Fisher’s exact test, and unpaired
Student’s t-test, as appropriate. To take into account the poten-
tial correlation between the multiple cross-sections and segments
derived from the same patient, generalized estimation equation
(GEE)with binary logistic regressionwas applied to obtain patient-
clustered values, adjusted for distance from the ostium and type
of vessel (RCA, LAD or LCX). Adjusted sensitivity, speciﬁcity, pos-
itive predictive value (PPV) and negative predictive value (NPV)
of MDCT to detect plaque were calculated and the 95% conﬁdence
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Table 1
Patient characteristics.
Included Excluded p-Value
Patients n=32 n=14
Age (mean± SD), years 54±10 53±11 0.613
Male gender, n (%) 25 (78) 12 (86) 0.701
Risk factors
Hypertension, n (%) 10 (31) 4 (29) 1.000
Hypercholesterolemia, n (%) 8 (25) 6 (43) 0.301
Diabetes mellitus, n (%) 2 (6) 1 (7) 1.000
Current smoking, n (%) 17 (53) 5 (36) 0.346
Family history of CAD, n (%) 17 (53) 5 (36) 0.346
Obesity, n (%) 5 (16) 3 (21) 0.684
Clinical condition at enrolment
Unstable angina, n (%) 8 (25) 5 (36) 0.493
Acute myocardial infarction, n (%) 24 (75) 9 (64) 0.493
SD, standard deviation; CAD, coronary artery disease.
intervalsweredetermined inaddition to the crude (non-GEEbased)
analyses. Cohen’s kappawas calculated to determine interobserver
agreement. Receiver operating characteristics (ROC) curve analysis
was performed in order to evaluate the ability of quantitative char-
acteristics measured byMDCT to detect plaque, and the area under
the curve (AUC) was calculated. Comparison between plaque vol-
umes was performed using paired Student’s t-test. Correlation and
agreement between MDCT and IVUS measurements were evalu-
atedbyPearson’s correlationcoefﬁcient andBland–Altmananalysis
respectively. The 95% limits of agreement were deﬁned as the
range of values between ±2 standard deviations from the mean
difference. A two-tailed p-value <0.05 was considered statistically
signiﬁcant. The statistical package SPSS 17.0 was used for the anal-
ysis.
3. Results
Forty-seven vessels from 32 patients (mean age: 54±10years)
with MDCT and IVUS of good image quality were successfully co-
registered. From the total study population, 14 patients were not
included in this analysis (4 did not have IVUS imaging, 2 had low
quality IVUS imaging, 4 had low quality MDCT imaging and 4 could
not be co-registered with the fusion technique due to technical
problems, i.e. too few landmarks for matching). The mean time
interval between IVUS and MDCT acquisitions was 4.8±6.0days.
The baseline characteristics of all patients are presented in Table 1.
Three vessels were excluded from further analysis because the
ROI was occupied by long stents, thus 44 vessels were available
for ﬁnal head-to-head comparison [right coronary artery (RCA),
n=10; left anterior descending artery (LAD), n=22; left circum-
ﬂex artery (LCX), n=12]. The mean length of the investigated ROIs
was 31±14mm and comprised a total of 1364 registered 1-mm
cross-sections and 255 segments of 5-mm length.
3.1. Diagnostic performance on cross-sectional level
Presence of atherosclerotic plaque was conﬁrmed by IVUS in
1109 out of the 1364 cross-sections (81.3%). Using the cut-off of
>0.5mm wall thickness, the 64-slice CT enabled a correct detec-
tion of any plaque in 957 of 1109 cross-sections, resulting in a
sensitivity of 86%. Of these detected plaques, 755 were charac-
terized as non-calciﬁed (79%), 115 as mixed (12%) and 83 (1%) as
calciﬁed by MDCT. In 180 of 255 cross-sections, the presence of
atherosclerotic lesionswas correctly ruledout (speciﬁcity 71%). The
75 normal cross-sections misclassiﬁed by MDCT as diseased, were
all incorrectly considered as containing non-calciﬁed plaque. Both
the crude and the adjusted analysis values for diagnostic perfor-
mance are presented in Table 2. Coronary plaques thatweremissed
on MDCT had smaller maximum plaque thickness (0.8mm±0.2
vs. 1.1mm±0.4, p<0.001) and plaque area (5.1mm2 ±1.9 vs.
7.0mm2 ±2.6,p<0.001)by IVUS, compared to thedetectedplaques
(Table 3). The sensitivity of MDCT to detect plaque increased with
plaque size (Fig. 2A), while it decreased with the distance from the
coronary ostium (Fig. 2B), dropping below 80% for plaques located
at 50mmormore from theostium. Logistic regression analysis con-
ﬁrmed that the distance from the ostiumhad a signiﬁcant inﬂuence
on sensitivity (odds ratio 1.38, 95% CI 1.09–1.76, for every 10mm
fromtheostium).Moreover, the typeof vessel hadeffect on theNPV
(odds ratio 2.37, 95% CI 1.04–5.39). Cohen’s kappa coefﬁcient for
the detection of atherosclerotic cross-sections usingMDCT-derived
wall thickness was 0.51, indicating moderate interobserver agree-
ment.
3.2. Cut-off values of MDCT-derived quantitative parameters for
plaque detection
ROC curve analysis for MDCT maximal wall thickness, plaque
area and plaque burden is shown in Fig. 3. TheMDCTmaximal wall
thickness presented non-signiﬁcantly better discriminatory ability
for plaque detection (AUC 0.876) than plaque area (AUC 0.847) and
plaqueburden (AUC0.834). IfMDCTplaque area andplaqueburden
were to be used as quantitative characteristics to detect plaque,
the cut-off values of 3.8mm2 and 35% respectively would provide
a sensitivity exceeding 80% with corresponding speciﬁcity values
of 75% and 68%.
3.3. Diagnostic performance on segmental level
The analysis on a segmental basis revealed that MDCT correctly
detected213of 220 segmentswith anyatherosclerotic plaque (sen-
sitivity 96%), whereas the presence of any plaque was correctly
ruled out in 28 of 32 segments (speciﬁcity 88%). Themajority of the
segments with plaque detected by MDCT contained non-calciﬁed
plaque (154 out of 213, 72%). Mixed plaque was present in 44
segments (21%) and calciﬁed plaque in 15 segments (7%). Four non-
diseased segments were incorrectly characterized as containing
non-calciﬁed plaque. The crude and the adjusted analysis values
for diagnostic performance are shown in Table 2. Mean plaque
Table 2
Diagnostic accuracy of 64-slice MDCT to detect coronary plaque on cross-sectional and segmental level.
Sensitivity Speciﬁcity PPV NPV
Crude analysis
Cross-sections (n=1364) 86.2 (84.0–88.2) 70.6 (64.5–76.0) 92.7 (90.9–94.2) 54.1 (48.5–59.5)
5-mm segments (n=255) 95.5 (91.7–97.7) 87.5 (70.1–96) 98.2 (95.0–99.4) 73.7 (56.6–86.0)
Adjusted analysisa
Cross-sections (n=1364) 86.3 (85.8–86.8) 70.6 (69.8–71.4) 92.7 (92.5–92.9) 54.2 (52.5–55.9)
5-mm segments (n=255) 95.5 (94.8–96.3) 87.5 (84.5–90.5) 98.2 (97.6–98.7) 73.7 (67.3–80.1)
Values are presented as % (95% conﬁdence interval). MDCT, multidetector computed tomography; PPV, positive predictive value; NPV, negative predictive value.
a Patient-clustered and adjusted for distance from the ostium and vessel type.
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Table 3
IVUS quantitative characteristics of MDCT detected vs. not detected coronary plaques.
Detected (true positives) Not detected (false negatives) p-Value
Cross-sections 1mm thickness
n 957 152
Maximum plaque thickness (mm) 1.1±0.4 0.8±0.2 <0.001
Plaque area (mm2) 7.0±2.6 5.1±1.9 <0.001
% plaque burden 47±12 40±11 <0.001
Vessel area (mm2) 15.1±5.0 13.3±5.2 <0.001
Distance from the ostium (mm) 36±13 44±13 <0.001
5-mm segments
n 213 10
Mean plaque area (mm2) 6.7±2.6 4.1±1.5 0.002
Mean plaque volume (mm3) 34±13 21±7 0.002
Mean % plaque burden 45±12 37±10 0.03
IVUS, intravascular ultrasound; MDCT, multidetector computed tomography. Quantitative parameters are presented as means± standard deviation.
area measured by IVUS in the 10 segments with a false-negative
MDCT result was 4.1±1.5mm2 versus 6.7±2.6mm2 (p=0.002) for
the 213 segments with a true-positive MDCT result (Table 3). The
interobserver agreement for the detection of atherosclerotic seg-
ments using MDCT-derived wall thickness was excellent (Cohen’s
kappa=1.0).
3.4. Plaque volume comparison between MDCT and IVUS
Pearson’s correlation coefﬁcient for regional plaque vol-
umes measured by MDCT and IVUS was very good (r=0.91,
Fig. 2. Detection of plaque according to maximum intima thickness by IVUS (panel
A) and according to distance from the coronary ostium (panel B).
Fig. 3. Receiver operating characteristics (ROC) curve analysis of quantitative char-
acteristics measured by 64-slice MDCT.
p<0.001). Bland–Altman analysis showed a slight non-signiﬁcant
underestimation of plaque volume by MDCT (177±101mm3
vs. 181±107mm3, p=0.5; see Fig. 4), with a mean differ-
ence of −4.5mm3 and 95% limits of agreement between −92.7
and 83.7mm3. A sub-analysis per ROI plaque type revealed
that non-calciﬁed plaque volumes (n=19) were systemati-
cally but non-signiﬁcantly underestimated (129.3±88.2mm3 vs.
141.7±93.2mm3, p=0.22). Plaque volume in the mixed/calciﬁed
ROIs (n=25) was slightly overestimated (213.2±96.5mm3 vs.
211.7±108.3mm3, p=0.87).
4. Discussion
In the present study, we evaluated the ability of 64-slice MDCT
to detect and quantify coronary atherosclerotic plaque, based on
MDCT-derived parameters, using IVUS as a reference standard. The
novel fusion technique we applied for the co-registration of IVUS
and MDCT [8] provided cross-sectional images at identical posi-
tions for the whole length of the ROI and enabled a head-to-head
comparison of the 2 imaging modalities.
The main ﬁndings of our study can be summarized as follows:
plaque detection based on the threshold of >0.5mm for MDCT-
derived maximum wall thickness resulted in a reasonably good
diagnostic accuracy on the cross-sectional level (sensitivity 86%,
speciﬁcity 71%), and very good on the segmental level (sensi-
tivity 96%, speciﬁcity 88%). Moreover, the accurate detection of
atherosclerotic plaque depended on plaque and vessel size. Smaller
plaques could not be reliably detected, which was in accordance
with previous reports [11,12]. Plaque location was also playing
an important role for the diagnostic accuracy; the sensitivity sig-
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Fig. 4. Correlation plot (A) and Bland–Altman analyses (B–D) for plaque volumes per vessel determined by IVUS versus 64-slice MDCT.
niﬁcantly decreased for plaques located more distally. Finally,
quantiﬁcation of plaque volumes showed a signiﬁcantly strong
correlation between MDCT and IVUS. The mean differences were
small, with underestimation of non-calciﬁed and overestimation
for mixed/calciﬁed plaque, however the limits of agreement were
relatively wide.
MDCT angiography has the potential to become a non-invasive
alternative to IVUS for plaque quantiﬁcation and to be used for
risk stratiﬁcation of asymptomatic individuals or the assessment
of atherosclerosis progression/regression. Previous studies [13–16]
have focused on the comparison ofMDCT- and IVUS-derived quan-
titative parameters, such as plaque area or plaque burden, showing
moderate to good correlation, but the presence of atherosclerosis
on MDCT was based on binary (yes/no) visual scoring. This is the
ﬁrst study, to our knowledge, that used a MDCT-derived quantita-
tive parameter (wall thickness) to assess diagnostic accuracy on a
slice-by-slice and segmental basis. Our data demonstrated that the
detectionof atherosclerotic plaquebasedonMDCT-derivedquanti-
tative parameters in a similar fashion to IVUS was feasible. Plaques
located within the proximal 40mm were detected with very high
sensitivity (88–100%) and as invasive imaging studies have shown,
the most clinically relevant lesions are highly clustered within the
proximal sections of the coronaries [17–19]. Moreover, the very
good diagnostic accuracy obtained at segmental level is promising
for thepotentialdevelopmentofpredictionmodelsbasedonplaque
presence on a per-segment basis. Nevertheless, it is important to
keep in mind that the clinical use of MDCT for detection of early
atherosclerosis is still limited by the current spatial and temporal
resolution of the technique. Further technical improvements of the
acquisitionand reconstruction techniqueswill enablemore reliable
visualisation of the coronary arteries with better signal-to-noise
ratio and decrease of partial voluming and motion artifacts.
Regarding the quantiﬁcation of plaque volume by MDCT, our
results add to the existing literature which only deals with sta-
ble angina patients. Several researchers compared plaque volumes
derived fromMDCTangiographywith corresponding IVUSdata and
reported strong correlation and moderate agreement [20–25]. The
differences between MDCT and IVUS volumetric measurements,
whichwerealsoobserved inouranalysis, couldbeattributed to sev-
eral technical and methodological factors. The spatial resolution of
64-slice CTmay still be inadequate for accurate edgediscrimination
of MDCT images. The smaller coronary plaques, in particular non-
calciﬁed plaques, cannot be well deﬁned and may occasionally not
be detected, resulting in underestimation of plaque volume. More-
over, the real size of calciﬁed plaque is overestimated by MDCT
due to the blooming effects. Quantiﬁcation of calciﬁed plaque by
IVUS can also be imprecise, because the acoustic shadowing in
areas of calciﬁcation blocks the view of the outer vessel borders. In
addition, on IVUS the outer boundaries were deﬁned by the exter-
nal elastic membrane (EEM), whereas on MDCT the outer vessel
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border was annotated at the adventitia-fat boundary, which may
also have accounted for the discrepancies in the measurements.
Furthermore, the IVUS images are not strictly perpendicular to
the centerline, depending on the catheter position and vessel tor-
tuosity. The slice thickness is slightly different between the two
techniques, but this was largely overcome by the co-registration
technique we used.
5. Limitations
This study was performed on a selected patient population
with acute coronary syndromes and the examined vessels were
only the major epicardial arteries, for which IVUS data were avail-
able. This population presented with high prevalence of disease
and diagnostic accuracy might be lower in populations with lower
prevalence, i.e. asymptomatic patients. In addition, some patients
were excluded, however their characteristics were not different
from the study group, thus we assumed that exclusion of these
patients did not have any major inﬂuence on our study. Fur-
thermore, the ROIs selected for our analysis were free of image
artifacts (for instance causedby coronarymotionornoise),whereas
in everyday clinical routine those artifacts occasionally do occur.
However, contrary to other studies, we have to point out that we
included extensively calciﬁed plaques. In addition, manual plaque
segmentation largely depended on the individual operator and
was rather time consuming; more automated validated software
would be required for MDCT plaque analysis in a routine clinical
setting. Finally, the high radiation exposure during MDCT coro-
nary angiography remains a matter of concern. For this study,
the estimated radiation exposure for the contrast-enhanced scan
without prospective X-ray tube modulation was 17±1mSv; nev-
ertheless, this radiation dose reﬂected the CT technology available
at that time. Signiﬁcant reduction of radiation dose can currently
be achieved by implementation of several dose-saving techniques
[26], which does result in effective dose comparable or lower than
invasive coronary angiography. By applying image reconstruction
algorithms, such as iterative reconstruction [27], supplementary
to other radiation dose-saving techniques, dose reduction can be
achieved with comparable image noise at lower tube currents.
6. Conclusions
The present study demonstrated that 64-MDCT is able to detect
and quantify atherosclerotic plaque using MDCT-derived param-
eters. Further improvement in CT resolution is required for more
reliable assessment of very small and distal coronary plaques.
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Abstract Reproducibility of the quantitative assessment
of atherosclerosis by computed tomography coronary
angiography (CTCA) is paramount for the design of lon-
gitudinal studies. The purpose of this study was to assess
the inter- and intra-observer reproducibility using semiau-
tomated CT plaque analysis software in symptomatic
individuals. CTCA was performed in 10 symptomatic
patients after percutaneous treatment of the culprit lesions
and was repeated after 3 years. The plaque quantitative
analysis was performed in untreated vessels with mild-to-
moderate atherosclerosis and included geometrical and
compositional characteristics using semiautomated CT
plaque analysis software. A total of 945 matched cross-
sections from 21 segments were analyzed independently by
a second reviewer to assess inter-observer variability; the
first observer repeated all the analyses after 3 months to
assess intra-observer variability. The observer variability
was also compared to the absolute plaque changes detected
over time. Agreement was evaluated by Bland–Altman
analysis and concordance correlation coefficient. Inter-
observer relative differences for lumen, vessel, plaque area
and plaque burden were 1.2, 0.6, 2.2, 1.6 % respectively.
Intra-observer relative differences for lumen, vessel, pla-
que area and plaque burden were 1.0, 0.4, 0.2, 0.4 %
respectively. For the average plaque attenuation values the
inter- and intra-observer variability was 5 and 2 %
respectively. For the % low-attenuation-plaque the inter-
and intra-observer variability was 16 and 6 % respectively.
The absolute intra-observer variability for the plaque bur-
den was 1.30 ± 1.09 %, while the temporal plaque burden
difference was 3.55 ± 3.02 % (p = 0.001). The present
study shows that the geometrical assessment of coronary
atherosclerosis by CTCA is highly reproducible within and
between observers using semiautomated quantification
software and that serial plaque changes can be detected
beyond observer variability. The compositional measure-
ments are more variable between observers than geomet-
rical measurements.
Keywords Agreement  Atherosclerosis 
Computed tomography angiography 
Plaque quantification  Reproducibility
Introduction
Coronary atherosclerosis is a worldwide disease with a
burden of 17 million deaths annually [1]. In the past,
quantitative coronary angiography (QCA) [2] and intra-
vascular ultrasound (IVUS) have been used to study the
extent of the disease [3] and monitor the progression/
regression of atherosclerosis. Nevertheless, both imaging
techniques are invasive, expensive and not free of com-
plications, thus unsuitable for routine serial assessment of
atherosclerosis.
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Computed tomography coronary angiography (CTCA)
has been introduced as a noninvasive technique for athero-
sclerotic plaque quantification in vivo. To date, there are
several CTCA studies describing the extent, severity, dis-
tribution, and morphology of coronary atherosclerosis,
including several longitudinal studies assessing plaque pro-
gression/regression by CTCA [4–11].
Reproducibility of measurements is crucial for the
internal validity of longitudinal studies using CTCA; as
previous serial studies using IVUS and CTCA have shown,
the temporal changes in atherosclerotic plaque are small
[11, 12]. The use of semiautomated plaque analysis soft-
ware which can produce accurate and reproducible quan-
titative measurements can facilitate the serial assessment of
atherosclerosis by CTCA. However, only scarce data are
available about the reproducibility of quantitative mea-
surements for geometrical and compositional parameters of
atherosclerotic plaque and a comparison with serial chan-
ges in plaque parameters is lacking.
Therefore, the aims of our study were the following: (1)
to assess the inter-observer and intra-observer agreement of
plaque geometrical measurements using semiautomated
CTCA plaque analysis software; and as secondary objec-
tives (2) to investigate the influence of the variability of the
plaque contours position on the compositional measure-
ments; and (3) to compare the observer variability with the
serial changes in plaque burden and plaque area.
Methods
Patient population
In this exploratory study, the population comprised 10
randomly selected patients (21 segments and 945 cross-
sections) from a prospective cohort of symptomatic
patients; this main cohort included 32 patients with acute
coronary syndromes who underwent CTCA after percuta-
neous treatment of the culprit lesions and follow-up CTCA
after 3 years to assess plaque temporal changes in the
untreated vessels, as part of the PROSPECT MSCT sub-
study in our institution [11]. The institutional review board
approved the study and all patients gave written informed
consent.
CTCA acquisition
All patients received CT coronary angiography at baseline
and 3 years follow-up which was performed using a
64-slice single source scanner (Sensation 64, Siemens
Medical Solutions, Forchheim, Germany) and a 64-slice
dual source CT scanner (Somatom Definition, Siemens
Medical Solutions, Forchheim, Germany) respectively; the
scanning protocol has been previously described in detail
[11]. The patients received nitrates and b-blockers prior to
the scan provided there were no contraindications. The CT
angiographic scan parameters were: (1) for the single
source CT scanner a gantry rotation time of 330 ms;
32 9 2 slices per rotation; 0.6 mm detector collimation;
spiral scan mode with a table feed of 3.8 mm per rotation; a
tube voltage of 120 kV; and tube current of 900 effective
mAs. A bolus of 100 mL of contrast material (400 mgI/
mL; Iomeron, Bracco, Milan, Italy) was injected intrave-
nously at 5 mL/s flow rate followed by a saline chaser. The
initiation of the scan was synchronized to the arrival of
contrast in the coronary arteries by a bolus-tracking tech-
nique; (2) for the dual source CT scanner 32 9 2 9
0.6 mm collimation with z-flying focal spot for both
detectors, gantry rotation time 330 ms, tube voltage
120 kV and tube current of 320–412 mAs per rotation. A
bolus of iodinated contrast material (370 mgI/mL, Ultra-
vist; Schering, Berlin, Germany), which varied between 60
and 100 mL, depending on the expected scan time, was
injected intravenously (flow rate 5.5 mL/s) followed by a
40 mL saline chaser at the same injection rate. A bolus
tracking technique was used to synchronize the arrival of
contrast in the coronary arteries and the start of the
acquisition. The mean effective radiation dose was
14.0 ± 0.8 mSv for the baseline and 10.4 ± 3.0 mSv for
the follow-up scan, using the dose-length product and a
conversion factor k (0.014 mSv/mGy/cm) [13]. For all
datasets, axial images were reconstructed using retrospec-
tive ECG-gating, with a slice thickness of 0.75-mm, slice
increment of 0.4-mm and a medium-to-smooth convolution
kernel (filtered back projection method). Optimal datasets
with the best image quality were reconstructed mainly in
the mid- to end-diastolic phase.
CTCA image analysis
All datasets (baseline and follow-up) were transferred to an
offline workstation for analysis using semi-automated
plaque analysis software (QAngioCT Research Edition
v1.3.61, Medis Medical Imaging Systems, Leiden, The
Netherlands) [14]. An experienced observer (3 years
CTCA experience) blinded to the sequence of imaging
analyzed all the scans of the main study cohort; the com-
plete results of this temporal analysis have been previously
published [11]. To examine inter-observer variability of
plaque analysis a second observer (1 year CTCA experi-
ence) performed blindly the analysis on 21 segments from
10 randomly selected patients at the follow-up time point,
starting completely from the raw datasets; to examine the
intra-observer variability, the first reader re-analyzed all
the segments in a similar blinded fashion 3 months after
his/her original analysis.
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The major vessels (LAD, LCX, RCA) were considered
for analysis using the modified 17-segment American Heart
Association model for coronary segment classification
[15]. The segments were carefully matched for all the
comparisons using the bifurcations carina as landmarks.
The segments of poor quality due to stack or movement
artifacts, or severe calcification (with blooming artifacts
preventing reliable assessment of the lumen) were exclu-
ded from analysis.
Definition of the inner lumen and outer vessel areas was
performed semi-automatically following a stepwise
approach. First, a centerline originating from the ostium was
automatically extracted after an ostial proximal point and a
distal point were placed by the observer; then straightened
multi-planar reformatted images were generated and the
lumen and vessel borders were detected longitudinally in 4
different longitudinal cutplanes by the software and then
corrected by the observer. Based on these updated longitu-
dinal contours, cross-sectional images at 0.5 mm intervals
were calculated in order to create transversal lumen and
vessel wall contours, which were examined and, if necessary,
adjusted by the observer (Fig. 1). Gradient magnitude ima-
ges, which are derived from the CTCA images and display
the degree of CT density change, were used to verify the
lumen and vessel wall borders.
The following quantitative parameters were derived per
cross-section: the lumen area, the lumen diameter, the
vessel area and the plaque burden [(plaque area/vessel
area) * 100]. The plaque area was calculated by subtract-
ing lumen area from vessel area. Geometrical parameters
determined on a segmental level included the following:
the mean lumen area, the mean vessel area, the mean
plaque area, the plaque burden, the minimal lumen diam-
eter (MLD) and the minimal lumen area (MLA). The mean
areas were the averaged measurements of all cross-sections
for each segment. Furthermore, the plaque composition
was evaluated in each cross-section and in each coronary
segment based on attenuation values in HU (Hounsfield
Units); the mean HU and the % of voxels with attenuation
values \30 HU (representing low attenuation plaque—
%LAP) were calculated for each cross-section and each
coronary segment.
Observer variability and detected plaque changes
over time
In order to investigate whether the observer variability
using semi-automated analysis software is acceptable for
monitoring the longitudinal plaque changes over time, we
compared the absolute plaque change with the absolute
observer variability for each segment. In this way by
comparing the absolute differences, we can investigate
whether the magnitude of observer variability is smaller
than the magnitude of the plaque changes, while the
direction of the change (positive/negative) is irrelevant to
the comparison.
Statistical analysis
Continuous variables are presented as mean ± SD or
median (interquartile range—IQR) if not normally dis-
tributed. Discrete variables are presented as counts and/or
percentages. The analyses were performed on both cross-
sectional and segmental level. The inter-observer and intra-
observer agreement were assessed using the Lin’s con-
cordance correlation coefficient [CCC with the 95 % con-
fidence interval (CI)] [16]; Bland–Altman analysis [17]
was performed by plotting the mean against the difference
in measurements. Limits of agreement were determined by
adding 1.96 standard deviations to the mean difference for
the upper limit and by subtracting 1.96 standard deviations
from the mean difference for the lower limit. The paired
t test was used to compare the absolute plaque change with
the absolute observer variability. A two-sided p value of
less than 0.05 was used to indicate statistical significance.
Statistical analyses were performed with SPSS 17.0
software (SPSS, Chicago IL).
Results
The baseline characteristics of the included patients
(n = 10) are as follows: mean age was 56 ± 4 and 80 %
were male. Regarding cardiac risk factors, 40, 10, and 50 %
had hypertension, diabetes mellitus, and hyperlipidemia,
respectively. The untreated vessels were examined (n = 19)
and the ones with low image quality (due to motion or stack
artifacts or extremely calcified coronary arteries) were
excluded (n = 8). The analyzed vessels were the left anterior
descending (n = 4, 36 %), the left circumflex (n = 4, 36 %)
and the right coronary artery (n = 3, 27 %).
Inter-observer agreement
For the assessment of the inter-observer agreement, 945
matched cross-sections from 21 paired coronary segments
were analyzed separately by 2 independent observers.
At the cross-sectional level, the mean differences for
geometrical parameters were small (Table 1a), with narrow
limits of agreement between observers (limits of agreement
for lumen, vessel, plaque and plaque burden measurements
of 2.39, -2.03 mm2; 2.81, -2.99 mm2; 2.86, -3.41 mm2;
and 9.44, -11.10 %, respectively). The Bland–Altman
analysis is shown in Fig. 2. The concordance correlation
coefficients were high (Table 2a), except for the maximal
plaque thickness (CCC: 0.65). For the compositional
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analysis as expressed by the plaque attenuation values
(Table 3a), the median (IQR) difference of the attenuation
between observers was 6 (-4, 22) HU, which corresponds
to a median of 5 % variability. The median (IQR) differ-
ence of the %LAP was -1.6 (-6.3, 2.1), which corre-
sponds to a median of 16 % inter-observer variability.
At the segmental level, the mean differences for
geometrical parameters were also small (Table 1b), with
narrow limits of agreement between observers (limits of
agreement for lumen, vessel, plaque and plaque burden
measurements of 1.12, -0.76 mm2; 1.10, -1.26 mm2;
0.94, -1.46 mm2; and 3.64 %, -5.50 % respectively). The
concordance correlation coefficients were high (Table 2b).
For the compositional analysis as expressed by the plaque
attenuation values (Table 3a), the median (IQR) difference
of the attenuation between observers was 4 (-9, 9) HU,
which corresponds to a median of 4 % variability. The
median (IQR) difference of the %LAP was -1.7 (-3.9,
1.2), which corresponds to a median of 12 % inter-observer
variability.
Intra-observer agreement
For the assessment of the intra-observer agreement, 945
matched cross-sections from 21 paired coronary segments
were fully re-analyzed by the first observer after 3 months.
At the cross-sectional level, the mean differences for
geometrical parameters were small (Table 4a), with narrow
limits of agreement between the two rounds of analysis
(limits of agreement for lumen, vessel, plaque and plaque
burden measurements of 1.62, -1.77 mm2; 2.33,
-2.54 mm2; 2.59, -2.66 mm2; and 7.49 %, -7.15 %
respectively). The Bland–Altman analysis is shown in
Fig. 3. The concordance correlation coefficients were high
(Table 5a). For the compositional analysis as expressed by
the plaque attenuation values (Table 3b), the median (IQR)
difference of the attenuation between the two rounds of
analysis was 2 (-5, 11) HU, which corresponds to a median
of 2 % variability. The median (IQR) difference of the
%LAP was -0.7 (-3.9, 2.2), which corresponds to a median
of 6 % intra-observer variability.
Fig. 1 Example of quantitative analysis of a left anterior descending artery. The analyzed cross-sections at 3 different levels are also shown
(panels a–c)
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At the segmental level, the mean differences for
geometrical parameters were small (Table 4b), with
narrow limits of agreement between the two rounds of
analysis (limits of agreement for lumen, vessel, plaque and
plaque burden measurements of 0.83, -0.91 mm2; 0.67,
-0.81 mm2; 0.83, -0.89 mm2; and 3.55 %, -3.15 %
respectively). The concordance correlation coefficients
were very high (Table 5b). For the compositional analysis
as expressed by the plaque attenuation values (Table 3b),
the median (IQR) difference of the attenuation between the
two rounds of analysis was 1 (-1, 5) HU, which corre-
sponds to a median of\1 % variability. The median (IQR)
difference of the %LAP was -0.6 (-1.6, 0.3), which
corresponds to a median of 3 % intra-observer variability.
Table 1 Inter-observer
variability of geometrical
measurements
CSA cross-sectional area, SD
standard deviation
Parameters Observer 1 Observer 2 Mean absolute
difference ± SD
Mean relative
difference (%)
(a). Matched cross-sections (n = 945)
Lumen CSA (mm2) 9.08 ± 4.27 9.26 ± 4.44 0.18 ± 1.13 1.2
Lumen diameter (mm) 3.31 ± 0.77 3.34 ± 0.80 0.03 ± 0.19 0.6
Vessel CSA (mm2) 19.96 ± 5.65 19.87 ± 5.71 0.09 ± 1.48 0.6
Plaque CSA (mm2) 10.88 ± 2.84 10.61 ± 2.61 0.27 ± 1.60 2.2
Plaque burden (%) 56.07 ± 10.54 55.24 ± 10.83 0.83 ± 5.24 1.6
Plaque max. thickness (mm) 1.15 ± 0.36 1.10 ± 0.39 0.05 ± 0.26 5.5
(b). Matched segments (n = 21)
Average lumen CSA (mm2) 8.92 ± 3.90 9.09 ± 4.10 0.18 ± 0.48 1.3
Average vessel CSA (mm2) 19.64 ± 5.54 19.56 ± 5.62 0.08 ± 0.60 0.6
Average plaque CSA (mm2) 10.73 ± 2.29 10.47 ± 2.20 0.26 ± 0.61 2.4
Plaque burden (%) 56.15 ± 7.97 55.22 ± 8.61 0.93 ± 2.33 1.9
Minimum lumen area (mm2) 6.12 ± 2.80 6.33 ± 3.18 0.21 ± 0.62 1.4
Minimum lumen diameter (mm) 2.72 ± 0.64 2.76 ± 0.71 0.03 ± 0.12 0.7
Fig. 2 Bland-Altman plots of inter-observer comparisons for lumen, vessel, plaque area and plaque burden
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Comparison of the observer variability with the plaque
serial changes
For the 21 segments included in the reproducibility anal-
ysis, the absolute change (irrespectively of progression or
regression) in mean plaque area between the two time
points was 1.65 ± 1.42 mm2 and the absolute change in %
plaque burden was 3.55 ± 3.02 %.
The absolute intra-observer variability for these
parameters was significantly smaller than the serial plaque
changes (0.36 ± 0.24 mm2, p \ 0.001 for mean plaque
area and 1.30 ± 1.09 %, p = 0.001 for plaque burden).
The absolute inter-observer variability for these
parameters was also smaller than the serial plaque changes
(0.51 ± 0.41 mm2, p \ 0.001 for mean plaque area and
1.99 ± 1.49 %, p = 0.044 for plaque burden).
Discussion
The purpose of this study was to assess in detail the inter-
and intra-observer reproducibility of plaque geometrical
and compositional parameters using dedicated semiauto-
mated CT plaque analysis software in vessels with mild-to-
moderate atherosclerosis. To our knowledge this is the first
Table 2 Correlation between different observers for geometrical and
compositional parameters
Geometrical and compositional parameters CCC 95 % CI
(a) Cross-sectional basis
Lumen area (mm2) 0.97 0.966–0.974
Lumen diameter (mm) 0.97 0.969–0.976
Vessel area (mm2) 0.97 0.964–0.972
Plaque area (mm2) 0.83 0.810–0.849
Plaque burden (%) 0.89 0.872–0.899
Maximal plaque thickness (mm) 0.65 0.615–0.688
Mean plaque attenuation (HU) 0.85 0.837–0.869
% LAP 0.65 0.608–0.680
(b) Segmental basis
Mean lumen area (mm2) 0.99 0.988–0.998
Mean vessel area (mm2) 0.99 0.986–0.998
Mean plaque area (mm2) 0.96 0.902–0.983
Plaque burden (%) 0.96 0.913–0.983
Minimal lumen area (mm2) 0.98 0.952–0.988
Minimal lumen diameter (mm) 0.98 0.968–0.992
Mean plaque attenuation (HU) 0.73 0.526–0.855
% LAP 0.73 0.490–0.865
CCC concordance correlation coefficient, CI confidence interval, LAP
low attenuation plaque
Table 3 Reproducibility of compositional measurements
Observer 1 Observer 2 Mean absolute
difference ± SD
Median absolute
difference (IQR)
Median relative
difference (%)
(a). Between different observers
Cross-sections (n = 945)
Average attenuation (HU) 124 ± 45 135 ± 52 11 ± 25 6 (-4, 22) 5.1
LAP (%) 12.7 ± 8.2 10.5 ± 8.7 2.2 ± 6.9 -1.6 (-6.3, 2.1) 16.4
Segments (n = 21)
Average attenuation (HU) 125 ± 26 136 ± 39 12 ± 22 4 (-9, 9) 4.3
LAP (%) 13.1 ± 5.6 10.6 ± 7.3 2.6 ± 4.2 -1.7 (-3.9, 1.2) 12.4
Observer 1
(1st time)
Observer 1
(2nd time)
Mean absolute
difference ± SD
Median absolute
difference (IQR)
Median relative
difference (%)
(b). Between the 2 rounds of the same observer
Cross-sections (n = 945)
Average attenuation (HU) 124 ± 45 126 ± 46 4 ± 22 2 (-5, 11) 1.6
LAP (%) 12.7 ± 8.2 12.1 ± 8.1 -1.0 ± 5.4 -0.7 (-3.9, 2.2) 6.1
Segments (n = 21)
Average attenuation (HU) 125 ± 26 127 ± 27 2 ± 5 1 (-1, 5) 0.5
LAP (%) 13.1 ± 5.5 12.4 ± 5.6 -0.7 ± 1.4 -0.6 (-1.6, 0.3) 2.5
IQR interquartile range, LAP low attenuation plaque, SD standard deviation
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study in which the observer variability is compared with
actual serial changes in atherosclerotic plaque size. The
main findings of the present study were as follows: (1) the
CTCA geometrical measurements were highly reproduc-
ible in both intra- and inter-observer comparisons; (2) the
compositional measurements were indeed more variable
than geometrical measurements, and mostly influenced by
the inter-observer variability; and (3) the intra- and inter-
observer variability were lower than the detected changes
in plaque burden and plaque area after 3 years.
Over the recent few years, CTCA has been more com-
monly used as a tool to non-invasively assess the temporal
Table 4 Intra-observer
variability of geometrical
measurements
CSA cross-sectional area, SD
standard deviation
Parameters Observer 1
(1st time)
Observer 1
(2nd time)
Mean absolute
difference ± SD
Mean relative
difference (%)
(a). Matched cross-sections (n = 945)
Lumen CSA (mm2) 9.08 ± 4.27 9.00 ± 4.19 0.08 ± 0.87 1.0
Lumen diameter (mm) 3.31 ± 0.77 3.30 ± 0.77 0.01 ± 0.15 0.5
Vessel CSA (mm2) 19.96 ± 5.65 19.85 ± 5.49 0.11 ± 1.24 0.4
Plaque CSA (mm2) 10.88 ± 2.84 10.85 ± 2.53 0.03 ± 1.34 0.2
Plaque burden (%) 56.07 ± 10.54 56.23 ± 10.33 0.17 ± 3.74 0.4
Plaque max. thickness (mm) 1.15 ± 0.36 1.16 ± 0.37 0.01 ± 0.24 0.7
(b). Matched segments (n = 21)
Average lumen CSA (mm2) 8.92 ± 3.90 8.87 ± 3.85 0.04 ± 0.44 0.8
Average vessel CSA (mm2) 19.64 ± 5.54 19.57 ± 5.44 0.07 ± 0.38 0.3
Average plaque CSA (mm2) 10.73 ± 2.29 10.70 ± 2.12 0.03 ± 0.44 0.1
Plaque burden (%) 56.15 ± 7.97 56.35 ± 8.16 0.20 ± 1.71 0.4
Minimum lumen area (mm2) 6.12 ± 2.80 5.93 ± 2.82 0.20 ± 0.69 4.1
Minimum lumen diameter (mm) 2.72 ± 0.64 2.63 ± 0.67 0.09 ± 0.24 3.7
Fig. 3 Bland-Altman plots of intra-observer comparisons for lumen, vessel, plaque area and plaque burden
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effect of medical therapies on coronary plaque size in
longitudinal studies [4–11]. Moreover, this method has the
potential to assess plaque composition and therefore to
assess the effect of drug therapies on the phenotype of
coronary atherosclerosis. As the impact of medical treat-
ment on the atherosclerotic plaque size and composition
over time is relatively small, highly reproducible CTCA
quantitative measurements are pivotal.
Geometrical measurements
In the present study, the CTCA geometrical measurements
were highly reproducible in both intra- and inter-observer
comparisons. Furthermore, in comparison with IVUS
studies, the CTCA reproducibility appears to be compara-
ble or better (Table 6). This improved reproducibility could
be partly attributed to the semi-automated manner of the
contouring in CTCA analysis. Another important consid-
eration is the methodology for the actual analysis, since in
CTCA all frames were analyzed in a stepwise approach;
first the lumen and vessel wall borders were delineated as
continuous lines in the longitudinal view (L-view). These
contour positions functioned as landmarks for the auto-
mated contour detection in the individual cross sections; a
visual inspection was performed in every cross-section and
a manual correction was applied if necessary. In contrast,
in IVUS only the individual cross-sections are drawn
without the first step (i.e. longitudinal drawing). An addi-
tional issue is the fact that in CTCA all frames of the
analyzed vessel are taken from the same cardiac cycle
phase, whereas in IVUS this varies from cross-section to
cross-section. In other words, in IVUS the frames are not
only scrambled images (due to the longitudinal movement
of the catheter inside the vessel), but also they are taken at
fixed distances (i.e. 0.5–1.0 mm) irrespective of the cardiac
cycle phase.
The moderate concordance correlation coefficient
between observers for the maximal wall thickness can be
mostly attributed to the fact that this parameter depends
highly on the shape of the lumen and vessel contour; a
small ‘‘bump’’ in one of the contours would not cause a
large difference in the area measurement but could sub-
stantially influence the plaque thickness.
Compositional measurements
Regarding the plaque composition, overall the differences
of the average plaque attenuation between observers were
very small on the cross-sectional and segment level anal-
yses. Despite this finding, the %LAP (\30 HU) showed a
relatively high inter-observer variability of 12 %, which is
of major significance since the temporal change of such
component could potentially become an imaging endpoint
of longitudinal studies. The LAP is probably the most
clinically relevant component of coronary plaques as it has
been shown to correlate closely with plaques of low ech-
ogenicity (presumably lipid rich) on IVUS [18] and to have
prognostic value for the development of acute coronary
syndromes [19]. On the other hand, the intra-observer
variability for %LAP was low (median 3 % approxi-
mately), which underlines the fact that the position of the
plaque contours can play a detrimental role in the distri-
bution of attenuation values. Small differences in the
lumen or vessel wall delineation would not dramatically
influence the geometrical measurements, but they could
result in much bigger differences in the compositional
measurements due to partial volume, i.e. in case part of the
lumen or the pericoronary fat is incorrectly included in the
plaque area.
Implications for the design of longitudinal studies
In the present study, the observer variability was lower than
the serial changes in plaque burden—the most common
endpoint in IVUS progression/regression studies. This
finding suggests that CTCA data analysis using semiauto-
mated software can detect changes in atherosclerotic pla-
que size beyond the observer bias. Certainly, the best
approach is that the same analyst analyzes in a blind
fashion both the baseline and follow-up CTCA images,
Table 5 Correlation between the 2 rounds of the same observer for
geometrical and compositional parameters
Geometrical and compositional parameters CCC 95 % CI
(a). Cross-sectional basis
Lumen area (mm2) 0.98 0.976–0.981
Lumen diameter (mm) 0.98 0.978–0.983
Vessel area (mm2) 0.98 0.972–0.980
Plaque area (mm2) 0.88 0.860–0.889
Plaque burden (%) 0.94 0.927–0.943
Maximal plaque thickness (mm) 0.79 0.762–0.810
Mean plaque attenuation (HU) 0.95 0.938–0.952
% LAP 0.82 0.798–0.840
(b). Segmental basis
Mean lumen area (mm2) 0.99 0.984–0.997
Mean vessel area (mm2) 0.99 0.994–0.999
Mean plaque area (mm2) 0.98 0.956–0.991
Plaque burden (%) 0.98 0.945–0.991
Minimal lumen area (mm2) 0.97 0.923–0.987
Minimal lumen diameter (mm) 0.93 0.826–0.968
Mean plaque attenuation (HU) 0.98 0.945–0.990
% LAP 0.96 0.909–0.984
CCC concordance correlation coefficient, CI confidence interval, LAP
low attenuation plaque
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since the difference is much lower in the intra-observer
comparison for both the cross-sectional and segment based
analyses than in the inter-observer comparison; more
importantly, for the compositional measurements only the
intra-observer variability was below the generally accept-
able threshold of 10 %.
It should be noted that the present study was conducted on
a population with mild-to-moderately diseased arteries
receiving contemporary medical therapy. This was driven by
the intention to study the reproducibility of this quantitative
method on patients that would be the most suitable candi-
dates for serial assessment of atherosclerosis in the ‘‘real
life’’; since the severe lesions would have been treated with
percutaneous coronary intervention, the efficacy of the statin
therapy would be monitored mainly in the untreated, mild-
to-moderately diseased atherosclerotic arteries.
Limitations
The studied population was small in terms of patients
included; nevertheless the geometric and compositional
analysis was performed on 945 matched cross-sections.
Furthermore, our analysis was restricted to good quality
images, which is a prerequisite for such precise CTCA
quantitative analysis. We did not control for patients’ char-
acteristics in the 3 year longitudinal study. Finally, the
analyzed vessels belong to a cohort of patients with mild-to-
moderately diseased arteries, thus our results may not apply
to other patient populations with different extent of disease;
however the patients used for this study would mostly benefit
from the serial assessment of atherosclerosis.
Conclusions
Considering the small changes in atherosclerotic plaque
over time, reproducibility of measurements is paramount
for the validity of longitudinal studies. The present study
shows that the geometrical assessment of coronary ath-
erosclerosis by CTCA is highly reproducible within and
between observers using semiautomated quantification
software. The compositional measurements were more
variable than geometrical measurements, especially
between different observers. The absolute observer vari-
ability was lower than the absolute detected serial changes
in plaque burden and plaque area after 3 years.
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O B J E C T I V E S This study sought to analyze the natural history of coronary atherosclerosis by
multislice computed tomography (MSCT) and assess the serial changes in coronary plaque burden,
lumen dimensions, and arterial remodeling.
B A C KG ROUND MSCT can comprehensively assess coronary atherosclerosis by combining lumen
and plaque size parameters.
METHOD S Thirty-two patients with acute coronary syndromes underwent 64-slice computed
tomography angiography after percutaneous coronary intervention at baseline and after a median of 39
months. All patients received contemporary medical treatment. All available coronary segments in every
subject were analyzed. The progression of atherosclerosis per segment and per patient was assessed by
means of change in percent atheroma volume (PAV), change in normalized total atheroma volume
(TAVnorm), and percent change in TAV (% change in TAV). Serial coronary remodeling was also assessed.
Measures of lumen stenosis included percent diameter stenosis (%DS), minimum lumen diameter (MLD),
percent area stenosis (%AS), and minimum lumen area (MLA). For each patient, the mean of all matched
segments was calculated at the 2 time points. Clinical events at follow-up were documented.
R E S U L T S The PAV did not change signiﬁcantly (0.15  3.64%, p  0.72). The mean change in
TAVnorm was 47.36 143.24 mm3 (p 0.071), and the % change in TAV was 6.7% (p 0.029). The MLD
and MLA increased by 0.15 mm (0.09 to 0.24, p  0.039) and 0.52 mm2 (0.38 to 1.04, p  0.034)
respectively, which was accompanied by vessel enlargement, with 53% of the patients showing
expansive positive remodeling. Patients with clinical events had a larger TAVnorm at baseline (969.72
mm3 vs. 810.77 mm3, p  0.010).
CONC L U S I O N S MSCT can assess the progression of coronary atherosclerosis and may be used for
noninvasive monitoring of pharmacological interventions in coronary artery disease. (PROSPECT: An
Imaging Study in Patients With Unstable Atherosclerotic Lesions; NCT00180466) (J Am Coll Cardiol Img
2012;5:S28–37) © 2012 by the American College of Cardiology Foundation51
oronary atherosclerosis is a worldwide
pandemic disease and accounts for almost
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52C 17 million deaths annually (1). Althoughquantitative coronary angiography (QCA
has been used in the past to study the extent of th
disease (2), this technique can only depict th
contrast-enhanced lumen, whereas atheroscleroti
disease of the arterial wall does not necessarily resul
in narrowing of the vessel lumen. Currently, th
preferred method to study atherosclerosis is b
intracoronary, cross-sectional imaging methods
such as intravascular ultrasound (IVUS) (3). Ther
are numerous serial studies on atherosclerosis pro
gression/regression by QCA and IVUS, includin
randomized medical trials using imaged plaqu
modification as surrogate endpoints. However, QCA
and IVUS are invasive and costly and are not free o
complications and thus are not used for routin
serial assessment of atherosclerosis.
On the other hand, multislice computed tomog
raphy (MSCT) can assess coronary plaque in
noninvasive manner. MSCT coronary angiograph
has emerged as a noninvasive technique for th
detection of coronary artery disease and has dem
onstrated good accuracy for the detection of coro
nary artery stenosis (4,5). Furthermore, studies in
patients undergoing both IVUS and MSCT sup
port the feasibility of MSCT to assess atheroscle
rotic plaque burden, remodeling, eccentricity, and
calcified and noncalcified plaque in both stable and
unstable patients (6–8).
Although a few serial studies with MSCT hav
been published (9–15), most prior analyses wer
confined to a small segment of the coronary tree o
a specific subset of lesions (i.e., noncalcified). In th
present study, our objective was to study the natura
history of coronary atherosclerosis along the ful
length of the coronary tree by MSCT and to asses
the serial changes in coronary plaque size, lumen
dimensions, and arterial remodeling.
M E T H O D S
Study population. We prospectively included pa
tients who were enrolled at the Erasmus Medica
Center in the PROSPECT (Providing Regiona
Observations to Study Predictors of Events in th
Coronary Tree) study (16). PROSPECT was de
signed to identify nonobstructing lesions with an
increased risk for future acute coronary events in
patients presenting with acute coronary syndrome
(ACS) using IVUS and serological markers o
inflammation. ACS was defined as ST-segmenor unstable angina with ECG changes (troponin
negative). As a substudy of the multicenter study
we additionally performed contrast-enhanced com
puted tomography (CT) coronary angiography t
noninvasively evaluate the extent of coronary ath
erosclerosis at baseline and at 3 years’ follow-up
Patients were considered for inclusion in th
MSCT substudy only if they had a heart rate lowe
than 70 beats/min during the MSCT acquisition
and had no prior coronary bypass surgery. Exclusion
criteria included impaired renal function (serum
creatinine 120 mmol/l), contrast allergy, and ir
regular heart rhythms. Levels of fasting lipids wer
measured at baseline and follow-up. Med-
ication use (including statins) after dis-
charge was according to standard of care.
The institutional review board of our hos-
pital approved the study, and all patients
provided written informed consent before
study participation.
MSCT acquisition. At baseline, all patients
underwent CT coronary angiography with
a 64-slice scanner (Sensation 64, Siemens
Medical Solutions, Forchheim, Germany).
Because patients in the acute phase of
ACS were already treated with intrave-
nous nitrates and beta-blockers, additional
medication before CT scan was not nec-
essary. Scan parameters were as follows: a
gantry rotation time of 330 ms, 32 2 slices
per rotation, 0.6-mm detector collimation,
spiral scan mode with a table feed of 3.8
mm per rotation, a tube voltage of 120 kV,
and tube current of 900 effective mAs.
Prospective ECG-triggered x-ray tube
modulation was not applied. A bolus of
100 ml of contrast material (400 mg/ml; Iomeron
Bracco, Milan, Italy) was injected intravenously at
ml/s flow rate followed by a saline chaser. Th
initiation of the scan was synchronized to the arrival o
contrast in the coronary arteries by a bolus-trackin
technique. The mean effective radiation dose was 14.0
0.8 mSv, using the dose-length product and
conversion factor k (0.014 mSv/mGy/cm) (17)
Axial CT images were reconstructed with a slic
thickness of 0.75-mm and 0.4-mm increment
using a retrospective ECG gating algorithm t
obtain optimal, motion-free image quality. Optima
datasets with the best image quality were recon
structed mainly in the mid- to end-diastolic phase
using a medium-smooth convolution kernel.
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The follow-up scan was performed after 3 years,
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Germany). Sublingual nitroglycerin was adminis
tered before the scan (0.4 mg/dose) provided tha
there were no contraindications, and pre-scan beta
blockers were given to patients with high heart rates7
beats/min. The CT angiographic scan parameter
were as follows: 32  2  0.6 mm collimation with
z-flying focal spot for both detectors, gantry rota
tion time of 330 ms, tube voltage of 120 kV, and
tube current of 320 to 412 mAs per rotation. A
bolus of iodinated contrast material (370 mg/ml
Ultravist, Schering, Berlin, Germany), which varied
between 60 and 100 ml, depending on the expected
scan time, was injected intravenously (flow rate 5.
ml/s) followed by a 40-ml saline chaser at the sam
injection rate. A bolus tracking technique was used
to synchronize the arrival of contrast in the coronar
arteries and the start of the acquisition. A spira
scan protocol with prospective ECG-triggered
x-ray tube modulation and variable table feed de
pending on the heart rate was applied. The esti
mated mean effective radiation dose was 10.0  3.
mSv. Axial images were reconstructed using retro
spective ECG gating, with a slice thickness of 0.75
mm, slice increment of 0.4-mm, and medium-to
Figure 1. Multislice Computed Tomography Angiography Ana
Example of vessel analyzed at baseline (A) and 3-year follow-up (
cross-sections shown at the bottom of the ﬁgure (from proximal t
tently from baseline to follow-up in the 5 cross-sections analyzedthe mid- to end-diastolic phase.
MSCT analysis. All datasets were transferred to an
offline workstation for analysis using a semiauto
mated plaque analysis software (QAngioCT Re
search Edition version 1.1.8, Medis Medical Imag
ing Systems, Leiden, the Netherlands) (18). An
experienced observer blinded to the sequence o
imaging evaluated the scans. Planimetry of th
inner lumen and outer vessel areas was performed
following a stepwise approach. First, a centerlin
originating from the ostium was automatically ex
tracted; then straightened multiplanar reformatted
images were generated, and the lumen and vesse
borders were detected longitudinally on 4 differen
vessel views by the software. On the basis of thes
longitudinal contours, cross-sectional images a
0.5-mm intervals were calculated in order to creat
transversal lumen and vessel wall contours, which
were examined and, if necessary, adjusted by an
experienced observer (Fig. 1). The settings fo
window level and width were fixed at 740 HU and
220 HU, respectively. Gradient magnitude images
which are derived from the MSCT images and
display the degree of CT density change, were used
both panels, 5 lines indicate the location in the vessel of the
istal). In this lesion, the plaque burden (PB, %) decreases consis-lysis
B). In
o d
.53
to facilitate detection of lumen and vessel wall
borders.
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baseline to 3 years) of 10% for %DS and 0.2 mm for
MLD (20).
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54All 3 vessels were assessed in every patient usin
the modified 17-segment American Heart Associ
ation model for coronary segment classification
(19). Only the major epicardial vessels were consid
ered for analysis (segments 1, 2, 3, 6, 7, 8, 11, 13
and 15). All anatomically available segments with
out implanted stents were examined; the segment
of poor quality due to stack or movement artifact
or extreme calcification were excluded from analy
sis, as well as the segments distal to stents.
The following parameters were derived per seg
ment: the mean lumen area, the mean vessel area
the mean percent plaque burden, the minimum and
maximum lumen diameter, and the minimum and
maximum lumen area. The mean areas were th
averaged measurements of all cross-sections fo
each segment. The mean plaque area was calculated
by subtracting mean lumen area from mean vesse
area, and the plaque volume was calculated for ever
segment by using the mean segment length from
the 2 time points (3). Furthermore, the composition
of each coronary segment was semiquantitativel
evaluated: Each individual cross-section was binar
labeled for the presence of calcium (yes/no), and th
degree of calcification was assessed as a percent o
the segment length (number of frames containin
calcium/total number of frames in the segment). T
examine inter- and intra-observer variability, a sec
ond reader re-analyzed 7 randomly selected seg
ments, and the first reader re-analyzed 11 randoml
selected segments 3 months after his/her origina
analysis.
Study imaging endpoints. The following parameter
were calculated per segment and per patient.
QCA-LIKE PARAMETERS
Minimum lumen diameter (MLD): the nar
rowest lumen diameter within each segment
Percent diameter stenosis (%DS): [(referenc
diameter – MLD)/reference diameter]  100%
The reference diameter was the largest (maximal
lumen diameter within each segment.
For each patient, the average %DS of all seg
ments at baseline and follow-up was calculated
From these values, the change from baseline wa
calculated for each patient. In addition, the per
patient average of MLD (mm) of all segments wa
calculated at baseline and at follow-up for th
matching segments. The average change in MLD
at baseline was calculated for each patient usin
these values. Clinically relevant regression or pro
gression was defined as a nominal change (fromIVUS-LIKE PARAMETERS
Percent atheroma volume (PAV): [(total vesse
volume – total lumen volume)/total vessel volume] 
100%
Total atheroma volume (TAV): total vesse
volume – total lumen volume
Normalized TAV (TAVnorm): [(total vesse
volume – total lumen volume)/segment length] 
mean segment length in the population. Normal
ization for segment length provides equal weightin
of each patient in the calculation of atherom
volume (3).
Percentage change in TAV (% change in
TAV): [(TAV follow-up  TAV baseline)/TAV
baseline]  100%
Minimum lumen area (MLA): the narrowes
lumen area in each segment
Percent area stenosis (%AS): [(reference lumen
area  MLA)/reference lumen area]  100. Th
reference lumen area used was the largest (maximal
lumen area within each segment.
For each patient, the average %AS of all seg
ments at baseline and follow-up was calculated
From these values, the change from baseline wa
calculated for each patient. Also, the per-patien
average of MLA (mm2) of all segments was calcu
lated at baseline and at follow-up for the corre
sponding segments. The average change in MLA
from baseline was calculated for each patient usin
these values.
Clinically relevant regression or progression in
PAV was defined as a change (from baseline t
follow-up) of1% for PAV, which was the thresh
old for significant regression previously detected
under intensive lipid-lowering treatment (21).
Coronary remodeling. As recommended for seria
studies (3), remodeling was assessed as vessel area a
follow-up minus vessel area at baseline. An increas
in vessel area was considered positive remodeling
no change in vessel area was considered absence o
remodeling, and a decrease in vessel area wa
considered negative remodeling. Furthermore, seg
ments with positive remodeling were subdivided a
expansive (over-compensatory) when vessel area
atheroma 1 or incomplete when vessel area
atheroma was between 0 and 1.
Clinical endpoints. Clinical event data were collected
throughout the duration of the study at regula
follow-up intervals and registered in the hospita
clinical database. Major adverse cardiovascula
events were defined as the composite of cardia
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Table 1. Baseline Patient Characteristics (n  32)death, cardiac arrest, myocardial infarction, and
rehospitalization due to unstable or progressiv
angina (16).
Statistical analysis. Continuous variables are pre
sented as mean  SD and median (interquartil
range [IQR]), as indicated. Categorical variables ar
presented as counts and percentages. Continuou
variables between the 2 different time points wer
compared by the paired samples t test if the dat
were normally distributed or the Wilcoxon signed
rank test for non-normal data (as tested by th
Kolmogorov-Smirnov test). A p value 0.05 wa
considered significant. Statistical analyses were per
formed with use of SPSS version 17.0 softwar
(SPSS, Chicago, Illinois).
. Flow of Study Patients
computed tomography coronary angiography.
Age, yrs 53 10
Male 26 (81)
Risk factors
Hypertension 9 (28)
Hypercholesterolemia 11 (34)
Diabetes mellitus 3 (9)
Current smoking 18 (56)
Family history of coronary artery disease 19 (59)
Obesity 3 (9)
Clinical condition at enrollment
Unstable angina 9 (28)
Acute myocardial infarction 23 (72)
Cholesterol
Total, mg/dl 180 41
Low-density lipoprotein, mg/dl 124 42
High-density lipoprotein, mg/dl 43 12
Triglycerides, mg/dl 139 87
Values are mean  SD or n (%).Baseline clinical and angiographic characteristics
From the original cohort of 47 patients undergoin
baseline CTCA, 36 (77%) underwent a follow-up
CTCA at 3 years. The follow-up scan was under
taken at a mean of 38  3 months (median 3
months, IQR: 37 to 40 months) after the initia
examination. The patients’ baseline characteristic
are shown in Table 1, and their disposition is shown
in Figure 2. In total, 129 segments from 32 patient
were analyzed. The mean length of analysis wa
22.0 9.5 mm per segment and 89.0 40.5 mm pe
patient. The proportion of calcified frames pe
segment at baseline was 6  12% versus 11  17%
at follow-up (p  0.001).
All patients at discharge received standard-of
care medical therapy, including statins (29 patient
received atorvastatin 40 mg/day, 2 patients received
simvastatin 40 mg/day, and 1 patient received
rosuvastatin 10 mg/day). One patient discontinued
statin use due to an adverse effect. The mean tota
cholesterol was 180  41 mg/dl at baseline and 150 
20 mg/dl at follow-up. The mean low-densit
lipoprotein (LDL) level was 124  42 mg/dl a
baseline and 85 13 mg/dl at follow-up. The mean
high-density lipoprotein level was 43 12 mg/dl a
baseline and 46 15 mg/dl at follow-up. The mean
triglycerides value was 139  87 mg/dl at baselin
and 114  76 mg/dl at follow-up.
MSCT QCA-like analysis. MEASURES OF STENOSI
PER SEGMENT. From baseline to 3-year follow-up
there was an increase in lumen dimensions, result
ing in a decrease in the relative lumen stenosi
(Table 2). In particular, there was a significan
increase in MLD by 0.11 mm (IQR: 0.15 to 0.2
mm; p  0.010), and this was accompanied by
decrease in %DS of 1.05% (IQR 7.15% t
5.08%; p  0.257).
There were no clinically relevant changes in MLD
(0.2mm) in 45.7% of the segments, whereas 32.6%
segments showed regression (0.2-mm increase in
MLD) and 21.7% showed progression (0.2mm
decrease in MLD) (Online Appendix). There was n
statistically significant difference in the prevalence o
progressors and regressors.
There were also no clinically relevant changes in
%DS (10%) in most of the segments (70.5%)
whereas 17.8% of the segments showed regression
(10% decrease in %DS) and 11.6% showed pro
gression (10% increase in %DS). There was n
statistically significant difference in the prevalenc
of progressors and regressors.Figure 2
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Table 2. MSCT QCA-Like Analysis
56MEASURES OF STENOSIS PER PATIENT. Simila
findings were found on a per-patient level (i.e., an
increase in lumen diameter and relative decrease in
stenosis). The MLD increased by 0.15 mm (IQR
0.09 to 0.24 mm; p  0.039) and the %DS
decreased by 0.83% (IQR: –6.3 to 3.16; p 0.326)
There were no clinically relevant changes in
MLD (0.2 mm) in 46.9% of the patients, wherea
37.5% of patients showed regression (0.2 mm
increase in MLD) and 15.6% showed progression
(0.2 mm decrease in MLD). There was n
statistically significant difference in the prevalenc
of progressors and regressors.
There were also no clinically relevant changes in
%DS (10%) in most of the patients (87.5%)
whereas considerably fewer patients (9.4%) showed
regression (10 decrease in %DS), and 3.1%
showed progression (10% increase in %DS)
There was no statistically significant difference in
the prevalence of progressors and regressors.
MSCT IVUS-like analysis. PLAQUE VOLUMETRIC
MEASURES PER SEGMENT. From baseline to 3-yea
follow-up, the PAV did not change significantly
whereas there was a significant relative percentag
change in TAV by 5.8 18.0% (p 0.001) (Table 3)
There were no clinically relevant changes in PAV
(1%) in 24.0% of the segments, whereas 38.8%
segments showed regression (1% decrease in
PAV) and 37.2% showed progression (1% in
crease in PAV) (Online Appendix). There was n
statistically significant difference in the prevalenc
of progressors and regressors.
Baseline
Baseline and follow-up quantitative parameters
analyzed per segment (n  129)
Minimum lumen diameter (mm)
Mean SD 2.49 0.61
Median (IQR) 2.36 (2.04–2.85
% Diameter stenosis
Mean SD 28.3 10.0
Median (IQR) 27.6 (21.1–35.0
Baseline and follow-up quantitative parameters
analyzed per patient (n  32)
Minimum lumen diameter (mm)
Mean SD 2.51 0.52
Median (IQR) 2.42 (2.09–2.87
% Diameter stenosis
Mean SD 28.1 6.6
Median (IQR) 28.6 (23.8–32.2
*Wilcoxon signed rank test; †paired t test.
IQR  interquartile range; MSCT  multislice computed tomography; QCPLAQUE VOLUMETRIC MEASURES PER PATIENT. A
3-year follow-up, there was no significant change in
PAV (mean difference 0.15  3.64 mm3; p 
0.819), whereas there was a trend toward increase in
normalized TAV of 47.36  143.24 mm3 (p 
0.071). Similarly, there was a significant percentag
change in TAV by 6.7  16.6% (p  0.029).
There were no clinically relevant changes in PAV
(1%) in 21.8% of the patients, whereas 34.4%
patients showed regression (1% decrease in PAV
and 43.8% showed progression (1% increase in
PAV). There was no statistically significant differ
ence in the prevalence of progressors and regressors
CORONARY REMODELING. Overall, the plaque in
crease occurred without compromising the lumen
and was compensated for by an increase in vesse
size (mostly expansive positive remodeling) (Table 4
Approximately one third of the patients/segment
showed negative remodeling.
Clinical events. There were 8 clinical events in thi
cohort during the length of the study. Five event
were related to the stented segment (3 patients with
stent thrombosis, myocardial infarction, and repea
revascularization and 2 with repeat revascularization
with angina), and the other 3 patients developed
progressive angina. Of note, these patients present
ing with clinical events had larger normalized TAV
at baseline (969.72 vs. 810.77 mm3; p 0.010). W
found no difference between patients with and
without events regarding plaque progression (i.e.
change from baseline in PAV or TAV).
Follow-Up Change p Value
n (%) With
Regression
82 (64)
2.58 0.72 0.09 0.42
2.41 (2.01–3.09) 0.11 (–0.15 to 0.27) 0.010*
71 (55)
27.6 11.1 –0.68 10.03
26.0 (20.7–35.0) –1.05 (–7.15 to 5.08) 0.257*
23 (72)
2.63 0.62 0.11 0.32
2.47 (2.23–3.09) 0.15 (–0.09 to 0.24 0.039*
17 (53)
27.0 7.5 –1.13 6.39 0.326†
26.4 (20.4–32.2) –0.83 (–6.30 to 3.16)
quantitative coronary angiography.r
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Table 3. MSCT IVUS-Like AnalysisObserver variability. For the 11 segments included
in the intra-observer analysis, there were a total o
523 cross-sections analyzed. The mean difference
were small for both lumen (0.16  0.93 mm2
and vessel areas (0.11  1.17 mm2). The corre
lations between the original and subsequent analysi
were high (r  0.98 for lumen areas, r  0.98 fo
vessel areas). For the 7 segments included in th
inter-observer analysis, there were a total of 335
cross-sections analyzed. The mean differences wer
also small for both lumen (0.01  1.19 mm2) and
Baseline Fo
p plaque quantitative parameters
segment (n  129)
volume (%)
56.7 7.3 56
58.0 (52.0–63.0) 58.0
lume (mm3)
217.2 134.0 224
183.4 (130.2–280.0) 194.2
atheroma volume
p lumen quantitative parameters
segment (n  129)
rea (mm2)
5.16 2.68 5.
4.38 (3.27–6.34) 4.55
47.6 14.1 46
47.8 (37.4–57.9) 44.8
p plaque quantitative parameters
patient (n  32)
volume (%)
56.0 7.0 55
56.6 (50.0–61.5) 57.9
theroma volume (mm3)
850.5 155.7 897
833.7 (753.4–930.1) 892.0
atheroma volume
p lumen quantitative parameters
patient (n  32)
rea (mm2)
5.26 2.26 5.
4.66 (3.48–6.66) 4.84
47.3 9.4 45
48.5 (41.8–43.5) 45.5
est; †paired t test; ‡1-sample t test.
ultrasound; other abbreviations as in Table 2.vessel areas (0.08  1.31 mm2). Close correla
tions between the original analysis and re-analysi
were found (r  0.97 for lumen, r  0.98 for vesse
areas). The repeatability results are very much in
line with previous IVUS reports.
D I S C U S S I O N
The purpose of this exploratory substudy was t
assess the natural history of coronary atherosclerosi
by MSCT in patients with an ACS who wer
-Up Change p Value
n (%) With
Regression
59 (46)
7.7 –0.07 4.34
–62.0) 0.0 (–3.0 to 3.0) 0.790*
49 (38)
136.9 7.52 42.54
.6–274.4) 7.08 (–14.38 to 29.01) 0.019*
49 (38)
5.84 17.98 0.001‡
4.55 (–4.27 to 20.96)
82 (64)
3.21 0.49 1.84
–7.49) 0.44 (–0.73 to 1.15) 0.009*
70 (54)
15.2 –1.18 13.86 0.336†
–57.6) –1.58 (–10.6 to 7.3)
15 (47)
7.3 –0.15 3.64 0.819†
–61.3) 0.72 (–2.75 to 2.41)
11 (34)
175.4 7.36 143.24 0.071†
.0–993.1) 31.39 (–42.08 to 163.06)
11 (34)
6.7 16.55 0.029‡
3.54 (–4.27 to 20.96)
22 (69)
2.78 0.57 1.43
–7.73) 0.52 (–0.38 to 1.04) 0.034*
17 (53)
10.6 –1.72 8.96 0.286†
–52.8) –0.68 (–9.31 to 3.92)llow
Baseline and follow-u
analyzed per
Percent atheroma
Mean SD .7
Median (IQR) (51.0
Total atheroma vo
Mean SD .7
Median (IQR) (129
% Change in total
Mean SD
Median (IQR)
Baseline and follow-u
analyzed per
Minimum lumen a
Mean SD 65
Median (IQR) (3.17
% Area stenosis
Mean SD .4
Median (IQR) (37.1
Baseline and follow-u
analyzed per
Percent atheroma
Mean SD .9
Median (IQR) (50.4
Normalized total a
Mean SD .9
Median (IQR) (736
% Change in total
Mean SD
Median (IQR)
Baseline and follow-u
analyzed per
Minimum lumen a
Mean SD 83
Median (IQR) (3.98
% Area stenosis
Mean SD .5
Median (IQR) (36.5
*Wilcoxon signed rank t
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Table 4. Coronary Remodeling Endpoints
58treated with percutaneous coronary intervention
and contemporary medical therapy.
The main findings of this report are as follows
despite standard-of-care treatment, the atherom
size in untreated non-culprit lesions increased ove
3 years, compensated for by an increase in the vesse
size (positive expansive remodeling) and withou
compromising the lumen. Our MSCT findings on
atherosclerosis progression fit closely to the regres
Per segment (n  129)
Serial remodeling (mm2) 0.82 2.83*
Positive remodeling
Expansive 61 (47)
Incomplete 23 (18)
Negative remodeling 45 (35)
Per patient (n  32)
Serial remodeling (mm2) 1.10 2.68†
Positive remodeling
Expansive 17 (53)
Incomplete 6 (19)
Negative remodeling 9 (28)
Values are mean  SD and n (%). *p  0.001; †p  0.027.
Figure 3. Association Between Mean Low-Density Lipoprotein
Percent Atheroma Volume for Several Intravascular Ultrasoun
A-Plus  Avasimibe and Progression of Lesions on Ultrasound (22
vascular Ultrasound-Derived Coronary Atheroma Burden (21); CAM
of Thrombosis (23); ILLUSTRATE  Investigation of Lipid Level Ma
sclerosis by CETP Inhibition and HDL Elevation (24); REVERSAL  Re
Study of Coronary Atheroma by Intravascular Ultrasound: Effect o
Reduce Atherosclerosis Development Involving Administration of
Providing Regional Observations to Study Predictors of Events in t
Modiﬁed from Nissen et al. (21).previous IVUS studies (Fig. 3).
Plaque burden and coronary events. IVUS studie
(28) have demonstrated that there is a direct associa
tion between the burden of coronary atherosclerosis
its progression, and the presence of clinical events a
follow-up. Similarly, in the main PROSPECT study
lesions with plaque burden 70% were shown to b
strongly associated with future clinical events (16)
Our data are in accordance with these findings
because the patients presenting with clinical event
had greater amount of plaque at baseline. Thi
observation could contribute to the potential devel
opment of prediction models based on atheroscle
rotic plaque burden.
Coronary remodeling. Motoyama et al. (29) and
Hoffmann et al. (6) described that the plaques in
patients with ACS have positive remodeling and ar
associated with events. Consistent with the origina
description by Glagov et al. (30), our MSCT dat
showed that arteries enlarge as atherosclerosis pro
gresses. Previous serial IVUS reports have demon
strated that atheroma burden does not limit com
lesterol Levels and Median Change in
udies
STEROID  A Study to Evaluate the Effect of Rosuvastatin on Intra-
T  Comparison of Amlodipine vs. Enalapril to Limit Occurrences
ement Using Coronary Ultrasound to Assess Reduction of Athero-
l of Atherosclerosis With Aggressive Lipid-Lowering (25); SATURN 
suvastatin versus Atorvastatin (26); STRADIVARIUS  Strategy to
onabant—The Intravascular Ultrasound Study (27); PROSPECT 
oronary Tree (multislice computed tomography substudy).Cho
d St
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pensatory remodeling (31), whereas there is a broad
spectrum of serial remodeling responses in coronary
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but the full coronary tree can be assessed. Con-
versely, considering the resolution and reproducibil-
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,atherosclerosis (32,33).
Importantly, arterial remodeling changes closel
relate to changes in PAV, which is the mos
common primary IVUS endpoint. In the absence o
actual change in plaque volume, positive remodel
ing could reduce PAV, whereas negative remodel
ing would increase PAV.
Progression/regression analysis using MSCT. MSCT
can assess coronary atherosclerosis by combinin
the 2 “worlds” of QCA-like and IVUS-like param
eters. To our knowledge, this comprehensive ap
proach used in our study was not performed in
previous MSCT studies. Furthermore, the follow-up
time of our report (median 39 months) is th
longest duration to date reported in progression
regression studies.
Previous papers have shown that MSCT is com
parable to QCA angiography regarding lumen ste
nosis assessment (4,5); similarly, IVUS and MSCT
comparative studies (6–8) have shown that th
MSCT can reasonably evaluate atheroscleroti
plaque size, remodeling, eccentricity, and composi
tion, despite the acknowledged limitations of th
technique. Voros et al. (8) suggested that quantita
tive MSCT angiography could be acceptably used
in population-based approaches, given the smal
mean differences between MSCT and IVUS-virtua
histology measurements.
Interestingly, our results closely fit the regression
line in the classical graph depicting the relation
between mean LDL levels and median change in
PAV for several previous IVUS progression
regression studies.
Most prior IVUS studies have used PAV as th
primary endpoint; however, the percentage chang
in TAV may be more suitable for MSCT studies
because not only 1 coronary segment can be imaged1. Smith SC Jr., Jackson R, Pearson TA,
l
-
e
-
J,
.
o
f
-
l
SJ, et al. Clinical e
ment on standardsity of MSCT, the minute changes in PAV observed
in IVUS studies may be more difficult to detect.
Study limitations. This is a single-center feasibilit
study that comprised a selected small population o
patients presenting with ACS, and the findings ma
be different in stable patients. Due to the smal
sample size, multivariate analysis was not per
formed. Furthermore, the baseline CT scans wer
obtained with an earlier generation 64-slice CT
scanner, which may have produced inferior imag
quality compared with dual-source CT equipmen
used during follow-up. Nevertheless, we were abl
to detect changes of coronary atherosclerosis durin
the follow-up period. Because this was not a dru
efficacy study, the patients received contemporar
medical therapy at the discretion of the treatin
physician; however, the vast majority of patient
(91%) received 40 mg of atorvastatin, which mad
the statin use relatively uniform. Finally, radiation
exposure during MSCT coronary angiography stil
remains a matter of concern. Nonetheless, signifi
cant reductions of radiation dose are currently bein
achieved by implementation of dose-saving tech
niques (34), which result in effective dose less than
the 5 mSv of the invasive coronary angiography
C O N C L U S I O N S
MSCT provides insightful information on the nat
ural history of coronary atherosclerosis and may b
used for noninvasive monitoring of pharmacologica
interventions for coronary artery disease.
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Computed tomographic coronary angiography (CTCA) is a reliable, noninvasive imaging modality to visual-
ize coronary artery disease with a high diagnostic accuracy 
compared with invasive coronary angiography (ICA).1–3 In 
addition, CTCA can provide quantitative information of a 
coronary stenosis, similar to intravascular ultrasound (IVUS), 
cross-sectional information, and plaque burden. In daily prac-
tice, lesions with a diameter stenosis ≥50% on visual CTCA 
are generally considered for referral to ICA. However, similar 
to ICA, CTCA is an anatomic imaging technique; thus, it may 
result in both under- and overestimation of a lesion’s severity 
and is often inaccurate in identifying functionally significant 
coronary lesions that cause ischemia.4,5 Current guidelines 
suggest that treatment decisions based on the hemodynamic 
effect of a coronary lesion may improve clinical outcome.6–8 
Therefore, it would be relevant if quantitative parameters 
derived from CTCA could be optimized to predict the func-
tional significance of a coronary stenosis.
Background—Coronary lesions with a diameter narrowing ≥50% on visual computed tomographic coronary angiography 
(CTCA) are generally considered for referral to invasive coronary angiography. However, similar to invasive coronary 
angiography, visual CTCA is often inaccurate in detecting functionally significant coronary lesions. We sought to compare 
the diagnostic performance of quantitative CTCA with visual CTCA for the detection of functionally significant coronary 
lesions using fractional flow reserve (FFR) as the reference standard.
Methods and Results—CTCA and FFR measurements were obtained in 99 symptomatic patients. In total, 144 coronary 
lesions detected on CTCA were visually graded for stenosis severity. Quantitative CTCA measurements included lesion 
length, minimal area diameter, % area stenosis, minimal lumen diameter, % diameter stenosis, and plaque burden 
[(vessel area−lumen area)/vessel area×100]. Optimal cutoff values of CTCA-derived parameters were determined, and 
their diagnostic accuracy for the detection of flow-limiting coronary lesions (FFR ≤0.80) was compared with visual 
CTCA. FFR was ≤0.80 in 54 of 144 (38%) coronary lesions. Optimal cutoff values to predict flow-limiting coronary 
lesion were 10 mm for lesion length, 1.8 mm2 for minimal area diameter, 73% for % area stenosis, 1.5 mm for minimal 
lumen diameter, 48% for % diameter stenosis, and 76% for plaque burden. No significant difference in sensitivity was 
found between visual CTCA and quantitative CTCA parameters (P>0.05). The specificity of visual CTCA (42%; 95% 
confidence interval [CI], 31%–54%) was lower than that of minimal area diameter (68%; 95% CI, 57%–77%; P=0.001), 
% area stenosis (76%; 95% CI, 65%–84%; P<0.001), minimal lumen diameter (67%; 95% CI, 55%–76%; P=0.001), % 
diameter stenosis (72%; 95% CI, 62%–80%; P<0.001), and plaque burden (63%; 95% CI, 52%–73%; P=0.004). The 
specificity of lesion length was comparable with that of visual CTCA.
Conclusions—Quantitative CTCA improves the prediction of functionally significant coronary lesions compared with 
visual CTCA assessment but remains insufficient. Functional assessment is still required in lesions of moderate stenosis 
to accurately detect impaired FFR.  (Circ Cardiovasc Imaging. 2014;7:43-51.)
Key Words: CT coronary angiography ◼ coronary stenosis ◼ fractional flow reserve
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The aim of this study was to compare the diagnostic perfor-
mance of CTCA-derived quantitative parameters with visual 
CTCA in the detection of functionally significant coronary 
lesions using fractional flow reserve (FFR) as the reference 
standard.
Methods
Study Population
We retrospectively included patients with stable angina who under-
went both CTCA and ICA and a subsequent measurement of FFR 
in 2 teaching hospitals. The decision to measure FFR was based on 
the visual assessment of ICA and was made at the discretion of the 
interventional cardiologist. Because of the potential hemodynamic 
interaction between ≥2 stenoses in series,9,10 we only included pa-
tients with a single coronary lesion per coronary vessel.
Exclusion criteria were impaired renal function (creatinine clear-
ance <60 mL/min), known allergy to iodine contrast material, calci-
um score per vessel >400, left main coronary lesions, and poor image 
quality. Poor image quality was defined as severe motion artifacts or 
poor contrast opacification.
All patients gave written informed consent to undergo CTCA as 
part of research protocols approved by the institutional review boards 
of the participating institutions. FFR was performed as part of routine 
clinical management.
CTCA Acquisition
All patients received nitroglycerin (0.4 mg/dose) sublingually just 
before the CT scan, provided there were no contraindications, 
Figure 1. Quantitative com-
puted tomographic coronary 
angiography (CTCA) and 
fractional flow reserve (FFR) 
measurement in a moderate 
coronary lesion. Example of a 
patient with a moderate (50%–
70% lumen narrowing by visual 
CTCA) coronary lesion because 
of a partly calcified plaque in 
the left descending coronary 
artery. A, The screenshot of 
the quantitative CTCA analysis 
using dedicated software. The 
lesion was assessed as mod-
erate by visual CTCA. Lumen 
(yellow) and wall (orange) 
contours were semiautomati-
cally detected. At the level of 
the minimal lumen area (yellow 
line), lumen area, % area ste-
nosis, and plaque burden were 
measured as 1.6 mm2, 83%, 
and 91%, respectively. The 
FFR was 0.68 (B).
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and patients with a heart rate >65 bpm received preparation with 
 β-blockers (50–100 mg metoprolol orally 1 hour before scanning or 
1–30 mg metoprolol IV directly before scanning). The CT scan was 
performed using either a 64-slice dual-source scanner (Somatom 
Definition, Siemens Medical Solutions, Forchheim, Germany) or 
a 128-slice second-generation dual-source CT scanner (Somatom 
Definition Flash, Siemens Medical Solutions, Forchheim, Germany). 
First, all patients underwent an unenhanced scan for the calculation 
of the calcium score with the Agatston method (32×1.2 mm colli-
mation, 120-kV tube voltage, 75-mA tube current, and 3-mm slice 
thickness with increment 1.5 mm). The CT angiographic scan pa-
rameters were (1) for the 64-slice dual-source CT (DSCT) scanner, 
a gantry rotation time of 330 ms, 32×2×0.6 mm collimation with 
z-flying focal spot for both detectors, gantry rotation time of 330 
ms, tube voltage of 120 kV, and tube current of 320 to 412 mA per 
rotation; and (2) for the 128-slice  DSCT scanner, a gantry rotation 
time of 280 ms, 64×2×0.6 mm collimation with z-flying focal spot 
for both detectors, tube voltage of 100 or 120 kV, and tube current 
of 320 to 412 mA per rotation. A bolus of iodinated contrast agent 
(370 mgI/mL, Ultravist; Schering, Berlin, Germany, or 300 mgI/mL, 
Omnipaque, GE Healthcare, Milwaukee, MI), which varied between 
60 and 100 mL depending on the expected scan time, was injected 
intravenously at an injection rate of either 5.5 or 7 mL/s (depend-
ing on the type of contrast used) followed by a 45-mL saline chaser 
at the same injection rate. The iodine deliver rates achieved with 
both injection protocols were similar (2.0–2.1 gI/s). A bolus track-
ing technique was used to synchronize the start of image acquisi-
tion with the arrival of the iodinated contrast agent in the coronary 
arteries. With the 64-slice DSCT scanner, an ECG-gated spiral scan 
mode with ECG pulsing was used for image acquisition. When scan-
ning with the 128-slice DSCT, the prospectively ECG-triggered se-
quential scan mode (step-and-shoot) or the retrospective ECG-gated 
spiral scan mode with ECG pulsing or a high-pitch spiral scan mode 
was used, depending on the heart rate.
All CT images were reconstructed with a slice thickness of 0.75 
mm and an increment of 0.4 mm. Images were analyzed using 
 medium-to-smooth convolution kernels for noncalcified lesions and 
sharp convolution kernels for calcified lesions. More details about the 
CT protocol were previously described in detail.11
FFR Measurements
FFR was measured with a sensor-tipped 0.014-inch guidewire 
(Pressure Wire, Radi Medical Systems, Uppsala, Sweden). The pres-
sure sensor was positioned just distal to the stenosis, and maximal 
myocardial hyperemia was induced by a continuous intravenous infu-
sion of adenosine in a femoral vein (140 μg/kg per minute for a mini-
mum of 2 minutes). FFR was calculated as the ratio of mean distal 
pressure measured by the pressure wire divided by the mean proximal 
pressure measured by the guiding catheter. A coronary stenosis with 
an FFR value ≤0.80 was considered functionally significant.12
CTCA Image Analysis
First, the CTCA data sets were evaluated visually, and the coro-
nary lesion was graded as nonobstructive (<50% lumen narrowing), 
moderate (50%≤lumen narrowing<70%), and severe (≥70% lumen 
narrowing). Afterward, all data sets were transferred to an offline 
workstation for analysis using semiautomated plaque analysis soft-
ware (QAngioCT Research Edition v1.3.61; Medis Medical Imaging 
Systems, Leiden, The Netherlands). The location and extent of the 
region of interest were manually defined using proximal and distal 
markers as the coronary vessel region where the lumen diameter 
was reduced ≥30% compared with the normal vessel. Planimetry of 
the inner lumen and outer vessel areas was performed following a 
stepwise approach as previously described.13–15 In summary, a center-
line originating from the ostium was automatically extracted; then, 
straightened multiplanar reformatted images were generated, and the 
lumen and vessel borders were detected longitudinally on 4 different 
vessel views by the software; based on these longitudinal contours, 
cross-sectional images at 0.5 mm intervals were calculated to create 
transversal lumen and vessel wall contours, which were examined 
and, if necessary, adjusted by a single experienced observer. Based 
on the detected contours proximal and distal from the lesion region, 
a reference area function was derived modeling the tapering of a 
healthy vessel. From these data, the following cross-sectional CTCA-
derived parameters were provided automatically by the software: le-
sion length, minimum lumen area (MLA), and % area stenosis (%AS) 
at the level of the MLA defined by [1-(MLA/corresponding reference 
lumen area)×100]. In addition, minimum lumen diameter (MLD) and 
Table 1. Baseline Clinical Characteristics
All (n=99)
FFR >0.80 
(n=55)
FFR ≤0.80 
(n=44) P Value*
Men, n (%) 77 (78) 40 (73) 37 (84) 0.177
Age, y 61 ±11 60 ±12 62 ±10 0.222
Risk factors, n (%)
  Smoker 17 (17) 7 (13) 10 (23) 0.190
  Hypertension† 63 (64) 36 (66) 27 (61) 0.674
  Dyslipidemia‡ 75 (76) 40 (73) 35 (79) 0.432
  Diabetes mellitus§ 22 (22) 16 (29) 6 (14) 0.066
  Family history  
of CAD‖
51 (52) 29 (53) 22 (50) 0.787
Calcium score 
(Agatston)
284 (43–629) 197 (36–631) 355 (100–640) 0.428
Values are mean±standard deviation, median (interquartile range) or n (%). 
CAD indicates coronary artery disease; and FFR, fractional flow reserve.
*Comparison between FFR >0.80 vs FFR ≤0.80.
†Blood pressure ≥140/90 mm Hg or treatment for hypertension.
‡Total cholesterol >180 mg/dL or treatment for hypercholesterolemia.
§Treatment with oral antidiabetic medication or insulin.
‖Family history of coronary artery disease having first- or second-degree 
relatives with premature CAD (age <55 y).
Table 2. Cross-Sectional CT-Derived Parameters, Vessel 
Distribution, and FFR
All (n=144)
FFR >0.80 
(n=90)
FFR ≤0.80 
(n=54) P Value*
FFR 0.83 (0.75–0.90) 0.88 (0.84–0.93) 0.72 (0.68–0.77) <0.001
Lesion length, 
mm
13 (9–19) 11 (8–17) 16 (11–25) 0.001
MLA, mm2 1.8 (1.0–2.7) 2.3 (1.5–2.8) 1.0 (0.3–1.6) <0.001
%AS 71 (62–82) 67 (56–73) 84 (74–91) <0.001
MLD, mm 1.5 (1.1–1.8) 1.7 (1.4–1.9) 1.1 (0.6–1.4) <0.001
%DS 47 (39–58) 44 (35–49) 60 (49–71) <0.001
Plaque burden, % 76 (71–79) 73 (69–77) 79 (76–82) <0.001
Vessel, n(%) 0.050
  RCA 36 (25) 24 (27) 12 (22)
  LAD 76 (53) 41 (46) 35 (65)
  LCX 32 (22) 25 (28) 7 (13)
Lesion location, 
n(%)
0.121
  Proximal 76 (53) 43 (48) 33 (61)
  Mid 68 (47) 47 (52) 21 (39)
Values are median (interquartile range) or n (%). %AS indicates % area 
stenosis; %DS, % diameter stenosis; CT, computed tomography; FFR, fractional 
flow reserve; LAD, left anterior descending coronary artery; LCX, left circumflex 
coronary artery; MLA, minimal lumen area; MLD, minimal lumen diameter; and 
RCA, right coronary artery.
*Comparison between FFR >0.80 and FFR ≤0.80.
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% diameter stenosis (%DS) were provided as derived mathematically 
from the contour and reference area functions. Plaque burden was 
calculated for the whole coronary lesion by the following equation: 
(vessel area−lumen area)/vessel area×100 (Figure 1).
Statistical Analysis
Statistical analysis was performed using commercially available 
software (IBM SPSS Statistic, version 20). Results are reported 
in accordance with the STARD criteria (Standards for Reporting 
of Diagnostic Accuracy).16 Continuous variables are presented as 
mean±SD or median with interquartile range when not normally 
distributed and compared using the unpaired t test or the Mann–
Whitney test, respectively. Categorical variables are presented as 
frequencies and percentages and compared using the χ2 test.
The correlation between quantitative CTCA-derived parameters 
and FFR was assessed using linear regression analysis with nonlin-
ear predictors. Receiver operating characteristic curves were used 
to assess the optimal cutoff values of quantitative CTCA-derived 
parameters to predict FFR ≤0.80. In the choice of the cutoff value, 
we optimized the specificity, provided that sensitivity was ≥80%. 
Diagnostic performance of visual CTCA-derived and quantitative 
CTCA-derived parameters for the detection of functionally signifi-
cant lesions was evaluated on a per-lesion level and expressed as sen-
sitivity, specificity, positive and negative predictive values, and their 
corresponding 95% confidence intervals. A generalized estimating 
equation model was used to account for the clustering between le-
sions in the same subject. The McNemar test was used to compare 
the sensitivities and specificities of each quantitative CTCA-derived 
parameter versus visual CTCA.
Coronary lesions were divided into 3 groups based on visual as-
sessment: nonobstructive (<50% lumen narrowing), moderate 
(50%≤lumen narrowing<70%), and severe (≥70% lumen narrowing). 
The cutoff values of quantitative CTCA-derived parameters derived 
from the receiver operating characteristic curves were used individu-
ally and in combination to investigate whether they could decrease 
Figure 2. Curvilinear relationship between fractional flow reserve (FFR) and minimal lumen area (MLA), % area stenosis (%AS), minimal 
lumen diameter (MLD), and % diameter stenosis (%DS).
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the number of misclassified lesions in the 3 categories of lesion se-
verity. When the combined approach was used, a positive outcome 
was adjudicated if both quantitative CTCA-derived parameters were 
positive as defined by the optimal cutoff value. A misclassified lesion 
was defined as a mismatch between CTCA results and FFR measure-
ments. Statistical significance was defined as P<0.05.
Results
Study Population
In total, 124 patients were considered for inclusion in the 
study. Twenty-five patients were excluded because of 
extreme calcifications (vessel calcium score >400) in the tar-
get vessel (n=17), left main coronary lesions (n=2), and poor 
image quality (n=6). Therefore, 144 coronary lesions in 99 
patients were finally included in the analysis. Baseline clini-
cal characteristics and quantitative CTCA-derived param-
eters are shown in Tables 1 and 2, respectively. The range 
of FFR values was between 0.24 and 1.00; 36% (36/99) of 
patients had multivessel FFR measurements. The FFR was 
≤0.80 in 54 lesions (38%). Coronary lesions with FFR ≤0.80 
were longer lesions with smaller lumen area and diameter, 
more severe stenosis, and higher plaque burden than those 
with FFR >0.80 (Table 2).
FFR Versus Cross-Sectional CTCA-Derived 
Parameters
Nonlinear regression analysis between quantitative 
 CTCA-derived parameters and FFR demonstrated a sig-
nificant curvilinear relationship for %AS, %DS, MLA, and 
MLD (Figure 2). Significant curvilinear relationship was 
also found for plaque burden (R2=0.302; P<0.001) and lesion 
length (R2=0.148; P<0.001). Receiver operating characteris-
tic analysis yielded an area under the curve of 0.66 (0.57–
0.75) for length, 0.82 (0.75–0.89) for MLA, 0.82 (0.75–0.89) 
for MLD, 0.83 (0.75–0.90) for %AS, 0.82 (0.74–0.89) for 
%DS, and 0.80 (0.73–0.87) for plaque burden (Figure 3). 
Optimal cutoff values to predict the functional significance of 
coronary lesions were 10 mm for length, 1.8 mm2 for MLA, 
73% for %AS, 1.5 mm for MLD, 48% for %DS, and 76% for 
plaque burden.
Diagnostic Performance of Visual CTCA-Derived 
and Quantitative CTCA-Derived Parameters in 
Predicting Functionally Significant Coronary 
Lesions
The diagnostic performance of visual CTCA and quantita-
tive CTCA for the assessment of functionally significant 
Figure 3. Receiver operating 
characteristic curves of mini-
mal lumen area (MLA), % area 
stenosis (%AS), minimal lumen 
diameter (MLD), and % diam-
eter stenosis (%DS).
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coronary lesions (FFR ≤0.80) is detailed in Table 3. No sig-
nificant difference was found for sensitivity between visual 
CTCA and quantitative CTCA in terms of lesion length, 
MLA, %AS, MLD, %DS, and plaque burden (P>0.05). The 
specificity of MLA, %AS, MLD, %DS, and plaque bur-
den was significantly higher than the specificity of visual 
CTCA (P=0.001, P<0.001, P=0.001, P<0.001, and P=0.004, 
respectively) for the detection of functionally significant 
coronary lesions. Specificity of lesion length was not signifi-
cantly different than specificity of visual CTCA (P=0.749).
Moderate Coronary Lesions
Visual CTCA showed 42 (29%) nonobstructive lesions, 85 
(59%) moderate lesions, and 17 (12%) severe lesions. In the 
moderate lesion category, 46 lesions were misclassified by 
visual CTCA; the use of %AS and plaque burden in combi-
nation decreased the number of lesions incorrectly classified 
from 46 of 85 (54%) to 20 of 85 (24%), of which 15 lesions 
were incorrectly classified as nonfunctionally significant 
(Tables 4–9).
Discussion
In this exploratory study, we sought to investigate the abil-
ity of quantitative parameters derived by CTCA to predict the 
functional significance of coronary lesions using FFR as the 
reference standard.
The major findings of our study were the following: (1) the 
relationship between coronary lesion severity, as described 
by quantitative CTCA-derived parameters, and FFR is curvi-
linear; (2) the optimal cutoff values to predict the functional 
significance of coronary lesions were 10 mm, 1.8 mm2, 73%, 
1.5 mm, 48%, and 76% for lesion length, MLA, %AS, MLD, 
%DS, and plaque burden, respectively; (3) in the moderate 
lesion category, the combined use of %AS and plaque burden 
decreased the number of lesions incorrectly classified from 
46 of 85 (54%) to 20 of 85 (24%), of which 15 lesions were 
incorrectly classified as nonfunctionally significant.
Relationship Between Quantitative CTCA-Derived 
Parameters and FFR
As shown in previous IVUS studies,17,18 MLA is important in 
determining coronary blood flow based on the Bernoulli equa-
tion. However, other important factors can affect coronary 
flow: the degree of diameter stenosis, lesion length, plaque 
burden, vessel size, lesion morphology, plaque characteristics, 
blood viscosity, collateral circulation, and supplied myocar-
dium.19 Several of these parameters can be measured using 
CTCA.14 In our study, similar to Kristensen et al,20 a curvi-
linear significant relationship was found between quantitative 
CTCA-derived parameters and FFR for a wide range of coro-
nary lesion severity.
Several IVUS studies have validated an MLA of 3.0 or 4.0 
mm2 as an anatomic predictor for physiological lesion signifi-
cance.21,22 However, it has been shown that these cutoff val-
ues are not accurate; especially when applied in small vessels 
(diameter <2.5 mm),17 a smaller cutoff value should be used. 
In our study, similar to the finding reported by Kristensen 
et al,20 we found an MLA CT-derived cutoff value of 1.8 
Table 3. Diagnostic Accuracy of Visual CTCA and Optimal Cutoff Values of Lesion Length, MLA, %AS, MLD, %DS, and %DS Derived 
From Quantitative CTCA in the Detection of Flow-Limiting Coronary Lesions as Defined by an FFR ≤0.80
TP TN FP FN Sensitivity, % Specificity, % PPV, % NPV, %
Visual assessment 50 38 52 4 93 (82–97) 42 (31–54) 49 (38–60) 91 (77–96)
Length, mm 44 35 55 10 82 (69–90) 39 (28–51) 44 (34–56) 78 (63–88)
MLA, mm2 43 61 29 11 80 (67–88) 68 (57–77)† 60 (46–72) 85 (75–91)
%AS 43 68 22 11 80 (65–89) 76 (65–84)† 66 (53–77) 86 (76–92)
MLD, mm 44 60 30 10 82 (69–90) 67 (55–76)† 60 (46–72) 86 (76–92)
%DS 43 65 25 11 80 (65–89) 72 (62–80)† 63 (50–74) 86 (75–92)
Plaque burden, % 43 57 33 11 80 (66–89) 63 (52–73)† 57 (43–69) 84 (72–91)
%AS indicates % area stenosis; %DS, % diameter stenosis; CTCA, computed tomographic coronary angiography; FFR, fractional flow reserve; FN, false negative; 
FP, false positive; MLA, minimal lumen area; MLD, minimal lumen diameter; NPV, negative predictive value; PPV, positive predictive value; TN, true negative; and TP, 
true positive.
†P<0.05 derived from McNemar comparing the specificities of lesion length, MLA, %AS, MLD, %DS, and plaque burden with the specificity of visual assessment.
Table 4. Distribution of coronary lesion severity based on 
visual CTCA
Visual Assessment
Nonobstructive  
Stenoses (n=42)
Moderate  
Stenoses (n=85)
Severe  
Stenoses (n=17)
FFR >0.80 38 46* 6
FFR ≤0.80 4 39 11
Values are numbers. CTCA indicates computed tomographic coronary 
angiography; and FFR, fractional flow reserve.
*The number of misclassified coronary lesions in the moderate stenosis 
category.
Table 5. Diagnostic Performance of MLA to Predict 
Functionally Significant Lesions (FFR≤0.80)
MLA, mm2
Nonobstructive 
Stenoses (n=42)
Moderate  
Stenoses (n=85)
Severe  
Stenoses (n=17)
>1.8 ≤1.8 >1.8 ≤1.8 >1.8 ≤1.8
FFR >0.80 28 10 29 17* 4 2
FFR ≤0.80 1 3 10* 29 0 11
Values are numbers. Upper left cell=true negative, upper right cell=false 
positive, lower left cell=false negative, and lower right cell=true positive. FFR 
indicates fractional flow reserve; and MLA, minimal lumen area.
*The number of misclassified coronary lesions in the moderate stenosis 
category. 
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mm2, which is smaller compared with the IVUS-derived one 
reported by Kang et al.17 This may be related to inherent dif-
ferences between invasive and noninvasive imaging modali-
ties. For instance, to avoid the induction of coronary spasm 
by the IVUS catheter, intracoronary nitrates are usually given 
before imaging at a dose of 100 to 200 μg, causing a status of 
coronary vasodilation greater than the one induced by nitrates 
administered orally before the CTCA acquisition. In addition, 
IVUS does not assess severe coronary lesions because of the 
large profile of the IVUS catheter, which is unable to pass 
through small coronary lumen.
CTCA-Derived Parameters in Predicting  Flow-
Limiting Coronary Lesions
Previous investigations have demonstrated that, similar 
to ICA, the anatomic assessment of a coronary stenosis by 
CTCA correlates poorly with the functional significance 
of the stenosis defined by FFR.4,5 As previously shown in a 
study by Tonino et al,23 there was a high rate of nonfunction-
ally significant lesions in the range of angiographic severity 
of 50% to 70% diameter stenosis. Similarly, in our study, 
54% of the coronary stenoses with an angiographic severity 
between 50% and 70% were not functionally significant. The 
use of quantitative CTCA decreased the number of misclassi-
fied lesions by half, mainly by reducing the number of lesions 
incorrectly classified as functionally significant from 46 to 20. 
However, 15 of these misclassified lesions were incorrectly 
classified as nonfunctionally significant, highlighting the fact 
that the increase in the specificity comes at the expense of a 
decrease in the sensitivity. Similarly, Godoy et al24 and Gaem-
perli et al25 found only a moderate diagnostic accuracy of 
quantitative CTCA for the detection of myocardial ischemia 
by single photon emission computed tomography. The mod-
est association of anatomic assessment by quantitative CTCA 
with functional assessment may be explained by the complex-
ity of factors leading to myocardial ischemia.26 As proposed 
by Marzilli et al,27 obstructive epicardial coronary stenosis is 
only 1 of the contributors to myocardial ischemia, and inflam-
mation, endothelial dysfunction, microvascular dysfunction, 
platelet dysfunction, thrombosis, and vasomotor dysfunction 
should also be considered.
Limitations
First, our study was a retrospective study performed in a rela-
tively small number of patients; the possibility of a type II 
error should be considered. Second, we included only patients 
referred for ICA with moderate-to-severe diseased coronary 
arteries. Future studies with a prospective design are required 
to evaluate the diagnostic accuracy of quantitative CTCA for 
the selection of patients who will benefit most from revascu-
larization. In addition, the discriminatory power of CTCA 
cross-sectional quantitative parameters in the detection of 
functionally significant coronary lesions requires further 
investigation in the typical population, at low-to-intermediate 
pretest probability of coronary artery disease, referred for 
Table 6. Diagnostic Performance of %AS to Predict 
Functionally Significant Lesions (FFR≤0.80)
%AS
Nonobstructive 
Stenoses (n=42)
Moderate 
Stenoses (n=85)
Severe  
Stenoses (n=17)
<73 ≥73 <73 ≥73 <73 ≥73
FFR >0.80 33 5 31 15* 4 2
FFR ≤0.80 1 3 10* 29 0 11
Values are numbers. Upper left cell=true negative, upper right cell=false 
positive, lower left cell=false negative, and lower right cell=true positive. %AS 
indicates % area stenosis; and FFR, fractional flow reserve.
*The number of misclassified coronary lesions in the moderate stenosis 
category.
Table 8. Diagnostic Performance of MLA + Plaque Burden to 
Predict Functionally Significant Lesions (FFR ≤0.80)
MLA, mm2 and Plaque Burden, %
Nonobstructive 
Stenoses (n=42)
Moderate  
Stenoses (n=85)
Severe  
Stenoses (n=17)
MLA>1.8, 
PB<76
MLA≤1.8, 
PB≥76
MLA>1.8, 
PB<76
MLA≤1.8, 
PB≥76
MLA>1.8, 
PB<76
MLA≤1.8, 
PB≥76
FFR >0.80 35 3 36 10* 4 2
FFR ≤0.80 1 3 15* 24 0 11
Values are numbers. Upper left cell=true negative, upper right cell=false 
positive, lower left cell=false negative, and lower right cell=true positive. FFR indi-
cates fractional flow reserve; MLA, minimal lumen area; and PB, plaque burden.
*The number of misclassified coronary lesions in the moderate stenosis 
category. 
Table 7. Diagnostic Performance of Plaque Burden to Predict 
Functionally Significant Lesions (FFR≤0.80)
Plaque Burden, %
Nonobstructive 
Stenoses (n=42)
Moderate  
Stenoses (n=85)
Severe  
Stenoses (n=17)
<76 ≥76 <76 ≥76 <76 ≥76
FFR >0.80 27 11 29 17* 1 5
FFR ≤0.80 1 3 10* 29 0 11
Values are numbers. Upper left cell=true negative, upper right cell=false 
positive, lower left cell=false negative, and lower right cell=true positive. FFR 
indicates fractional flow reserve.
*The number of misclassified coronary lesions in the moderate stenosis 
category.
Table 9. Diagnostic Performance of %AS + Plaque Burden to 
Predict Functionally Significant Lesions (FFR ≤0.80)
%AS and Plaque Burden, %
Nonobstructive 
Stenoses (n=42)
Moderate  
Stenoses (n=85)
Severe  
Stenoses (n=17)
%AS<73, 
PB<76
%AS≥73, 
PB≥76
%AS<73, 
PB<76
%AS≥73, 
PB≥76
%AS<73, 
PB<76
%AS≥73, 
PB≥76
FFR >0.80 36 2 41 5* 4 2
FFR ≤0.80 1 3 15* 24 0 11
Values are numbers. Upper left cell=true negative, upper right cell=false 
positive, lower left cell=false negative, and lower right cell=true positive. 
%AS indicates percentage area stenosis; FFR, fractional flow reserve; and 
PB, plaque burden.
*The number of misclassified coronary lesions in the moderate stenosis 
category. 
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CTCA. Third, because of the relative small number of posi-
tive observations, we did not perform multivariate logistic 
regression to identify independent predictors of a positive 
FFR. Finally, we excluded vessels with poor image quality on 
CTCA; good image quality is a prerequisite for the reliable 
calculation of CT-derived cross-sectional parameters.
Clinical Implications and Future Directions
The interest in overcoming the mismatch between anatomy 
and function in cardiac imaging has initiated intense research 
to assess the feasibility of new noninvasive diagnostic tech-
niques. In this study, we determined whether the analysis of 
quantitative cross-sectional CTCA parameters could improve 
the prediction of functionally significant lesions without fur-
ther irradiation, contrast, or drug administration. In our study, 
stenosis quantification prolonged the postprocessing analysis 
time by 5 to 10 minutes, mainly depending on the amount of 
calcium per lesion, with a significant reduction in the number 
of moderate lesions incorrectly classified as functionally sig-
nificant. Several automated software programs are now com-
mercially available for stenosis quantification, and their use 
may be useful in clinical routine.
The possibility of a noninvasive FFR measurement has 
been shown with promising results.28 In a multicenter study 
involving 252 patients with stable angina, noninvasive FFR in 
addition to CTCA improved the diagnostic accuracy and dis-
crimination of CTCA alone for the diagnosis of functionally 
significant lesions.29 Similar to our results, the diagnostic spec-
ificity and positive predictive value remained low, and further 
studies are warranted to determine the potential clinical impli-
cation of this more comprehensive coronary lesion assessment.
The safety and feasibility of stress myocardial CT perfu-
sion imaging have also been demonstrated in few experimen-
tal and human studies.30–35 The addition of stress myocardial 
CT perfusion imaging to the standard CTCA can provide 
complementary anatomic and functional information in a 
single examination. However, CT perfusion imaging involves 
increased patient radiation exposure, increased contrast vol-
ume, and potential patient’s discomfort related to the adminis-
tration of a pharmacological stress agent.
Conclusions
CTCA quantitative parameters improve the prediction of flow-
limiting lesions, compared with visual assessment, but remain 
insufficient. Functional assessment is still needed for lesions 
of moderate severity to accurately detect impaired FFR.
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CLINICAL PERSPECTIVE
Computed tomographic coronary angiography (CTCA) is a reliable, noninvasive imaging modality to visualize coronary 
artery disease with a high diagnostic accuracy compared with invasive coronary angiography. In daily practice, lesions with 
a diameter stenosis ≥50%, interpreted visually, are generally considered for referral to invasive coronary angiography. How-
ever, similar to invasive coronary angiography, CTCA is an anatomic imaging technique; thus, it may result in both under and 
overestimation of a lesion’s severity and is often inaccurate in identifying functionally significant coronary lesions that cause 
ischemia. Current guidelines suggest that treatment decisions based on the hemodynamic effect of a coronary lesion may 
improve clinical outcome. Studies using intravascular ultrasound have demonstrated that cross-sectional measurements of 
coronary artery stenosis correlated well with fractional flow reserve. Similar to intravascular ultrasound, quantitative CTCA, 
using automated border lumen detection algorithms, allows assessment of parameters such as minimum lumen area, % area 
stenosis, minimum lumen diameter, % diameter stenosis, and plaque burden. A more comprehensive coronary lesion assess-
ment using quantitative CTCA-derived parameters, without further patient irradiation or administration of contrast material, 
may improve the overall diagnostic accuracy of visual CTCA in the detection of functional significant coronary lesions as 
defined by a fractional flow reserve ≤0.80. The results of our study show that the additional use of quantitative CTCA-derived 
parameters improves the prediction of flow-limiting lesions, compared with visual assessment, but remain insufficient. Func-
tional assessment is still needed for lesions of moderate severity to detect impaired fractional flow reserve accurately.
73
 
PART III 
 CT coronary angiography for the assessment of coronary bifurcations  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 6      
 Assessment of Atherosclerotic Plaques at Coronary Bifurcations with Multidetector Computed Tomography Angiography and Intravascular Ultrasound – Virtual Histology                                                                                                                                        European Heart Journal – Cardiovascular Imaging. 2012 Aug;13(8):635-42. 
 
S.L. Papadopoulou, S. Brugaletta, H.M. Garcia-Garcia, A. Rossi, C. Girasis, A. S. Dharampal, L. A. Neefjes, J. Ligthart, K. Nieman, G.P. Krestin, P.W. Serruys, P. J. de Feyter                                    
 
 
  
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Assessment of atherosclerotic plaques
at coronary bifurcations with multidetector
computed tomography angiography
and intravascular ultrasound-virtual histology
Stella-Lida Papadopoulou1,2*, Salvatore Brugaletta1, Hector M. Garcia-Garcia1,
Alexia Rossi1,2, Chrysafios Girasis1, Anoeshka S. Dharampal1,2, Lisan A. Neefjes1,2,
Jurgen Ligthart1, Koen Nieman1,2, Gabriel P. Krestin2, Patrick W. Serruys1,
and Pim J. de Feyter1,2
1Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, PO Box 2040, Rotterdam, 3000 CA, The Netherlands; and 2Department of Radiology, Erasmus
University Medical Center, PO Box 2040, Rotterdam, 3000 CA, The Netherlands
Received 5 January 2012; accepted after revision 29 March 2012
Aims We evaluated the distribution and composition of atherosclerotic plaques at bifurcations with intravascular ultra-
sound-virtual histology (IVUS-VH) and multidetector computed tomography (MDCT) in relation to the bifurcation
angle (BA).
Methods
and results
In 33 patients (age 63+11 years, 79% male) imaged with IVUS-VH and MDCT, 33 bifurcations were matched and
studied. The analysed main vessel was divided into a 5 mm proximal segment, the in-bifurcation segment, and a 5 mm
distal segment. Plaque contours were manually traced on MDCT and IVUS-VH. Plaques with .10% confluent nec-
rotic core and ,10% dense calcium on IVUS-VH were considered high risk, whereas plaque composition by MDCT
was graded as non-calcified, calcified, or mixed. The maximum BA between the main vessel and the side branch was
measured on diastolic MDCT data sets. Overall the mean plaque area decreased from the proximal to the distal
segment [8.5+2.8 vs. 6.0+ 3.0 mm2 (P, 0.001) by IVUS-VH and 9.0+ 2.6 vs. 6.5+2.5 mm2 (P, 0.001) by
MDCT]. Similarly, the necrotic core area was higher in the proximal compared with the distal segment
(1.12+ 0.7 vs. 0.71+ 0.7 mm2, P ¼ 0.001). The proximal segment had the higher percentage of high-risk plaques
(13/25, 52%), followed by the in-bifurcation (6/25, 24%), and the distal segment (6/25, 24%); these plaques were char-
acterized by MDCT as non-calcified (72%) or mixed (28%). The presence of high-risk and non-calcified plaques in the
proximal segment was associated with higher BA values (71+198 vs. 55+198, P ¼ 0.028 and 74+208 vs.
50+148, P ¼ 0.001, respectively).
Conclusion The proximal segment of bifurcations is more likely to contain high-risk plaques, especially when the branching angle
is wide.
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Introduction
In patients with an atherogenic profile, plaque does not develop
evenly across the entire coronary tree, but shows a predilection
for sites where the laminar blood flow gets disturbed.1 The low-
oscillatory endothelial shear stress has been shown to facilitate
atherosclerosis and promote the development of plaques with
high-risk features;2,3 these phenomena may explain the increased
79
incidence of high-risk (i.e. lipid rich) plaques in the vicinity of cor-
onary artery bifurcations.4,5
Percutaneous treatment of coronary bifurcation lesions remains
a challenging task and has been associated with higher restenosis
and stent thrombosis rates.6–8 Better understanding of the under-
lying pathology, such as the tissue distribution and composition,
may allow for safer and more efficient treatment strategies. Intra-
vascular ultrasound–virtual histology (IVUS-VH) is an imaging
method that uses the spectral analysis of radiofrequency data to
encode four different plaque components, allowing for quantifica-
tion and characterization of atherosclerotic plaque.9,10
The complex three-dimensional (3D) geometry of coronary
artery bifurcations can affect the local haemodynamic conditions
and thereby the plaque distribution and composition. This plausible
effect mediated by the bifurcation angle (BA) can only be studied in
vivo by means of imaging modalities that provide a 3D reconstruc-
tion of the bifurcation, such as multidetector computed tomog-
raphy (MDCT). MDCT coronary angiography has emerged as a
means of non-invasive evaluation of coronary atherosclerotic
plaques; its ability to assess the plaque burden, remodelling, eccen-
tricity, and composition has been based on extensive cross-
sectional correlation with IVUS data in both stable and unstable
patients.11–13
The objective of the current study is two-fold: (i) to assess in vivo
the distribution, composition, and morphology of plaques at bifur-
cation sites using MDCT and IVUS-VH, and (ii) to explore any pos-
sible association of the BA with plaque distribution and
composition.
Methods
Study population
All patients admitted to our hospital between March 2008 and March
2010 who underwent both IVUS-VH and MDCT within a 2-month
interval were retrospectively screened for bifurcations adequately
visualized by both imaging techniques. The indication for the
IVUS-VH was the assessment of angiographically intermediate lesions
and/or the result of stent implantation; MDCT was performed for
either clinical or research purposes. All patients gave informed
consent. Only bifurcations visualized with high quality by both
imaging techniques and located at a distance .10 mm from adjacent
stents were considered for inclusion.
Bifurcation selection and matching
Bifurcation sites involving a side branch (SB) with an ostial diameter
≥1.5 mm on MDCT were only considered for inclusion; left main cor-
onary artery bifurcations were not part of this analysis, because of their
entirely different morphology.14 To avoid multiple observations, only a
single bifurcation site per patient, the one with the largest SB diameter,
was analysed. To ensure proper matching between IVUS-VH and
MDCT, the identical bifurcations were identified using the coronary
ostia and other bifurcations as landmarks. We chose to analyse only
the main branch; the region of interest (ROI) comprised: (i) the prox-
imal segment, extending 5 mm upstream from the proximal take-off of
the SB; (ii) the in-bifurcation segment; and (iii) the distal segment,
extending 5 mm downstream from the distal take-off of the SB
(Figure 1).
IVUS-VH acquisition and analysis
The IVUS-VH imaging was performed using the Eagle Eye 20 MHz
catheter (Volcano Corp., Rancho Cordova, CA, USA) with an auto-
matic continuous pullback at a rate of 0.5 mm/s. Grayscale images
and radiofrequency data required for VH analysis were acquired
during the same pullback. The VH data processing was performed
offline by an experienced cardiologist with the VIAS software
(Volcano Corp., Rancho Cordova, CA, USA) that allows semi-
automated contour detection and provides the compositional analysis.
Quantitative IVUS measurements included the vessel area, lumen area,
plaque area (vessel area minus lumen area), and plaque burden %
[(plaque area/vessel area)*100]. For the radiofrequency-IVUS analyses,
four colour-coded tissue components [necrotic core (NC)—red;
dense calcium (DC)—white; fibrous (FT)—dark green; and fibrofatty
(FF)—light green] were identified with autoregressive classification
systems. For every frame, each individual tissue component was quan-
tified as cross-sectional area and percentage (NC + DC + FT + FF ¼
100%).9,15 Volumetric and compositional parameters obtained per
cross-section were averaged for each bifurcation segment.
MDCT acquisition
The patients were scanned with a first generation dual-source CT
scanner (Somatom Definition, Siemens Healthcare, Forchheim,
Germany) or a second generation dual-source CT scanner
(Somatom Definition Flash, Siemens Healthcare, Forchheim,
Germany) which was available after May 2009. Sublingual nitroglycerin
was administered prior to the scan (0.4 mg/dose), provided there were
no contraindications; no pre-scan beta-blockers were given. An initial
non-enhanced ECG-gated scan (120-kV tube voltage, 75-mAs tube
current, and 3-mm slice thickness) was performed to calculate
calcium-related scores (Agatston, volume, and equivalent mass),16–18
and was followed by a contrast enhanced CT angiography. The CT
angiographic parameters were (i) for the first generation dual-source
scanner: 32 × 2 × 0.6 mm collimation with the z-flying focal spot for
both detectors, gantry rotation time 330 ms, tube voltage 120 kV,
current of 320 to 412 mAs, and (ii) for the second generation dual-
source scanner: 64 × 2 × 0.6 mm collimation with the z-flying focal
spot for both detectors, gantry rotation time 280 ms, tube voltage
Figure 1 Bifurcation selection and region of interest. Bifurca-
tions that could be identified on both modalities were included.
Only the main branch was analysed. The region of interest con-
sisted of: (i) the proximal 5 mm segment; (ii) the in-bifurcation
segment; and (iii) the distal 5 mm segment.
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of 100–120 kV, current of 320–370 mAs. A bolus of iodinated con-
trast material (370 mgI/mL, Ultravist; Schering, Berlin, Germany),
which varied between 60 and 100 mL depending on the expected
scan time, was injected intravenously (flow rate, 5.5 mL/s) followed
by a 40 mL saline chaser at the same injection rate. A bolus tracking
technique was used to synchronize the arrival of contrast in the cor-
onary arteries and the start of the MDCT acquisition. For acquisitions
with the first generation dual-source CT scanner, retrospective ECG-
gated technique with ECG-pulsing was used; when scanning with
the second generation dual-source CT either the prospectively ECG-
triggered axial scan mode (‘step-and-shoot’) or the retrospective
ECG-gated spiral scan mode with ECG-pulsing was used, depending
on the heart rate. The pitch for the retrospective scan was set auto-
matically by the scanner software, prior to scanning. The mean effect-
ive radiation dose was 9.0+ 3.9 mSv, using the dose-length product
and a conversion factor k of 0.014 mSv/mGy/cm.19 All MDCT coron-
ary angiograms were reconstructed with a slice thickness 0.75 mm, an
increment 0.4 mm, and a medium-to-smooth (B26f) convolution
kernel. Optimal data sets with the best image quality were recon-
structed mainly in the mid- to end-diastolic phase.
MDCT image analysis
All data sets from the MDCT angiography scans were transferred to a
dedicated workstation (Leonardo; Siemens Medical Systems, Erlangen,
Germany) for further analysis by an experienced observer, blinded to
the results of the IVUS-VH analysis. After the identification of the bi-
furcation ROI in the original cross-sectional images, serial multiplanar
reformatted images (1.0-mm slice thickness, interval 0.5-mm) orthog-
onal to the longitudinal axis of the main vessel were rendered to
obtain cross-sectional images of the respective vessel segment
(Figure 2A). The settings for the window level and width were previous-
ly optimized by an independent investigator and fixed at 740 and
220 HU, respectively20 (Rengo M. et al., submitted). Subsequently,
the lumen and vessel areas were manually traced in each image, and
the plaque areas were calculated as the difference between the
vessel and lumen areas (Figure 2D). The plaque areas measured on
each cross-section were averaged for each segment and reported as
the mean areas.
Plaque type classification
For each one of the three bifurcation segments, the existing plaque
phenotype was examined by both modalities. Based on IVUS-VH,
lesions were considered present when the percentage plaque area
was ≥40% on three consecutive frames. Plaques with .10% confluent
NC and ,10% dense calcium on three consecutive frames were clas-
sified as high-risk (i.e. NC rich) and represented thick-capped
fibroatheromas (VH-ThCFAs) or thin-capped fibroatheromas
Figure 2 Bifurcation matching and analysis by MDCT and IVUS-VH. To ensure correct matching of the bifurcations with the two techniques,
anatomic landmarks, and characteristic calcifications were used. Longitudinal vessel view by MDCT (A), grayscale IVUS (B), and virtual histology
(C ). Examples of corresponding analysed cross-sections (D–F) in the proximal, in-bifurcation, and distal segment. IVUS-VH, intravascular
ultrasound-virtual histology; MDCT, multidetector computed tomography.
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(VH-TCFAs), which are considered high-risk plaques according to the
American Heart Association and Virmani classifications.21,22
Based on MDCT, plaques were classified into three types: calcified
plaques (≥50% of the plaque area occupied by calcified tissue),
mixed plaques (,50% of the plaque area occupied by calcified
tissue), and non-calcified plaques which did not contain any calcium
at all.11
Measurement of bifurcation angles with
MDCT
Multiplanar reconstructions (MPRs) were rendered exactly in the plane
defined by the main vessel and SB at the bifurcation site, as previously
described.23 The MPR view where the angulation between the main
vessel and SB was maximal was used to determine the BA values.
The angle was delineated by two centreline vectors drawn along the
initial 5-mm course of the distal main vessel and SB, respectively
(Figure 3); only diastolic data sets were used for BA measurements.
Statistical analysis
Continuous variables were presented as means+ 1 SD, unless other-
wise indicated, and categorical variables were reported as counts and/
or percentages. The distribution of data was examined with the
Shapiro-Wilk test of normality. Continuous variables were compared
between different bifurcation segments and between the two modal-
ities with the paired samples t-test or the Wilcoxon signed ranks
test for two-dependent samples as appropriate. The BA values were
compared between groups using the unpaired t-test. A two-sided
P–value ,0.05 was considered statistically significant. Statistical
analyses were performed using SPSS 17.0 for Windows (SPSS, Inc.,
Chicago, IL, USA).
Results
Clinical and procedural characteristics
Out of 64 consecutive patients with IVUS-VH and MDCT imaging
who were screened, 38 were eligible for inclusion. Reasons for ex-
clusion were poor MDCT or IVUS-VH image quality (n ¼ 6), pres-
ence of stents within the ROI (n ¼ 9), and lack of true bifurcations
(diameter of the SB ostium ,1.5 mm) (n ¼ 11). Moreover, in five
patients matching of bifurcations between the two imaging modal-
ities was not possible, because more than one bifurcation were
located in proximity to each other and could not be reliably iden-
tified for the analysis. A total of 33 bifurcation sites from 33
patients were analysed; the mean age was 63+ 11 years, and
79% of the patients were male. The patients’ characteristics are
summarized in Table 1. Regarding the bifurcation location, 14 left
anterior descending coronary artery/diagonal (42%), 8 left circum-
flex coronary artery/marginal (24%), 8 right coronary artery/right
Figure 3 Coronary bifurcation angle measurements with MDCT. Multiplanar reconstructions were rendered exactly in the plane described
by the main vessel and side branch at the bifurcation site. Examples of the bifurcation angles between LAD and D1 (A, 368 and B, 458) and
between RCA and RVB (C, 668 and D, 988). D1, first diagonal branch; LAD, left anterior descending coronary artery; MDCT, multidetector
computed tomography; RCA, right coronary artery; RVB, right ventricular branch.
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ventricular branch (24%), and 3 right coronary artery/acute mar-
ginal branch (9%) were studied.
Plaque volumetric and compositional
characteristics
Overall, the mean plaque area was   increased   in  the  proximal
compared with the distal segment (IVUS-VH: 8.5+ 2.8 vs. 6.0+
3.0 mm2, P, 0.001 and MDCT: 9.0+ 2.6 vs. 6.5+ 2.5 mm2,
P, 0.001, respectively). The mean plaque burden % was higher
in the proximal compared with the distal segment (IVUS-VH:
52+ 13 vs. 44%+15%, P ¼ 0.002 and MDCT 51+11 vs.
46%+11%, P ¼ 0.029, respectively). The volumetric data
(Table 2) did not differ significantly between the two modalities.
Finally, the mean NC area and the mean percentage of NC were
increased in the proximal compared with the distal segment
(Figure 4).
Frequency of plaque type
Based on IVUS-VH, 2 bifurcations (6%) had no atherosclerotic
plaques at all, whereas in 14 bifurcations (42%) the plaque was
contiguous from the proximal to the distal segment. In total
there were 69 bifurcation segments with plaques, where of 25
were high-risk plaques. The proximal segment had the higher per-
centage of high-risk plaques (13 of 25, 52%), followed by the
in-bifurcation segment (6 of 25, 24%) and the distal segment
Table 1 Baseline patients’ characteristics, n 5 33
Age (mean+ SD), years 63+11
Male gender, n (%) 26 (79)
Risk factors
Hypertension, n (%) 24 (73)
Hypercholesterolaemia, n (%) 27 (82)
Diabetes mellitus, n (%) 6 (18)
Current smoking, n (%) 7 (21)
Family history of CAD, n (%) 15 (45)
Previous ACS, n (%) 10 (30)
Previous PCI, n (%) 8 (24)
Clinical presentation
Stable angina, n (%) 24 (73)
Unstable angina, n (%) 6 (18)
Acute myocardial infarction, n (%) 3 (9)
Studied vessel
Left anterior descending, n (%) 14 (42)
Left circumflex, n (%) 8 (24)
Right coronary artery, n (%) 11 (34)
Vessel disease, n (%)
One vessel disease 16 (50)
Two vessel disease 13 (41)
Three vessel disease 3 (9)
Calcium-related scoresa
Agatston score 313 (147–842)
Equivalent mass, mg 59 (29–152)
Volume, mm3 259 (150–701)
aValues are median (inter-quartile range). ACS, acute coronary syndrome; CAD,
coronary artery disease; PCI, percutaneous coronary intervention; SD, standard
deviation.
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Table 2 Volumetric data in each segment of the
bifurcation by MDCT and IVUS-VH
Mean values
Parameter MDCT
(mean+ SD)
IVUS-VH
(mean+ SD)
P-value
(t-test)
Mean plaque area (mm2)
Proximal 9.0+2.6 8.5+2.8 0.09
In-bifurcation 7.2+2.4 7.4+3.0 0.94
Distal 6.5+2.5 6.0+3.0 0.09
Mean plaque burden (%)
Proximal 51+11 52+13 0.69
In-bifurcation 46+11 45+13 0.20
Distal 46+11 44+15 0.15
IVUS-VH, intravascular ultrasound-virtual histology; MDCT, multidetector
computed tomography; SD, standard deviation.
Figure 4 Necrotic core (NC) distribution. NC area (A) and
NC percentage (B) distribution in the proximal, in-bifurcation,
and distal segments.
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(6 of 25, 24%); the distribution of the different plaque types within
each segment is shown in Figure 5A. On MDCT, non-calcified
plaques presented more frequently in the proximal segment,
whereas the calcified plaques were more frequent in the distal
segment (Figure 5B). The majority of high-risk plaques as deter-
mined by IVUS-VH were characterized by MDCT as non-calcified
ones (72%); the remaining 28% were classified as mixed. The
plaque type distribution per segment is shown in Figure 6.
Plaque distribution and composition in
relation to the bifurcation angle
Bifurcations containing plaques in their proximal segments had
significantly larger BA values compared with those without
(P ¼ 0.002), Table 3. Moreover, the presence of high-risk and non-
calcified plaques in the proximal segment was associated with
higher BA values (71+ 19 vs. 55+ 198, P ¼ 0.028 and 74+20
vs. 50+ 148, P ¼ 0.001, respectively). The BA was not related
significantly with either plaque distribution or composition in the
other segments.
Discussion
In this exploratory study, we evaluated the distribution and com-
position of atherosclerotic plaques at coronary bifurcations using
invasive and non-invasive imaging. To our knowledge, this is the
first in vivo study to examine the volumetric and compositional
plaque characteristics in combination with the 3D geometry of
coronary bifurcations (as expressed by the BA).
Our main findings can be summarized as follows: (i) the prox-
imal segment has a more extensive plaque burden with more
NC; (ii) the plaques with high-risk features on IVUS-VH and the
non-calcified plaques on MDCT both show a differential distribu-
tion along the bifurcation being more frequent in the proximal
segment; (iii) the distribution and composition of plaques in the
proximal segment is associated with the BA values.
Figure 5 Distribution of the different plaque types in each
segment. (A) virtual histology, (B) multidetector computed tom-
ography. The percentages indicate the frequencies of the different
plaque types within each segment.
Figure 6 Classification of the high-risk plaques by MDCT. The
IVUS-VH high-risk plaques were characterized by MDCT as non-
calcified and mixed. The distribution per segment is presented.
IVUS-VH, intravascular ultrasound-virtual histology; MDCT, mul-
tidetector computed tomography.
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Table 3 Bifurcation angle in relation to plaque
distribution and composition
Bifurcation angle
Segment Any plaque No plaque P-value
Proximal 62+20 46+5 0.002
In-bifurcation 56+18 66+22 0.139
Distal 57+20 66+20 0.186
High-risk plaques Non-high-risk
plaques
Proximal 71+19 55+19 0.028
In-bifurcation 49+8 58+20 0.155
Distal 60+25 55+17 0.654
Non-calcified
plaquesa
Mixed/calcified
plaquesa
Proximal 74+20 50+14 0.001
In-bifurcation 61+20 52+16 0.286
Distal 74+22 50+14 0.047
aAs characterized by multidetector computed tomography.
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The current study corroborates earlier findings on plaque volu-
metric and compositional characteristics at bifurcation sites. In a
previous IVUS study, Badak et al.24 suggested that significantly
more atheroma was located proximal to the bifurcation than dis-
tally. Han et al.14 expanded on these findings using IVUS-VH to
report on tissue characterization; that study showed that the
plaque burden and the percentage of the NC were significantly
larger in the proximal segment of the non-left main bifurcations.
These data appear to be largely concordant with a prior report
by Gonzalo et al.,5 using IVUS-VH and Optical Coherence Tomog-
raphy (OCT); they suggested that the percentage of the NC was
higher at the proximal ‘rim’ of the bifurcation. It has been shown
that the distribution of inflammatory cells in atherosclerotic
plaques is associated with the direction of the arterial flow, with
higher content of macrophages in the upstream (proximal)
part.25 The differential distribution of the NC and the high-risk
plaques along the coronary tree could be attributed to the influ-
ence of local haemodynamic factors altered at bifurcation sites.
Our data demonstrated that predominantly non-calcified plaque
type by MDCT corresponded to the IVUS-VH high-risk pheno-
type. This finding is in agreement with histopathology studies22
and with previous greyscale IVUS studies showing that plaques
with low echogenicity (presumably lipid rich) are mainly soft (non-
calcified) by MDCT.11,26,27 Conversely, other studies suggested
that mixed plaques on MDCT are associated more frequently
with high-risk features on IVUS-VH.28,29 A recent more systematic
evaluation30 demonstrated that only the non-calcified plaques with
small (,1 mm) spotty calcifications on MDCT were associated
with plaque characteristics deemed more high risk on IVUS-VH;
however, these plaques did not have significantly more
VH-TCFAs compared with non-calcified plaques. In our analysis,
the ROI included only plaques located within 5-mm long segments
proximal and distal to the SB; since atherosclerotic plaque can be
diffuse, in case a spotty calcification was located outside this ROI, it
would have not been included in our analysis.
The present study extended the assessment of bifurcation
lesions beyond volumetric and compositional analysis by integrat-
ing the MDCT-based BA measurements, which emphasizes the
added value of this 3D imaging modality. Our in vivo data
showed that the presence and phenotype of atherosclerotic
plaque in the proximal bifurcation segment is related to the BA
size. This finding could be supported by computational fluid
dynamics31–33 and histopathology34 studies demonstrating that
the haemodynamic phenomena important in atherogenesis are
more pronounced in widely angulated bifurcations. Moreover,
the BA size has been described as a determinant of treatment
strategy in bifurcation lesions.35 In numerous bench and clinical
studies,36–40 a wide BA has been associated with a greater risk
for suboptimal post-procedural result and long-term adverse
clinical events. Additionally, our data demonstrated that a wide
BA is associated with a greater plaque burden and a high-risk
phenotype of bifurcation lesions, which make us speculate that
NC-rich plaques could be related to the higher restenosis and
thrombosis rates.41–43 Eventually, a comprehensive assessment
of bifurcation lesions including plaque characterization and BA
measurements could lead to optimized interventional strategies
and improved long-term clinical outcomes.
Limitations
Although this is the first study combining invasive and non-invasive
imaging of bifurcations, it was retrospectively performed in a
selected patient population undergoing invasive and non-invasive
imaging, thus generalization of our results should be done with
caution. Given the inclusion of a limited number of patients, the
possibility of a type II error should be considered and multivariate
analysis for risk factors was not performed. Furthermore, the
limited axial resolution of the IVUS (200 mm) does not permit
an accurate evaluation of the thin fibrous cap (,65 mm). A pro-
posed method of combined use of IVUS-VH and OCT5,44 could
facilitate more accurate identification of VH-TCFAs, but was not
available for this study. Finally, the radiation exposure during
MDCT coronary angiography remains a matter of concern; signifi-
cant reduction in radiation dose can currently be achieved by im-
plementation of dose-saving techniques.45
Conclusions
This study extended the evaluation of bifurcation lesions beyond
volumetric and compositional analysis by integrating information
on the geometry of coronary bifurcations. A larger plaque
burden and increased NC content were found in the proximal bi-
furcation segments. The high-risk plaques on IVUS-VH and the
non-calcified plaques on MDCT tend to accumulate in the prox-
imal bifurcation segments, especially in the presence of a wide BA.
Conflict of interest: None declared.
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A CT-based Medina Classification in Coronary
Bifurcations: Does the Lumen Assessment Provide
Sufficient Information?
Stella-Lida Papadopoulou,1,2 MD, Chrysafios Girasis,1 MD, Frank J. Gijsen,3 PhD,
Alexia Rossi,1,2 MD, Jade Ottema,3 MD, Alina van der Giessen,3 PhD,
Johan C. Schuurbiers,3 BSC, Hector M. Garcia-Garcia,1 MD, PhD,
Pim J. de Feyter,1,2 MD, PhD, and Jolanda J. Wentzel,3* PhD
Aims: To evaluate the distribution of atherosclerosis at bifurcations with computed to-
mography coronary angiography (CTCA) and propose a novel CT-Medina classification
for bifurcation lesions. Methods: In 26 patients (age 556 10 years, 81% male) imaged
with CTCA, 39 bifurcations were studied. The bifurcations analysis included the proxi-
mal main vessel, the distal main vessel and the side branch (SB). Plaque contours
were manually traced on CTCA; the lumen, vessel and plaque area were measured, as
well as plaque burden (%). The carina cross-sections were divided into four equal
parts according to the expected wall shear stress (WSS) to assess circumferential pla-
que distribution. All the bifurcation lesions were classified using the Medina classifica-
tion and a novel CT-Medina classification combining lumen narrowing and plaque
burden 70%. Results: Presence of severe plaque (plaque burden 70%) by CTCA
was demonstrated in 12.8% (5/39) of the proximal segments, 15.4% (6/39) of the distal
segments and 7.7% (3/39) of the SB segments. The thickest plaque was located more
often in low WSS parts of the carina cross-sections, whereas the flow divider was
rarely affected. Although in the majority of bifurcations plaque was present, based on
the Medina classification 92% of the assessed bifurcations were identified as 0,0,0.
Characterization of bifurcation lesions using the new CT-Medina classification provided
additional information in seven cases (18%) compared to the Medina classification
Conclusion: Atherosclerotic plaque is widely present in all bifurcation segments, even
in the absence of coronary lumen stenosis. A CT-Medina classification combining
lumen and plaque parameters is more informative than angiographic classification of
bifurcation lesions and could potentially facilitate the decision-making on the treat-
ment of these lesions. VC 2014 Wiley Periodicals, Inc.
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INTRODUCTION
In patients with risk factors for atherosclerosis, the
development of plaque is not uniform across the entire
coronary tree, but shows a predilection for sites where
the laminar blood flow gets disturbed [1,2]. The low-
oscillatory endothelial shear stress has been shown to
facilitate atherogenesis and promotes the development
of rupture-prone plaques in the vicinity of coronary ar-
tery bifurcations [3–5].
Percutaneous treatment of coronary bifurcation
lesions remains a challenging procedure and has been
associated with higher restenosis and stent thrombosis
rates [6–8]. More precise and detailed assessment of
the plaque distribution may allow for safer and more
efficient treatment strategies. Invasive coronary angiog-
raphy (ICA) is regarded as the common diagnostic tool
for the detection of significant (50% lumen diameter
stenosis) bifurcation lesions and the planning of percu-
taneous coronary intervention (PCI) in the coronary
bifurcations. The Medina classification [9] based on
ICA has been widely accepted as a simplified method
to characterize bifurcation lesions and facilitate the
decision-making on the treatment of these lesions.
Computed tomography coronary angiography
(CTCA) has emerged as a noninvasive method to visu-
alize coronary atherosclerosis, based on extensive
cross-sectional correlation with IVUS data [10–12].
Similarly to IVUS, CTCA goes beyond lumenography
and enables the assessment of atherosclerotic plaque.
Moreover, the complex three-dimensional (3D) geome-
try of coronary artery bifurcations can be better visual-
ized by means of this imaging modality which can
provide a 3D reconstruction of the bifurcation, without
the limitations of vessel foreshortening and overlap
that exist in conventional angiography; CTCA has been
previously shown to allow accurate assessment of com-
plex bifurcation lesions [13].
The objective of the current study is twofold: (1) to
assess the distribution of atherosclerosis at bifurcation
sites using CTCA; and (2) to propose a novel CT-
based Medina classification scheme for bifurcation
lesions, combining lumen stenosis and plaque severity.
METHODS
Patients
We retrospectively analyzed a cohort of patients
who were treated in our institution for acute coronary
syndromes between May 2005 and January 2006.
Acute coronary syndrome (ACS) was defined as ST-
segment elevation myocardial infarction, non-ST-
segment elevation myocardial infarction (troponin
positive) or unstable angina (troponin negative). Imme-
diately after initial management of the culprit lesions,
these patients were asked to participate in the CTCA
study. They were considered for inclusion only if they
had a heart rate lower than 70 bpm during the CTCA
acquisition and had no prior coronary bypass surgery.
Exclusion criteria included renal dysfunction (serum
creatinine >120 mmol L1), contrast allergy and irreg-
ular heart rhythm. The institutional review board of
our hospital approved the study, and all patients pro-
vided written informed consent before study participa-
tion.
CTCA Acquisition
All patients underwent CTCA with a 64-slice scan-
ner (Sensation 64, Siemens Medical Solutions, For-
chheim, Germany). As the ACS patients were already
treated with intravenous nitrates and b-blockers, addi-
tional medication prior to CT scan was not necessary.
The CT angiographic scan parameters were: gantry
rotation time of 330 ms; 32  2 slices per rotation; 0.6
mm detector collimation; spiral scan mode with a table
feed of 3.8 mm per rotation; a tube voltage of 120 kV;
and tube current of 900 effective mAs. Prospective
ECG-triggered X-ray tube modulation was not applied.
A bolus of 100 mL of contrast material (400 mgI
mL1; Iomeron, Bracco, Milan, Italy) was injected
intravenously at 5 mL sec1 flow rate followed by a
saline chaser. The initiation of the scan was synchron-
ized to the arrival of contrast in the coronary arteries
by a bolus-tracking technique. The mean effective radi-
ation dose was 14.06 0.8 mSv, using the dose-length
product and a conversion factor k (0.014 mSv/mGy/
cm) [14]. Axial CT images were reconstructed with a
slice thickness of 0.75 and 0.4 mm increments using a
retrospectively ECG gating algorithm to obtain opti-
mal, motion-free image quality. Optimal data sets with
the best image quality were reconstructed mainly in
the mid- to end-diastolic phase, using a medium-
smooth convolution kernel.
Bifurcation Selection
All untreated vessels with diameter 1.5 mm were
retrospectively screened for bifurcations visualized
with high quality; only major bifurcations [side branch
(SB) with an ostial diameter 1.5 mm] which were
located at a distance >10 mm from adjacent branches
were considered for inclusion. The region of interest
(ROI) selected for analysis comprised the three seg-
ments of the bifurcations: proximal main vessel (MV),
distal MV and SB, up to a distance of 5-mm away
from the bifurcation carina (5 mm to 5 mm from ca-
rina) (Fig. 1).
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CTCA Image Analysis
Datasets were transferred to an offline workstation for
further analysis using an in-house developed tool, based
on MeVisLab software (MeVisLab, Mevis, Bremen,
Germany, http://www.mevislab.de). The methodology
used for this analysis has been previously investigated
and described in detail [11], showing a correlation of
r¼ 0.91 between CTCA and IVUS for plaque volume
quantification. In brief, both the inner lumen and the
outer vessel boundaries were annotated following a step-
wise approach. Multiplanar reformatted images were
generated and the lumen and vessel borders were traced
longitudinally on at least three different vessel views;
the intersections between these longitudinal contours
and cross-sectional images at 1-mm intervals were cal-
culated in order to create cross-sectional contours,
which were inspected and, if necessary, adjusted by an
experienced observer (Fig. 2). The settings for window
level and width were fixed at 740 and 220 HU, respec-
tively. The annotation of lumen and vessel wall borders
was also facilitated by gradient magnitude images,
which are derived from the CTCA images (Fig. 2B) and
represent the amount of local change in image intensity.
Plaque quantitative parameters for each 1-mm cross-
section included lumen, vessel, and plaque area and they
were averaged over the 5-mm length of each one of the
three bifurcation segments. The % plaque burden [(pla-
que area/vessel area)  100] was also calculated and
two different thresholds were used to classify plaque
presence and distribution within the coronary bifurca-
tion segments: 40% for any plaque, similarly to previ-
ous IVUS studies [15]; and 70% for severe plaque,
which has been also shown to be an independent predic-
tor of events in the PROSPECT study [16]. Finally, for
the cross-sections at the level of the bifurcation carina
(MV carina cross-section and SB carina cross-section),
the maximum wall thickness was measured; the carina
cross-section was the frame immediately distal to the
take-off of the SB in which both ostia of the MV and
SB could be visualized as a figure-of-eight shape (0 mm
in MV Fig. 1). To investigate the plaque location in rela-
tion to the carina, we divided each carina cross-section
into four parts from the center of the lumen and the part
with the thickest plaque was documented. The cross-
section was divided is such way that the flow divider
was in the middle of one of the parts. We labelled the
part opposite to the flow divider, I; the part facing the
myocardial side of the heart, II; the part facing the peri-
cardium, III; and the part containing the flow divider,
IV (Fig. 3). In this way, the numbering of the parts is
according to the expected wall shear stress (WSS): in
part I the lowest and in part IV the highest WSS [17].
The Medina Classification and the CT-medina
Classification for Bifurcation Lesions
All coronary bifurcation segments were visually
scored for the presence of significant lesions (diameter
reduction of 50%) by carefully axial scrolling and
using multiplanar reconstructions, as previously
described [13]. The bifurcation lesions with significant
lumen narrowing were categorized using a widely used
classification scheme, known as the Medina [9] bifur-
cation classification. The Medina classification is a
simple binary system whereby significant lumen
Fig. 1. The region of interest selected for analysis comprised
the three segments of the bifurcations (proximal main vessel,
distal main vessel and side branch), up to a distance of 5 mm
away from the bifurcation carina.
Fig. 2. Example of bifurcation quantitative analysis. Panel A:
in the normal MDCT image, the vessel lumen is brightly
enhanced, and a non-calcified, eccentric plaque is visible.
Panel B: in the gradient MDCT image, the greater change in
image intensity is depicted brighter, which facilitates the dis-
crimination of borders between tissues with different inten-
sity. Panel C: longitudinal main vessel view.
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narrowing is classified as present (1) or absent (0) in the
proximal main vessel, distal main vessel and SB seg-
ments. The Medina classification was further modified
into a new CT-based Medina classification to incorpo-
rate information about severe (70%) plaque presence
by adding an asterisk (*) as a superscript to the existing
segments’ score (example shown in Fig. 4).
Statistical Analysis
Continuous variables were presented as means6 1
standard deviation, unless otherwise indicated, and cat-
egorical variables were reported as counts and/or per-
centages. Continuous variables were compared between
the different bifurcation segments using paired t test. A
two-sided P value <0.05 was considered statistically
significant with Bonferroni correction for multiple
comparisons when necessary. Statistical analyses were
performed using SPSS 17.0 for Windows (SPSS, Chi-
cago, IL).
RESULTS
Forty-four patients of the main cohort were screened,
and 66 major bifurcations (SB ostium 1.5 mm) were
inspected for inclusion. Reasons for exclusion of bifur-
cations were poor image quality due to coronary
motion or stack artifacts (n¼ 9), extreme calcification
(n¼ 2), and presence of trifurcations (n¼ 9). Moreover,
in seven cases more than one bifurcation were located
in proximity to each other and could not be isolated
for analysis. Finally, a total of 39 bifurcation sites
from 26 patients were analyzed; mean age was 556 10
years, whereas 81% of the patients were male. The
patients’ characteristics are summarized in Table I.
Regarding the bifurcation location, the bifurcations
studied were 13 left main (LM), 15 left anterior de-
scending artery (LAD)/diagonal, 3 left circumflex ar-
tery (LCX)/marginal, 3 right coronary artery (RCA)/
Fig. 3. The drawing illustrates the division of the carina
cross-section into parts and the corresponding numbering
according to the expected shear stress levels.
Fig. 4. The Medina classification was further modified into a new CT-based Medina classifi-
cation to incorporate information about severe (70%) plaque presence by adding an aster-
isk (*) as a superscript to the existing segments’ score. DS: diameter stenosis.
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right ventricular branch, 2 RCA/acute marginal branch
and 3 RCA/posterolateral branch.
Plaque Quantitative Geometrical Characteristics
Non-LM bifurcations. The analysis for the geo-
metrical characteristics of the 26 bifurcations is pre-
sented in Table II. Overall, as expected, the mean
lumen, vessel and plaque area were larger in the proxi-
mal compared to the distal main vessel (7.76 3.4 vs.
6.76 3.2 mm2, P< 0.001; 14.16 5.1 vs.11.96 5.0
mm2, P< 0.001; and 6.46 2.7 vs. 5.36 2.7 mm2,
P¼ 0.004, respectively). The plaque burden was not
significantly different between all three bifurcation seg-
ments.
LM bifurcations. The quantitative geometrical
characteristics are presented in Table III. Overall, the
mean plaque area was significantly lower in the LCX
compared to the LM (5.76 1.7 vs. 10.16 5.3 mm2,
P¼ 0.004) and to the LAD (5.76 1.7 vs. 8.36 3.3
mm2, P¼ 0.003). The plaque burden was highest in the
LAD, but not significantly different from the LM and
the LCX.
Plaque Location in Relation to the Flow Divider
In general, the MV carina cross-section and the SB
carina cross-section demonstrated a plaque burden of
47%6 14% and 43%6 16%, respectively (P¼ 0.124).
For the LM-bifurcations, the LAD carina cross-section
demonstrated a significantly higher plaque burden com-
pared to the LCX carina cross-section (54%6 15% vs.
37%6 12% respectively, P¼ 0.001) and a significantly
TABLE I. Patient Characteristics
Patients n¼ 26
Age (mean6 SD), yrs 556 10
Male gender, n (%) 21 (81%)
Clinical status at enrolment
AMI, n (%) 19 (73%)
Unstable angina, n (%) 7 (27%)
Risk factors
Obesity, n (%) 4 (15%)
Current smoking, n (%) 16 (61%)
Hypertension, n (%) 7 (27%)
Hyperlipidaemia, n (%) 7 (27%)
Diabetes mellitus, n (%) 1 (4%)
Family history of CAD, n (%) 15 (58%)
TABLE II. Geometrical Characteristics in Non-LM Bifurcation Sites (n526)
Variables Proximal main vessel Distal main vessel Side branch P/D P/SB D/SB
Volume
Average lumen CSA (mm3 mm1) 7.76 3.4 6.76 3.2 6.36 2.7 <0.001 NS NS
Average vessel CSA (mm3 mm1) 14.16 5.1 11.96 5.0 11.56 4.3 <0.001 NS NS
Average plaque CSA (mm3 mm1) 6.46 2.7 5.36 2.7 5.26 2.7 0.004 NS NS
Plaque burden (%) 456 12 446 12 456 13 NS NS NS
Minimum lumen area (mm2) 6.66 3.3 5.86 3.2 5.46 2.5 0.005 NS NS
Carina cross-section
Lumen CSA (mm2) – 6.76 3.4 6.86 3.1 – – NS
Vessel CSA (mm2) – 12.46 5.0 12.16 4.6 – – NS
Plaque CSA (mm2) – 5.76 2.7 5.36 3.2 – – NS
Plaque burden (%) – 476 14 436 16 – – NS
Maximum wall thickness – 1.156 0.46 1.066 0.40 – – NS
CSA: cross-sectional area; D: distal main vessel; LM: left main; P: proximal main vessel; SB: side branch.
TABLE III. Geometrical Characteristics in LM Bifurcation Sites (n5 13)
Variables LM LAD LCX LM/LAD LM/LCX LAD/LCX
Volume
Average lumen CSA (mm3 mm1) 11.06 3.5 8.36 2.7 8.56 4.5 0.004 NS NS
Average vessel CSA (mm3 mm1) 21.16 7.0 16.66 4.6 14.26 5.0 0.002 0.005 NS
Average plaque CSA (mm3 mm1) 10.16 5.3 8.36 3.3 5.76 1.7 NS 0.004 0.003
Plaque burden (%) 466 15 496 13 426 12 NS NS NS
Minimum lumen area (mm2) 8.96 3.7 6.96 2.3 7.56 4.1 0.014 NS NS
Carina cross-section
Lumen CSA (mm2) – 8.56 3.4 9.76 4.2 – – NS
Vessel CSA (mm2) – 18.96 6.5 15.46 5.4 – – NS
Plaque CSA (mm2) – 10.56 5.2 5.76 2.3 – – 0.002
Plaque burden (%) – 546 15 376 12 – – 0.001
Maximum wall thickness – 1.666 0.39 1.016 0.36 – – 0.001
CSA: cross-sectional area; LAD: left anterior descending artery; LCX: left circumflex artery; LM: left main.
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higher maximum wall thickness (1.666 0.39 mm vs.
1.016 0.36 mm, respectively, P¼ 0.001).
The thickest plaque was located in presumably low
WSS parts I and II in 53% (27/51) and 33% (17/51) of
the carina cross-sections respectively. The high WSS
parts III and IV were less often affected than parts I and
II, only in 10% (5/51) and 4% (2/51) of the cross-
sections (Fig. 5). The two cross-sections with the thickest
plaque located on the carina (part IV) were non-LM
bifurcations and the plaque was expanding to other parts.
Medina Classification and CT-based Medina
Classification of Plaque Distribution
Overall, in this study three bifurcations (8%) had a
stenosis 50% in at least one of the three segments of
the bifurcation, resulting in 92% having a Medina clas-
sification of 0,0,0 (Table IV). However, CTCA demon-
strated plaque burden 40% in 84.6% (33/39) of the
proximal segments, 82.1% (32/39) of the distal seg-
ments and 82.1% (32/39) of the SB segments. Presence
of severe plaque (plaque burden 70%) by CTCA was
demonstrated in 12.8% (5/39) of the proximal seg-
ments, 15.4% (6/39) of the distal segments and 7.7%
(3/39) of the SB segments.
The distribution of bifurcation lesions using both the
Medina classification and the CT-based Medina classifi-
cation combining lumen narrowing and plaque severity
is shown in Table IV. Characterization of the bifurcation
lesions using the new CT-based Medina classification
provided additional information in seven cases (18%)
compared to the original Medina classification.
DISCUSSION
In this exploratory study we sought to investigate
the distribution of atherosclerosis at bifurcation sites
using CTCA and to propose a novel CT-based Medina
classification scheme for bifurcation lesions, combining
lumen and plaque information. The main findings of
this report are as follows: (1) the plaque is widely pres-
ent in all bifurcation segments, even in the absence of
coronary lumen stenosis; (2) the plaque is more often
located opposite to the flow divider, whereas the carina
is rarely affected with plaque; and (3) a CT-Medina
classification scheme combining lumen and plaque se-
verity could be more informative than angiographic
classification for the description of atherosclerosis at
bifurcation sites.
In the present study, we found that atherosclerotic
plaque is widely present in all bifurcation segments.
Regarding the quantitative analysis, in the non-LM
bifurcations, the proximal segment had a greater plaque
burden than the distal, whereas in the LM bifurcations
greater plaque burden was found in the distal segment
(LAD). This observation is in line with earlier reports
on plaque geometrical characteristics at bifurcation
sites [18–20], which demonstrated the heterogeneous
nature of coronary atherosclerosis at coronary bifurca-
tions according to their segments and anatomical loca-
tions (LM vs. non-LM bifurcations).
As shown in previous reports, atherosclerosis has a
predilection for the outer wall of bifurcations, where
shear stress is low and blood flow is oscillatory; the
flow divider is minimally diseased or spared
[15,17,21–23]. Our analysis with CTCA corroborates
this pattern; the thickest plaque was primarily located
in low WSS parts I and II, while the high WSS parts
III and IV were less often affected.
Currently, angiographic classification of bifurcations
is widely accepted in clinical practice; nevertheless
conventional angiography is an imperfect tool, which
considerably underestimates the extent of atheroscler-
otic lesions when compensatory positive remodeling is
present [24–26]. In addition, the angiographic assess-
ment of coronary bifurcations is limited by vessel fore-
shortening and overlap. In a previous IVUS study,
Fig. 5. Circumferential plaque distribution in the carina
cross-sections. The figure gives the percentage (and absolute
number) of cross-sections with occurrence of maximal plaque
in each part.
TABLE IV. Distribution of Bifurcation Lesions Using Medina
Classification and CT-Medina Classification Schemes
Medina classification
CT-Medina classification
(50% lumen diameter reduction
and plaque burden 70%)
0,0,0 (n¼ 36) ! 0,0,0 (n¼ 32)
! 0,0*,0 (n¼ 1)
! 0,0,0* (n¼ 1)
! 0*,0*,0 (n¼ 2)
1,0,0 (n¼ 1) ! 1*,0*,0* (n¼ 1)
1,1,0 (n¼ 2) ! 1*,1*,0 (n¼ 1)
! 1*,1*,0* (n¼ 1)
CT: computed tomography.
J_ID: z7v Customer A_ID: CCD25496 Cadmus Art: CCD25496 Ed. Ref. No.: 13-1536.R1 Date: 29-March-14 Stage: Page: 6
ID: thangaraj.n Time: 00:41 I Path: N:/3b2/CCD#/Vol00000/140140/APPFile/JW-CCD#140140
96
Oviedo et al. [15] reported the distribution of plaque at
the LM bifurcation, and proposed an IVUS classification
of plaque morphology which was compared with the com-
monly used Medina system. The authors concluded that
there was no relation between the Medina angiographic
classification and IVUS plaque distribution. Similarly to
IVUS, imaging by CTCA goes beyond lumenography and
enables the assessment of atherosclerotic lesions that are
angiographically “silent.” In our investigation, we propose
a simple modification of the Medina classification to
incorporate plaque severity, by using a threshold of
70% plaque burden which was shown as independent
predictor of events in the PROSPECT study [16]. In addi-
tion, the severity of pre-procedural plaque burden at the
MV was shown to correlate with functional SB compro-
mise after stent implantation [27].
Clinical Implications
As CTCA is becoming widely available and its value
in detecting significant lumen narrowing has been
robustly established, many patients are being brought
into the cathlab based on the CTCA findings. Percutane-
ous treatment of coronary bifurcation lesions has been
associated with worse acute and late outcomes due to
higher restenosis and stent thrombosis rates [6–8]. Com-
prehensive pre-interventional assessment of both lumen
stenosis and plaque severity of a diseased coronary
bifurcation may be important to better plan a percutane-
ous strategy. Although carina shift is suggested to be the
predominant mechanism of SB lumen loss after MV
stent implantation, plaque shift from the MV also con-
tributes to the aggravation of an SB ostial lesion and
was more frequently observed in hemodynamically sig-
nificant SB lesions [27,28]. Therefore, we envision that
a CT-based Medina classification of bifurcation lesions
may assist the preparation for the bifurcation stent im-
plantation, regarding for example the location of the
stent or even the need for a second stent, whereas the
prevailing technique is the provisional stenting. Espe-
cially the presence of 0* at the side branch ostium in a
case of 1, 0, 0* classification, could herald acute SB
occlusion after provisional stenting, which could neces-
sitate a two-stent strategy from the beginning or the use
of dedicated bifurcation stent. Although novel, this clas-
sification was based on an analysis of a small number of
patients, thus it must be considered work in progress.
Larger studies with procedural and clinical outcomes
are warranted to examine the value of the newly intro-
duced CT-Medina classification.
Limitations
We acknowledge that our investigation has several
limitations. This exploratory study was retrospectively
performed and is relatively small in terms of number
of patients included, thus the possibility of a type II
error should be considered. The analysis was per-
formed on a cohort of consecutive ACS patients treated
in our hospital, thus our population may not be repre-
sentative of all the patients reaching the cath lab (for
example stable angina patients who tend to be older).
In this population, the majority of bifurcations did not
have significant lumen narrowing; however our inten-
tion was to investigate the plaque presence and distri-
bution at bifurcations irrespective of lumen stenosis. It
is not clear from this study how the clinical and proce-
dural outcome for the re-classified bifurcations would
be altered, thus larger prospective studies to obtain
prognostic information are warranted. Finally, the radi-
ation exposure during MSCT coronary angiography
remains a matter of concern; nevertheless, the imple-
mentation of dose-saving techniques results in effective
dose less than the 5 mSv of the invasive coronary an-
giography and plaque assessment using newer scanning
technology and protocols has been shown feasible [20].
CONCLUSION
Atherosclerotic plaque is widely present in all bifur-
cation segments, even in the absence of coronary
lumen stenosis. The plaque is more often located oppo-
site to the flow divider, whereas the carina is rarely
affected. A CT-Medina classification scheme combin-
ing lumen stenosis and plaque severity is more inform-
ative than angiographic classification of bifurcation
lesions and could potentially facilitate the decision-
making on the treatment of these lesions.
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 Chapter 8      
 The Multislice Computed Tomography (MSCT) SYNTAX Score: a feasibility and reproducibility study                                                                                                                   Based on: JACC Cardiovasc Imaging. 2013 Mar;6(3):413-5.  
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Abstract 
 
Objectives: To investigate the feasibility and reproducibility of the multislice computed tomography SYNTAX score (MSCT SXscore). 
Background: The invasive coronary angiography SYNTAX score (ICA SXscore) is an important prognostic tool in risk stratifying patients undergoing revascularisation, as well as an independent predictor of adverse cardiac events. 
Methods: The ICA SXscore definitions were reviewed and adapted for MSCT. The SXscore of 80 symptomatic patients who underwent ICA and MSCT was retrospectively calculated for both modalities by 2 independent teams of experienced reviewers. Corresponding scores were compared between modalities with the Spearman correlation coefficient and Bland-Altman analysis. The MSCT SXscore was re-calculated after two months in 40 random patients to assess intra-observer variability with kappa statistics. The Agatston calcium score was also calculated, reflecting the overall burden of disease.  
Results: There was good correlation between the ICA SXscore and the MSCT SXscore (rs=0.76, p<0.001), whereas the median MSCT SXscore was higher compared to the median ICA SXscore [13.0 (IQR 7-24) vs. 10.5 (IQR 5-20.75) respectively,p=0.004]. Kappa statistics indicated a substantial intra-observer agreement for MSCT SXscore tertiles (κ=0.80; 95%CI [0.67,0.94],p<0.001), and the correlation between the two rounds of analyses was high (r=0.95, p<0.001). The median calcium score across the MSCT SXscore tertiles was 145.8, 312.0 and 743.6 respectively (p<0.001); across the ICA SXscore tertiles, it was 145.8, 188.7 and 932.0 respectively (p<0.001). 
Conclusion: In this exploratory study the calculation of the MSCT SXscore in symptomatic patients appeared feasible and reproducible. The long-term prognostic role of this scoring methodology should be further investigated. 
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Abbreviations list: 
Ca score: calcium score 
CAD: coronary artery disease 
ECG: electrocardiogram 
ICA: invasive coronary angiography 
MSCT: multislice computed tomography 
SXscore: SYNTAX score
106
Introduction 
 The SYNTAX Score (SXscore) (1) is an important tool to grade angiographic complexity and to risk stratify patients being considered for revascularisation (2-4); in addition, it has been shown to be an independent predictor of major adverse cardiac events in ‘all-comers’ type populations with a varying extent of coronary artery disease (5-9). The SXscore has been integrated in both the European and U.S. revascularisation guidelines for the risk stratification of patients with complex coronary artery disease, facilitating the choice of the most appropriate revascularisation modality (10-12).  
The potential of multislice computed tomography (MSCT) to obtain information noninvasively comparable to that provided by invasive coronary angiography has been the most important factor behind the broad adoption and dissemination of cardiac CT imaging. It is envisioned that MSCT coronary angiography may have the ability to provide information not currently available from invasive angiography (i.e. plaque burden and calcium score) and may change the way patients with atherosclerotic cardiovascular disease are stratified and managed (13). 
A number of comparative reports have examined the diagnostic performance of MSCT angiography against conventional invasive coronary angiography (ICA), reporting a very high sensitivity and specificity (14). Therefore in this study we explore for the first time the feasibility of a MSCT-derived SXscore in a population of symptomatic patients with suspected coronary artery disease (CAD); in addition, we investigate the reproducibility of the newly developed MSCT SXscore. 
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UMethods 
 
Study population The study comprised all consecutive symptomatic patients suspected of having CAD who were referred for invasive coronary angiography and were invited to undergo a MSCT angiography examination between May 2009 and October 2010. Exclusion criteria were prior revascularization, iodine allergy or impaired renal function. All patients gave informed consent and were entered in our single center cardiac database.  
 
MSCT acquisition The patients were scanned with a second generation dual-source CT scanner (Somatom Definition Flash, Siemens Healthcare, Forchheim, Germany). All patients received nitroglycerin (0.4 mg/dose) sublingually just prior to the CT scan, provided there were no contraindications and patients with a heart rate above 65 bpm received beta-blockers. An initial non-enhanced ECG gated scan (120-kV tube voltage, 75 mAs tube current and 3-mm slice thickness) was performed to calculate the Agatston calcium score (15), and was followed by a contrast enhanced CT angiography. The CT angiographic parameters were: 64 x 2 x 0.6 mm collimation with z-flying focal spot for both detectors, gantry rotation time 280 ms, tube voltage of 100 to 120 kV, current of 320 to 370 mAs. A bolus of iodinated contrast material (370 mgI/mL, Ultravist; Schering, Berlin, Germany), which varied between 60 and 100 mL depending on the expected scan time, was injected intravenously (flow rate, 5.5 mL/sec) followed by a 45 mL saline chaser at the same injection rate. A bolus tracking technique was used to synchronize the arrival of contrast in the coronary arteries and the start of the MSCT acquisition. The prospectively ECG-triggered axial scan mode (“step-and-shoot”) or the low pitch ECG-gated spiral scan mode with ECG-pulsing was used, depending on the heart rate; the high pitch spiral scan protocol was used in selected patients (16). Overall, the mean effective radiation dose was 5.4 ±3.5 mSv, using the dose-length product and a conversion factor k of 0.014 mSv/mGy/cm (17): 4.8 ±3.2 mSv for the contrast-enhanced scan and 0.6 ±0.5 mSv for the non-enhanced scan. All MSCT coronary angiograms were reconstructed with a slice thickness 0.75 mm and an increment 0.4 mm. Datasets were reconstructed retrospectively for the low pitch scan and “step-and-shoot” sequential scans in systolic and diastolic phases of the RR-interval for 
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high (≥80 bpm) and low heart rates (≤65 bpm) respectively, to obtain motion-free images; both systolic and diastolic phases of the RR-interval were used in medium heart rates. Datasets for the high pitch spiral scans could only be reconstructed at one diastolic phase. Images were analyzed using medium-to-smooth convolution kernels for non-calcified lesions and sharp convolution kernels for calcified lesions.  
ICA SYNTAX Score and angiographic analysis The SYNTAX score algorithm, which is described in full elsewhere and is available on the SYNTAX score website (Uhttp://www.syntaxscore.com), was used to score all coronary lesions deemed to have a percentage diameter stenosis ≥50%, in vessels ≥1.5 mm. The conventional coronary angiograms were analysed side by side by a panel of 2 interventional cardiologists; in case of disagreement, the opinion of a third analyst was obtained and the final decision was reached by consensus. The final score was calculated on a patient basis from the individual lesion scores, which were saved in a dedicated database.  
MSCT SYNTAX Score and MSCT analysis  
U
All datasets were transferred for analyses to an offline multi-modality workstation (MMWP workstation, Leonardo, Siemens, Erlangen, Germany). All definitions of the ICA SXscore components were reviewed and adapted for the MSCT capabilities (Table 1); the online SXscore algorithm (Uhttp://www.syntaxscore.com) was used to calculate the MSCT SXscore. Similarly to the conventional angiography, the MSCT scans were analysed side by side by a panel of 2 experienced reviewers to identify the lesions with percentage diameter stenosis ≥50% and then calculate the MSCT SXscore (example shown in Figure 
1). Before the study, 20 cases were reviewed as training cohort for the MSCT SXscore calculation and then discarded from the final analysis. To assess intra-observer variability, the MSCT SXscore calculation was repeated in 40 randomly selected cases at a 2-month interval with the reviewers blinded to the original MSCT SXscores. The time required for the MSCT SXscore calculation was also measured, on top of the MSCT assessment for the detection of significant lesions. 
U
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Table 1. Definitions of the ICA SXscore features as reviewed and adapted for the MSCT SXscore 
Conventional definition [Sianos et al.(1), Serruys et al. (3)] MSCT definition 
Dominance 
Right dominance: the posterior descending coronary artery is a branch of the right coronary artery (segment 4) 
Left dominance: the posterior descending artery is a branch of the left coronary artery (segment 15). Co-dominance does not exist as an option in the SYNTAX score. 
Dominance (=) 
Right dominance: the posterior descending coronary artery is a branch of the right coronary artery (segment 4) 
Left dominance: the posterior descending artery is a branch of the left coronary artery (segment 15). Co-dominance does not exist as an option in the SYNTAX score. 
Total occlusion No intra-luminal antegrade flow (TIMI 0) beyond the point of occlusion. However, antegrade flow beyond the total occlusion might be maintained by bridging collaterals (Small channels running in parallel to the vessel and connecting proximal vessel to distal and being responsible for the ipsilateral collateralization) and/or ipsi collaterals. 
Total occlusion (~) No intra-luminal antegrade flow (TIMI 0) beyond the point of occlusion; it is visualized as the non-contrast enhanced segment of the vessel. Bridging collaterals and/or ipsi collaterals can only be measured by conventional angiography. (25)  
Stump Defined as the entry site of the occlusion that has either a tapered- (central or eccentric) or a blunt appearance.  
Stump (=) Defined as the entry site of the occlusion that has either a tapered- (central or eccentric) or a blunt appearance. (25) 
Segment numbers beyond the total occlusion  Specify the first that is visualized by antegrade or retrograde contrast. Segment numbers beyond the total occlusion (=) Specify the first that is visualized by antegrade or retrograde contrast. 
Sidebranch at the origin of the occlusion Specify whether this is smaller or at least 1.5 mm diameter. Sidebranch at the origin of the occlusion (=) Specify whether this is smaller or at least 1.5 mm diameter 
Trifurcation A trifurcation is a division of a mainbranch into three branches of at least 1.5mm. Trifurcations are only scored for the following segment junctions: 3/4/16/16a, 5/6/11/12, 11/12a/12b/13, 6/7/9/9a and 7/8/10/10a. 
Trifurcation (=) A trifurcation is a division of a mainbranch into three branches of at least 1.5mm. Trifurcations are only scored for the following segment junctions: 3/4/16/16a, 5/6/11/12, 11/12a/12b/13, 6/7/9/9a and 7/8/10/10a. 
Bifurcation A bifurcation is a division of a main, parent, branch into two daughter branches of at least 1.5mm. Bifurcation lesions may involve the proximal main vessel, the distal main vessel and the side branch according to the Medina classification. The smaller of the two daughter branches should be designated as the ‘side branch’. In case of the main stem either the LCX or the LAD can be designated as the side branch depending on their respective calibres. Bifurcations are only scored for the following segment junctions: 5/6/11, 6/7/9, 7/8/10, 11/13/12a, 13/14/14a, 3/4/16 and 13/14/15.  
Bifurcation (=) A bifurcation is a division of a main, parent, branch into two daughter branches of at least 1.5mm. Bifurcation lesions may involve the proximal main vessel, the distal main vessel and the side branch according to the Medina classification. The smaller of the two daughter branches should be designated as the ‘side branch’. In case of the main stem either the LCX or the LAD can be designated as the side branch depending on their respective calibres. Bifurcations are only scored for the following segment junctions: 5/6/11, 6/7/9, 7/8/10, 11/13/12a, 13/14/14a, 3/4/16 and 13/14/15.  
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Table 1. (Cont’d) 
Aorto ostial A lesion is classified as aorto-ostial when it is located immediately at the origin of the coronary vessels from the aorta (applies only to segments 1 and 5, or to 6 and 11 in case of double ostium of the LCA). 
Aorto ostial (=) A lesion is classified as aorto-ostial when it is located immediately at the origin of the coronary vessels from the aorta (applies only to segments 1 and 5, or to 6 and 11 in case of double ostium of the LCA). 
Severe tortuosity One or more bends of 90° or more, or three or more bends of 45° to 90° proximal of the diseased segment. Severe tortuosity (=) One or more bends of 90° or more, or three or more bends of 45° to 90° proximal of the diseased segment. 
Length >20mm Estimation of the length of that portion of the stenosis that has ≥50% reduction in luminal diameter in the projection where the lesion appears to be the longest. (In case of a bifurcation lesion at least one of the branches has a lesion length of >20mm). 
Length >20mm (=) Estimation of the length of that portion of the stenosis that has ≥50% reduction in luminal diameter in the projection where the lesion appears to be the longest. (In case of a bifurcation lesion at least one of the branches has a lesion length of >20mm). 
Heavy calcification Multiple persisting opacifications of the coronary wall visible in more than one projection surrounding the complete lumen of the coronary artery at the site of the lesion. 
Heavy calcification (≠) Severe calcification was defined as the presence of calcium that occupies more than 50% of the vessel cross-sectional area at any location within the lesion (25) 
Thrombus Spheric, ovoid or irregular intraluminal filling defect or lucency surrounded on three sides by contrast medium seen just distal or within the coronary stenosis in multiple projections or a visible embolization of intraluminal material downstream. 
Thrombus (≠)  It is difficult for MSCT to distinguish thrombus from plaque; therefore this feature was not scored. 
Diffuse disease Present when at least 75% of the length of any segment(s) proximal to the lesion, at the site of the lesion or distal to the lesion has a vessel diameter of <2mm. 
Diffuse disease (=) Present when at least 75% of the length of any segment(s) proximal to the lesion, at the site of the lesion or distal to the lesion has a vessel diameter of <2mm. Coding of the symbols used: = definition remains the same; ~ definition slightly different; ≠ definition totally different  ICA: invasive coronary angiography; MSCT: multislice computed tomography; SXscore: SYNTAX score 
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Coronary calcium  The unenhanced CT-scan was used to calculate the total calcium score (Ca score) using the Agatston method (15). The coronary calcium reflects the overall burden of disease per patient; furthermore it has been shown to have incremental prognostic value in asymptomatic individuals (18), as well as in symptomatic patients (19-22). Under this perspective, we examined the further categorization of the SXscore tertiles into 2 other categories, one with low Ca score (≤400) and the other with high Ca score (>400), referred to as “extended MSCT SXscore”. More importantly, coronary calcium often prevents the reliable assessment of the coronary lumen and constitutes one of the main limitations of MSCT imaging; thus it is relevant to our study to investigate whether higher amounts of calcium tamper with the calculation of SXscore by MSCT compared to ICA.   
Statistical Analysis Continuous variables were expressed as means ± standard deviation or medians with interquartile range (IQR) when not normally distributed; categorical variables were presented as counts and/or percentages. Spearman’s rank correlation coefficient (rs) was used to measure the strength of the association of MSCT SXscore with ICA SXscore and Bland-Altman analysis was performed. The continuous variables not normally distributed were compared with the non-parametric Kruskal-Wallis test and the Wilcoxon signed ranks test. Intra-observer variability was determined with weighted kappa statistics that reflect the agreement between two or more observations using weight to quantify the relative difference between categories (23). It is usual to characterize strength of agreement with kappa values as follows: <0 none, 0-0.20 slight, 0.21-0.40 fair, 0.41-0.60 moderate, 0.61-0.80 substantial, 0.81-1.00 almost perfect (24).  To complete our analysis, a stratified comparison of the Ca score was also performed across the ICA and MSCT SXscore tertiles. In addition, any potential association between the coronary calcium and the bias in MSCT SXscore calculation compared to ICA SXscore was evaluated with a scatter plot of the Ca score and the MSCT – ICA SXscore differences. A 2-sided p-value <0.05 was considered significant for all tests. Analyses were performed with SPSS 17.0 (SPSS Inc., Chicago IL, USA). 
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Results 
 In total 93 eligible patients were retrospectively screened for inclusion in the study; in 6 cases the conventional angiography recordings were not complete or available and in 7 cases the MSCT scan quality was low due to stack and motion artifacts. In total 80 patients were analyzed for the purpose of the MSCT SYNTAX score study. The mean age was 62 ±11 years, and 73% were male. Regarding cardiac risk factors, 74.4%, 20.5%, and 70.5% had hypertension, diabetes mellitus, and hyperlipidemia, respectively, and 16.7% were smokers. There were 12.5% of the patients without significant lesions, whereas 42.5% had one-vessel disease, 28.8% had two-vessel disease and 16.3% had three-vessel disease. The duration of the MSCT SXscore calculation was on average 5:30 (±4:23) min.   
Comparison of the ICA and the MSCT SYNTAX Scores  There was a good correlation between the ICA and the MSCT SXscores (rs =0.76, p<0.001), 
Figure 2. The overall median values of ICA and MSCT SXscores were 10.5 (IQR 5 - 20.75) and 13.0 (IQR 7 - 24) respectively, p=0.004 (Table 2). The mean difference was 2.7 with a standard deviation of 7.9; Bland-Altman analysis is shown in Figure 3. The tertiles by ICA were defined as SXscoreLOW ≤7, 7< SXscoreMID ≤16.5 and SXscoreHIGH >16.5, whereas the tertiles by MSCT were defined as SXscoreLOW ≤9, 9< SXscoreMID ≤22 and SXscoreHIGH >22. Taking ICA SXscore tertiles as reference, in the SXscoreLOW exact agreement was found in 64.5% cases, whereas in the remaining ones (35.5%) MSCT SXscore was overestimated. Within SXscoreMID, exact agreement was found in 52.2%, whereas MSCT SXscore was underestimated in 30.4% and overestimated in 17.4% of the cases respectively; finally, within SXscoreHIGH the rates of exact agreement were 80.8% whereas MSCT SXscore was underestimated in 19.2% of the cases.  
Reproducibility Analyses There was a high correlation between the first and second rounds of analyses of the raw MSCT SXscores, r=0.95 (p<0.001), Figure 4. The intra-observer variability for the MSCT SXscore tertiles showed substantial agreement [κ=0.80; 95% CI (0.67, 0.94)], Table 3.  The weighted kappa value for the number of lesions, total occlusions and 
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Table 2. Distribution of SYNTAX Score by ICA and MSCT  
 ICA MSCT 
No. of 
lesions 
ICA SYNTAX Score ICA No. of lesions MSCT SYNTAX Score MSCT Median (IQR) 2 (1 – 4) 10.5 (5 – 20.25) 2 (1 – 3) 13.5 (7 – 25) Range 0 - 9 0 - 36.5 0 - 6 0 - 41 1st tertile - SxScoreLOW ≤7 - SxScoreLOW ≤9 2nd tertile - 7< SxScoreMID ≤16.5 - 9< SxScoreMID ≤22 3rd tertile  - SxScoreHIGH >16.5 - SxScoreHIGH >22 ICA: invasive coronary angiography; MSCT: multislice computed tomography 
Table 3.  MSCT SYNTAX Score According to Tertiles Recorded During Both Rounds of the Study  
 Round one                                                                            MSCT SYNTAX Score 
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T 
SY
N
TA
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e 
 ≤9 >9-≤22 >22 Total 
≤9 14 3 0 17 
>9-≤22 1 9 1 11 
>22 0 2 10 12 
Total 15 14 11 40 
MSCT: multislice computed tomography 
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bifurcation/trifurcation lesions was 0.87, 0.88 and 0.70, respectively. The variable with the lowest agreement was the number of long lesions [κ=0.49; 95% CI (0.25, 0.73)]. 
 
Calcium score and the MSCT SXscore The overall median Ca score was 313 (IQR 81 - 688). There was a moderate but significant correlation between the Ca score and both the ICA and the MSCT SXscores (rs=0.53 and rs=0.54 respectively, p<0.001). There was no correlation between the amount of calcium and the differences between MSCT and ICA SXscores (Figure 5).  Across the ICA SXscore tertiles, the median Ca Score was 145.8, 188.7 and 932.0 in SXscoreLOW, SXscoreMID and SXscoreHIGH respectively (P<0.001); across the MSCT SXscore tertiles, the median Ca Score was 145.8, 312.0 and 743.6 in the SXscoreLOW, SXscoreMID and SXscoreHIGH respectively (P<0.001), Figure 6. The extended MSCT SXscore (categorization of the tertiles into 2 other categories, one with Ca score≤400 and the other with Ca score>400) is presented in Figure 7. In the Ca score≤400 patients, there were 50%, 40.5% and 9.5% patients across the ICA SXscoreLOW, SXscoreMID and SXscoreHIGH tertiles respectively, while there were 52.4%, 35.7% and 11.9% across the MSCT SXscoreLOW, SXscoreMID and SXscoreHIGH tertiles respectively. In the Ca score>400 patients, there were 27.3%, 18.2% and 54.5% patients with ICA SXscoreLOW, SXscoreMID and SXscoreHIGH respectively, while in MSCT SXscore, there were 18.2%, 30.3% and 51.5% with MSCT SXscoreLOW, SXscoreMID and SXscoreHIGH respectively.  
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UDiscussion 
The main findings of this exploratory study are: 1) The application of the newly developed MSCT SXscore is feasible and is comparable to ICA SXscore; 2) the MSCT SXscore appears to be highly reproducible considering historical conventional SXscore data.  
ICA SXscore vs. MSCT SXscore 
This report investigates for the first time the feasibility of the MSCT SXscore and shows that it is comparable to the conventional ICA SXscore. For the purpose of this study, we reviewed all the definitions from the ICA SXscore and adapted them to the MSCT capabilities. One example is the scoring of heavy calcification by ICA; this was defined as multiple persisting opacifications of the coronary wall visible in more than one projection surrounding the complete lumen of the coronary artery at the site of the lesion (1), however this is known to correlate weakly with the Ca score (25). In contrast, for the MSCT SXscore we have used the following modified definition: severe calcification was defined as the presence of calcium that occupies more than 50% of the vessel cross-sectional area at any location within the lesion (25). This definition was deemed more suitable for MSCT, since it has been reported as an independent predictor of procedural failure for percutaneous revascularization (25).  
Of note, in our study the absolute difference between MSCT and ICA SXscores per patient did not correlate with the Ca Score, as presented in Figure 5. Although it can be hypothesized that extreme calcification, which is making the assessment of the coronary lumen more difficult, is responsible for the overestimation of SXscore by MSCT, it appears that the presence of high amount of calcium does not account for the difference between the SXscore calculation with the 2 modalities. Not unexpectedly, the median Ca score in each MSCT SXscore tertile increased gradually and proportionally with the increase of the MSCT SXscore value; conversely, this was not the case with the ICA SXscore, as in the two lower tertiles, the median Ca score was similar. This finding suggests that the stratification based on the MSCT SXscore tertiles reflects better the overall burden of the disease. 
Furthermore, the inability of MSCT to evaluate the presence of bridging collaterals and thrombus did not appear to have a detrimental effect on the comparability with the conventional ICA SXscore.  
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Reproducibility of the MSCT SXscore  
A diagnostic tool should be easy to perform and to analyze, accessible and reproducible. Generally speaking, both SXscores share the first qualities, but the MSCT SXscore as investigated by our group appears to have better reproducibility considering historical data (3,26-29). The general correlation of MSCT SXscore values between the first and second rounds of analysis was high, and so was the intra-observer agreement of the MSCT SXscore tertiles (weighted kappa 0.80). The latter has been reported to be lower in all previous studies using conventional angiography (3,26-28), except for a study by Genereux et al. (29) reporting a kappa value of 0.88 for one of the reviewers. One important consideration is the fact that these reports have mean ICA SXcores ranging from 16.2 to 34.1 while our overall ICA SXscore was much lower (median 10.5, mean 13.05). We acknowledge that the extent and complexity of the disease may affect the reproducibility. Nevertheless, the ICA SXscores of the cases included in our study are in the same range of values reported in the SIRTAX (SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization) (8) and the LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) (5) all-comers trials; to put our results in perspective, we envision that the MSCT SXscore could be used in the future in such populations since it has a better precision.  
Finally, it could be assumed that the MSCT SXscore is in part more reproducible than the ICA SXscore because the coronary bifurcations can be better visualized by MSCT, without the limitations of the vessel foreshortening and overlap that exist in conventional angiography. Indeed the reproducibility of the number of bifurcation/trifurcation lesions in MSCT SXscore is much better than the one reported in the studies using conventional angiography (3,26-29). 
 
Coronary calcium and the MSCT SXscore 
Coronary calcium and lumen stenoses are both different manifestations of atherosclerosis. The ICA SXscore is a lesion-based angiographic scoring system which cannot only quantify coronary anatomy, but has an additional role in the short- and long-term risk stratification 
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of patients having percutaneous revascularisation, as previous studies have demonstrated (5-9). Furthermore, the Ca score has been identified as an independent predictor of events in asymptomatic individuals (18), as well as in symptomatic patients (19-22). We propose that the MSCT SXscore could be extended by adding the Ca score as a variable; thereafter, a categorization could be made within each tertile according to the Ca score and might improve the risk stratification of the patients. Using 400 as a cut-off for high Ca score in our study, we have observed that among patients with Ca score≤400 , there was 12% in the MSCT SXscoreHIGH tertile, which may have a different prognosis from their counterparts with Ca score>400; conversely, 18% of patients in the Ca score>400 group were in the MSCT SXscoreLOW tertile, and may also have different outcome that their counterparts with Ca score≤400.     
Study Limitations We acknowledge that our investigation has several limitations. This study is relatively small in terms of number of patients included (total number of readings 120 MSCTs and 80 ICAs) and the inclusion was not prospectively done. It has never been our intention to correlate the findings with clinical outcomes since our study might have been underpowered; therefore it should be seen only as an exploratory and feasibility study, without formal statistical hypotheses. Similarly to conventional angiography, the reliability of the MSCT SXscore depends considerably on the experience of the MSCT readers and on the quality of the scans. Finally, the radiation exposure during MSCT coronary angiography remains a matter of concern; nonetheless, the implementation of dose-saving techniques results in effective dose less than the ~5 mSv of the invasive coronary angiography. 
 
Future directions 
The development of an online algorithm customized for the MSCT SXscore calculation (i.e. incorporating the Ca score values), as is currently available for the conventional SXscore, could be of great interest. 
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Furthermore, the “functional SYNTAX score” – a fractional flow reserve guided SYNTAX score – has been shown to improve the diagnostic accuracy of the SXscore (30). Recently, the feasibility of non-invasive fractional flow measurements has been demonstrated, by applying computational fluid dynamics to MSCT angiography (31); thus the application of this promising technology to the MSCT SXscore may improve its diagnostic accuracy and reproducibility.  
In addition, the angiographic SYNTAX score is lacking the information related to clinical factors which are known to have prognostic value, such as a patients’ age, left ventricular ejection fraction and renal function (32). Integrating the aforementioned variables to the SYNTAX score resulted in the development of the Clinical SYNTAX score, which has shown improved predictive value for adverse clinical events after revascularization (8,33,34). Under this perspective, the ability of MSCT to comprehensively assess the heart can have great potential. Apart from the evaluation of the coronary vessels, MSCT can be used for the evaluation of the left ventricular ejection fraction, the valves and the ischemic myocardium; adding the information from all these parameters may serve to add incremental value to the prognostic utility of the MSCT SXscore. 
 
Conclusion 
The calculation of the MSCT SXscore in symptomatic patients appeared feasible and reproducible. The long-term prognostic role of this scoring methodology remains to be further investigated.  
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Abstract
Objectives To determine the diagnostic performance of CT
coronary angiography (CTCA) in detecting and excluding
left main (LM) and/or three-vessel CAD (“high-risk” CAD)
in symptomatic patients and to compare its discriminatory
value with the Duke risk score and calcium score.
Materials and methods Between 2004 and 2011, a total of
1,159 symptomatic patients (61±11 years, 31 % women) with
stable angina, without prior revascularisation underwent both
invasive coronary angiography (ICA) and CTCA. All patients
gave written informed consent for the additional CTCA.
High-risk CAD was defined as LM and/or three-vessel ob-
structive CAD (≥50 % diameter stenosis).
Results A total of 197 (17 %) patients had high-risk CAD as
determined by ICA. The sensitivity, specificity, positive pre-
dictive value, negative predictive value, positive and negative
likelihood ratios of CTCA were 95 % (95 % CI 91–97 %),
83 % (80–85 %), 53 % (48–58 %), 99 % (98–99 %), 5.47 and
0.06, respectively. CTCA provided incremental value (AUC
0.90, P<0.001) in the discrimination of high-risk CAD com-
pared with the Duke risk score and calcium score.
Conclusions CTCA accurately excludes high-risk CAD in
symptomatic patients. The detection of high-risk CAD is
suboptimal owing to the high percentage (47 %) of
overestimation of high-risk CAD. CTCA provides incremen-
tal value in the discrimination of high-risk CAD compared
with the Duke risk score and calcium score.
Key Points
• Computed tomography coronary angiography (CTCA) ac-
curately excludes high-risk coronary artery disease.
• CTCA overestimates high-risk coronary artery disease in
47%.
• CTCA discriminates high-risk CAD better than clinical
evaluation and coronary calcification.
Keywords Computed tomography coronary angiography .
Diagnostic performance . Left main and/or three-vessel
CAD . “High-risk”CAD . Calcium score, coronary
calcification . Duke risk score, clinical evaluation
Abbreviations
1VD One-vessel CAD
2VD Two-vessel CAD
3VD Three-vessel CAD
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ECG Electrocardiogram
HR Heart rate
ICA Invasive coronary angiography
LAD Left anterior descending artery
LM Left main
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NS Not significant
PPV Positive predictive value
NPV Negative predictive value
RCA Right coronary artery
SN Sensitivity
SP Specificity
SSCT Single-source CT
QCA Quantitative coronary angiography
Introduction
Cardiovascular disease is the leading cause of death in wom-
en and men in the western world [1–3]. Identification of
symptomatic patients with obstructive coronary artery dis-
ease (CAD), in particular those patients with left main (LM)
and/or three-vessel CAD (3VD), defined herein as “high-
risk” CAD, is important because optimal medical treatment
combined with revascularisation not only relieves symptoms
but also improves prognosis in this patient group [4–6].
Exercise testing (ET), myocardial perfusion imaging (MPI)
or stress echocardiography (SE) are performed for risk strati-
fication of obstructive CAD and high-risk CAD [7–10]. The
sensitivity for the diagnosis of LM and/or 3VD by ET is
comparable (88 % vs. 92 %) to that of MPI, while the speci-
ficity is slightly higher (46 % vs. 34 %) [8]. The sensitivity of
SE in detecting high-risk CAD is reported to be approximately
94 % with a specificity of 40 % [10].
Computed tomography coronary angiography (CTCA)
has been shown to be an alternative imaging technique for
the evaluation of CAD. CTCA excludes obstructive CAD
with high accuracy, but has the tendency to overestimate
stenosis severity compared with invasive coronary angiog-
raphy (ICA) [11]. CTCA may be used to detect or exclude
high-risk CAD; however, the diagnostic performance of
CTCA in detecting or excluding patients with high-risk
CAD has not been fully explored. The goal of this study
was to determine the diagnostic performance of CTCA in
detecting and excluding high-risk CAD in symptomatic pa-
tients suspected of having CAD and to compare its discrim-
inatory value, for detecting and excluding high-risk CAD,
with clinical risk factors (Duke risk score) and calcium score.
Materials and methods
Study population
Between July 2004 and August 2011 patients referred for ICA
on the basis of chest pain symptoms, risk factors, with or
without stress testing were invited to undergo a CTCA exam-
ination. Exclusion criteria were previous revascularisation,
iodine allergy or impaired renal function. Consenting patients
were entered into our single-centre cardiac database. The final
study population comprised 1,159 patients with stable chest
pain complaints whowere suspected of having CAD. The pre-
test probability of obstructive CAD was determined using the
Duke risk score [12] which uses clinical factors such as type of
complaints, gender, age, smoking, hypercholesterolaemia, di-
abetes mellitus, history of myocardial infarction and ECG
abnormalities [13]. Parts of this single-centre cardiac database
have been used in previous studies [14–18]. The study was
approved by the institutional review board of our medical
hospital.
Computed tomography imaging protocol and image
reconstruction
During the inclusion period three consecutive CT systems
were used (Table 1). All patients initially underwent
unenhanced CT. Subsequently a bolus tracking technique
was used to synchronise the start of image acquisition with
the arrival of the iodinated contrast agent [Iomeron, iomeprol
(400 mg I/mL), Bracco, Milan, Italy; Ultravist, iopromide
(370 mg I/mL), Schering Berlin, Germany] in the coronary
arteries followed by a saline chaser. CTCA was performed
using a conventional ECG-synchronised low-pitch helical
CT protocol between 2004 and 2006. Since 2006 CT proto-
cols have been adjusted to reduce the effective radiation
dose, to a low-pitch helical protocol with ECG-triggered
tube current modulation (2006–2009) [19], to the “step-
and-shoot” sequential CT protocol and in selected patients
a high-pitch helical protocol in subsequent years [20]. Data
sets were reconstructed retrospectively for the low-pitch and
step-and-shoot sequential CT protocols in systolic (31–
47 %) and diastolic phases (60–76 %) of the RR interval
for high (≥80 beats/min) and low heart rates (≤65 beats/min),
respectively, to obtain motion-free images; both systolic and
diastolic phases (30–77 %) of the RR interval were used in
medium heart rates (66–79 beats/min). CT data sets for the
high-pitch helical protocol could only be reconstructed at
one diastolic phase. Images were analysed using medium-to-
smooth convolution kernels for non-calcified lesions and
sharp convolution kernels for calcified lesions.
Computed tomography image evaluation
All data sets were transferred for analyses to an offline work-
station (MMWP workstation, Siemens, Erlangen, Germany).
The unenhanced CT was used to calculate the total calcium
score employing the Agatston method [21] (CaScoring®,
MMWP workstation, Siemens, Erlangen, Germany). Two
experienced observers with more than 2 years of experience
in cardiac CT, who were blinded to the ICA results, indepen-
dently evaluated all CTCA for the presence of CAD, using
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axial source images, multiplanar, curved reformatted recon-
structions, and thin-slab maximum intensity projections
(Circulation®, MMWP workstation, Siemens, Erlangen,
Germany). Inter-observer disagreements were resolved by a
joint consensus reading.
The modified 17-segment American Heart Association
model was used to classify each segment. Each segment
was visually scored as obstructive in the presence of at least
50 % lumen diameter stenosis and non-obstructive when the
lumen diameter stenosis was less than 50 % in comparison
with the proximal and distal lumen. All anatomically avail-
able segments with a diameter of at least 1.5 mm, irrespective
of image quality or calcification, were included and scored
with the intention to diagnose. Non-evaluable segments of
poor quality owing to calcification, stack and motion arte-
facts or low contrast enhancement were classified as obstruc-
tive. Coronary segments distal to a total occlusion were
excluded from the analyses.
Invasive coronary angiogram image evaluation
One experienced cardiologist, blinded to the CT results, visually
assessed each coronary segment (American Heart Association
model) for the presence of luminal stenosis in two orthogonal
Table 1 CT device generations and respective imaging protocols
64-slice SSCTa 64-slice DSCT 1st generation b 128-slice DSCT 2nd generation c
β-blocker d Yes No Yes
Nitroglycerin e No Yes Yes
X-ray tube 1 2 2
Z-FFS Yes Yes
Collimation 32×0.6 32×0.6 64×0.6
Gantry rotation time (ms) 330 330 285
Temporal resolution (ms) 165 83 75
Spatial resolution (mm) 0.4×0.4×0.4 0.4×0.4×0.4 0.4×0.4×0.4
Pitch 0.2 0.2–0.5 0.2–3.4
Unenhanced acquisition
Tube voltage (kV) 120 120 120
Tube current 200–150 effective mAs 75 mAs/rotation 75 mAs/rotation
ECG-triggered tube current modulation Yes Yes Yes
Imaging protocol
Low-pitch helical imaging Yes Yes No
High-pitch helical imaging f No No Yes
Step and shoot sequential imaging No No Yes
Contrast-enhanced imaging
Tube voltage (kV) 120 120 80–120
Tube current 850–960 effective mAs 320–412 mAs/rotation 320–412 mAs/rotation
ECG-triggered tube current modulation No Yes Yes
Imaging protocol
Low-pitch helical imaging Yes Yes Yes
High-pitch helical imaging f No No Yes
Step-and-shoot sequential imaging No No Yes
Effective radiation dose (mSv) 13.43 12.26 3.93
SSCT single-source CT, DSCT dual-source CT, Z-FFS Z-flying focal spot, ECG electrocardiogram, mAs/rotation total mA×rotation time; mSv
(millisievert) dose–length product×0.014 [50]
a Somatom Sensation, Siemens Healthcare, Forchheim, Germany
b Somatom Definition, Siemens Healthcare, Forchheim, Germany
c Somatom Definition Flash, Siemens Healthcare, Forchheim, Germany
dMetoprolol (Seloken, Astra Zeneca, Zoetermeer, Netherlands) administration before imaging when no contraindication was present to achieve
better quality images
e Nitrolingual (Nitroglycerin Pumpspray, G.Pohl-boskamp, Itohenlockstedt, Germany) was administered before imaging in the absence of contra-
indications for better visualisation of the small coronary arteries
f Imaging protocol in patients with regular stable heart rate below 65 beats/min
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planes. Segments scored as more than 20 % stenosis on visual
assessment were quantified using a validated quantitative coro-
nary angiography (QCA) algorithm [CAASII (Cardiovascular
Angiography Analysis System II); Pie Medical Imaging
Maastricht, the Netherlands]. Quantitative at least 50 % lumen
diameter stenosis was considered significantly obstructive.
Patients were classified as having one- (1VD), two- (2VD) or
three-vessel CAD (3VD) (at least 50% diameter stenosis in one,
two or three vessels, respectively) or LM CAD (at least 50 %
diameter stenosis). High-risk CAD was defined as LM and/or
three-vessel CAD.
Statistical analyses
The statistical analysis was performed using dedicated statistical
software programs (IBMSPSS statistics 20.0.0.1 and STATA/SE
12.0). Categorical variables were expressed as percentages and
continuous variables were expressed as means±standard devia-
tion. Continuous variables with a skewed distribution were
expressed as median with interquartile range. The inter-
observer agreement was tested between the two CT readers on
a vessel level using the κ statistic. CTCA results were compared
with ICA as the reference standard on a patient level to calculate
the κ statistic, sensitivity (SN), specificity (SP), positive predic-
tive value (PPV) and negative predictive value (NPV) for the
detection of at least one obstructive lesion, LM CAD, 3VD and
high-risk CAD (LM and/or 3VD). The Wilson score [22] was
used to calculate the confidence intervals for small groups. We
calculated the positive likelihood ratio (LR+) of CTCA, which is
equal to the ratio of the odds of high-risk CAD given a positive
CTCA result and the odds of high-risk CAD regardless of the
CTCA result (i.e. the pre-test odds of high-risk CAD). Thus,
LR+represents the performance of CTCA in detecting high-risk
CAD.We also determined the negative likelihood ratio (LR−) of
CTCA,which is equal to the odds of absent high-risk CADgiven
a negative CTCA result and the odds of absent high-risk CAD
regardless of the CTCA result (i.e. the pre-test odds of absent
high-risk CAD). Thus, LR−represents the performance of
CTCA in excluding high-risk CAD. The area under the receiver
operating characteristic curve (AUC)was calculated as the ability
of a diagnostic test to discriminate patients with and without
high-risk CAD. The AUC takes into account the influence of
referral bias that may influence the diagnostic performance in our
population [23, 24]. The AUC as a value of high-risk CAD
discrimination was calculated for univariate and multivariate
models that predicted high-risk CAD. Binary logistic regression
analysis was used to create these predicting models (see Table 5)
using the following variables separate and combined: Duke risk
score, calcium score, and CTCA model (LM CAD and 3VD
detected by CTCA). The method of Delong et al. [25] was
applied to compare the AUC.
Next we also tested whether other variables such as heart
rate, calcium score, body mass index and CT generation had
an influence on the diagnostic performance of CTCA in
ruling in/out high-risk CAD using multivariate logistic re-
gression. A P value of less than 0.05 was considered statis-
tically significant. This study was performed according to the
criteria set forth in the Standard for Reporting of Diagnostic
Accuracy Initiative [26].
Results
A total of 1,159 patients were included in the study; the mean
age was 61±11 years and 31 % (n=360) were women. The
patients’ clinical and angiographic demographics are detailed
in Table 2. High-risk CAD was present in 17 % of the patients
(197/1,159; Table 2). The LM coronary artery was absent in 1
patient. ICA identified LM CAD in 48 patients (4 %). In 4
patients with LM CAD there was no additional obstructive
CAD (8 %). In 35 % of patients with LM CAD (17/48) there
was additional 1VD, in 29 % (14/48) 2VD and in 27 % (13/48)
3VD. 3VD without LM CAD was identified in 149 patients
(13 %). The inter-observer agreement for per-vessel detection
of obstructive stenosis by the two CT readers showed a good
agreement (κ=0.94 [95 % CI 0.93–0.95]).
Diagnostic performance of CTCA
The diagnostic performance of CTCA in detecting CAD is
detailed in Table 3. CTCA excluded high-risk CAD in 805
patients out of the 1,159, which was correct in 99% (795/805)
but underestimated the severity of CAD in 10 patients (1 %;
Table 3). More specifically, CTCA underestimated 3VD in 13
patients and scored them all as 2VD (Table 4) and correctly
detected LM CAD in 3 of these 13 patients (Table 3).
CTCA detected high-risk CAD in 354 patients out of the
1,159, which was correct in 53 % (187/354), but
overestimated high-risk CAD in 167 patients (47 %;
Table 3). More specifically, CTCA overestimated 3VD in
148 patients, LM CAD in 9 patients, and both LM and 3VD
in another 10 patients. These patients with overestimated
high-risk CAD by CTCA showed 2VD in 69 % (115/167),
1VD in 27 % (45/167) and obstructive CAD was absent in
4 % (7/167) by ICA (Table 4).
Discrimination of high-risk CAD
All models, univariate and multivariate, significantly con-
tributed to the prediction and discrimination of high-risk
CAD (Table 5, Fig. 1). The CTCA outperformed the Duke
risk score (P<0.0001) as well as the calcium score
(P<0.0001) for the discrimination of high-risk CAD.
Calcium score (P=0.23) did not contribute to the prediction
and discrimination of high-risk CAD (Table 5) when it was
combined with the Duke risk score and CTCA.
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Influence of variables on the diagnostic performance
of CTCA
Heart rate during CTCA, calcium score, gender, body mass
index, CT imaging protocol, and CT device generation did
not have an influence on the sensitivity of CTCA in detecting
high-risk CAD (Table 6). The specificity of CTCA in
detecting high-risk CAD was influenced by the imaging
protocol and calcium score used. When the CTCA was
performed using a high-pitch helical imaging protocol or
when CTCAwas performed in a patient with a calcium score
above 400 the specificity decreased significantly. The NPV
also significantly decreased with increasing calcium score.
The PPV was influenced by the heart rate during the CTCA,
but a threshold of 60 beats/min did not result in a significant
difference in PPV. The CT device generation showed a
significant influence on the PPV. The inter-generation com-
parison showed no significant differences (Table 6).
Discussion
Numerous studies using ICA in the past [27–30] and more
recently using non-invasive CTCA have indicated that higher
extent and severity of CAD (LM/3VD) carry a worse prog-
nosis [31–33], which can be improved by revascularisation
[4]. In this study we demonstrated the performance of CTCA
in detecting and excluding out LM and/or 3VD, defined as
high-risk CAD.
The main results of this study are:
1. CTCA accurately excludes high-risk CAD. LM CAD
was never missed and 3VD was rarely missed (2 %).
2. CTCA accurately detects high-risk CAD. The high ac-
curacy of CTCA in detecting high-risk CAD was at the
expense of the overestimation of high-risk CAD.
3. CTCA provided independent incremental value in the
discrimination of high-risk CAD compared with the
Duke risk score or calcium score.
Current guidelines indicate that the diagnostic work-up of
patients with stable angina and intermediate pre-test proba-
bility of CAD requires initial assessment with stress testing
with or without imaging [6]. In the presence of ischaemia,
stress testing is often followed by anatomical assessment
with ICA to assess the appropriateness of percutaneous cor-
onary intervention (PCI) or coronary artery bypass graft
(CABG) in addition to optimal medical treatment [6].
However, stress tests such as ET, MPI and SE are limited
in detecting and excluding the presence of high-risk CAD
anatomy. ET is often used for risk stratification of symptom-
atic patients as a first-line diagnostic test, because it is widely
available, does not use radiation and is inexpensive [8, 34,
35]. In ET the presence of high-risk CAD may be suspected
with severe ST segment depression, short exercise duration
or blood pressure drop during exercise [7, 35–38] but these
parameters are not very sensitive. ET diagnostic perfor-
mance studies have shown sensitivities ranging from 74 %
to 91 % for the detection of LM CAD [8, 36] and from 63 %
Table 2 Patient characteristics
Mean Standard
deviation
Number patients 1,159
Women 31 % (360)
Age (years) 61 [10.8]
Chest pain complaints a
Typical 46 % (538) [0.50]
Atypical 30 % (353) [0.46]
Non-anginal 23 % (263) [0.41]
Current smoker 28 % (319) [0.45]
Diabetes mellitus b 17 % (196) [0.38]
CAD in family c 47 % (546) [0.50]
Hypercholesterolaemia d 57 % (664) [0.50]
Hypertension e 51 % (595) [0.51]
Body mass index (kg/m2) 27 [4.3]
ECG pathological Q 15 % (173) [0.36]
ECG repolarisation disturbances 36 % (423) [0.48]
Pre-test probability f 67 % [0.30]
Calcium score g 250 [42–679]
Prevalence of CAD h 74 % (849) [0.44]
One-vessel CAD 33 % (385) [0.47]
Two-vessel CAD 27 % (308) [0.44]
Three-vessel CAD 14 % (162) [0.35]
Left main CAD 4 % (48) [0.20]
Left main and/or three-vessel CAD 17 % (197) [0.38]
Heart rate during CTCA (beats per minute) 65 [12.1]
Effective radiation dose CTCA (mSv)i 11 [4.6]
Data are presented as means with the number of patients in parentheses.
Data in brackets are the standard deviations and for the calcium score
this is the 25th and 75th percentiles
aWe defined typical angina as substernal discomfort that was precipitated
by physical exertion or emotion and relieved by rest or nitroglycerin
within 10 min. We classified chest pain with only 1 or 2 of these 3
symptom characteristics as atypical angina pectoris; if none of the char-
acteristics was present, we classified it as non-anginal chest pain [51]
b Treatment with oral antidiabetic medication or insulin
c Patient had first- or second-degree relatives with premature coronary
artery disease
d Total cholesterol >180 mg/dL or treatment for hypercholesterolaemia
e Blood pressure >120/90 mmHg or treatment for hypertension
f Pre-test probability of obstructive CAD using the Duke risk score [13]
g Calcium score (Agatston) with median and interquartile range in brackets
h Prevalence of having at least one obstructive lesion on a patient level
determined by invasive coronary angiography
i mSv (millisievert): conversion factor 0.014 [mSv/mGy/cm]×dose–
length product
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Table 3 Diagnostic performance of CT coronary angiography
Prevalence TP TN FP FN κ SN % SP % PPV % NPV % LR+ LR−
CAD a 74 % 850 227 73 9 0.80* 99 [98–99] 76 [71–80] 92 [90–94] 96 [93–98] 4.07 0.01
LM CAD 4 % 48 1,081 29 0 0.76* 100 [93–100] 97 [96–98] 62 [51–72] 100 [100–100] 38.28 0.000
3VD 14 % 149 827 170 13 0.53* 92 [87–95] 83 [80–85] 47 [41–52] 98 [97–99] 5.39 0.10
LM and/or 3VD 17 % 187 795 167 10 0.59* 95 [91–97] 83 [80–85] 53 [48–58] 99 [98–99] 5.47 0.06
TP true positive, TN true negative, FP false positive, FN false negative, κ kappa statistic for the agreement analyses between invasive coronary
angiography and CTcoronary angiography, SN sensitivity, SP specificity, PPV positive predictive value,NPV negative predictive value, LR+positive
likelihood ratio, LR−negative likelihood ratio, CAD coronary artery disease, LM left main, 3VD three-vessel CAD
aDiagnosis of at least one significant stenosis per patient by ICA
*P<0.001
Table 4 The performance of CT coronary angiography in detecting and excluding high-risk CAD compared with invasive coronary angiography
CTCA
LM CAD − LM CAD +
3VD − 3VD + 3VD − 3VD +
IC
A
LM 
CAD − 3VD
− 795 148 9 10
+ 10 129 0 10
LM 
CAD + 3VD
− 0 0 23 12
+ 0 0 3 10
CTCA
LM CAD − LM CAD +
Extent vessel CAD Extent vessel CAD
0VD 1VD 2VD 3VD 0VD 1VD 2VD 3VD
IC
A
LM 
CAD −
Extent 
vessel 
CAD
0VD 224 56 13 4 1 0 1 1
1VD 7 212 a 104 39 0 2 1 3
2VD 2 13 164 105 0 0 4 6
3VD 0 0 10 129 0 0 0 10
LM 
CAD +
Extent 
vessel 
CAD
0VD 0 0 0 0 2 1 1 0
1VD 0 0 0 0 0 8 6 3
2VD 0 0 0 0 0 1 4 9
3VD 0 0 0 0 0 0 3 10
Correct exclusion of high-risk CAD
Correct detection of high-risk CAD
Overestimation of high-risk CAD
Underestimation of high-risk CAD
CAD coronary artery disease, CTCA computed tomography coronary angiography, ICA invasive coronary angiography, 0VD no obstructive CAD,
1VD 1-vessel CAD, 2VD two-vessel CAD, 3VD three-vessel CAD
aOne patient with 1VD with absent LM
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to 67 % for the detection of 3VD [7, 36]. The specificity of
ET for the diagnosis of LM and/or 3VD is around 46 % and
for LM CAD this is only 38 % [8].
MPI has a sensitivity of 92 % in detecting high-risk CAD
[8]. The specificity of MPI is slightly lower compared with ET
(34 % vs. 46 %, P<0.01). The under-diagnosis of high-risk
CAD by MPI is believed to be a result of a balanced reduction
of perfusion [10, 39–41]. The combination with other indirect
findings, such as LV function and stress-induced wall motion
abnormality (transient ischaemic dilatation), has been shown to
improve the prediction of high-risk CAD by MPI [37–40].
SE has a sensitivity and specificity of 94 % and 40 %,
respectively, in detecting high-risk CAD [10]. In a meta-
analysis by Mahajan et al., MPI (15 studies with 2,310 patients
in total) was compared with SE (14 studies with 1,403 patients
in total) for the detection of high-risk CAD; the investigators
found a significantly higher sensitivity by SE compared with
MPI (94% vs. 75%,P<0.001), with a similar specificity (40%
vs. 48 %, P=0.16) [10]. Although SE discriminates high-risk
CAD better than MPI [summary receiver operating character-
istic curve (ROC) AUC 0.82 vs. 0.73, P=0.01] [10] this
technique has its own inherent limitations [42]. Factors such
as suboptimal acoustic window can be partly improved by the
use of echo-contrast media, but still requires sufficient training
and experience for proper evaluation [43].
In our study we used CTCA as an alternative first-line non-
invasive diagnostic tool to detect high-risk CAD. CTCA
demonstrated a sensitivity of 95 %, which is at least compa-
rable to the conventional non-invasive diagnostic techniques
(ET, MPI and SE). Importantly, the specificity of CTCA in
excluding LM and/or 3VD appears to be higher (CTCA,
83 %; ET, 46 % [8]; MPI, 48 % [10]; SE, 40 % [10]) with a
better negative likelihood ratio of 0.06 compared with SE
(0.21) and MPI (0.47) [10]; and CTCA discriminates high-
risk CAD better than SE and MPI (AUC CTCA, 0.90; SE,
0.82; MPI, 0.73 [8]). We also assessed the discrimination of
high-risk CAD using the Duke risk score and calcium score in
addition to CTCA. CTCAwas superior to the Duke risk score
and calcium score, and showed that the calcium score did not
contribute to the prediction of high-risk CAD when the Duke
risk score and CTCAwere used in symptomatic patients.
The diagnostic performance of CTCA is limited because
it overestimates the extent and severity of CAD. Patients in
whom CTCA overestimated high-risk CAD (47 %) predom-
inantly had 2VD (69 %) and only 4 % had no obstructive
CAD (Table 4). The tendency to overestimate the stenosis
Table 5 Discrimination of high-risk CAD by univariate and multivariate models
High-risk CAD discrimination comparison b
Model a AUC [95 % CI] se AUC P Duke CaSc CTCA
Duke 0.68 [0.65–0.72] 0.02 <0.001
CaSc 0.72 [0.69–0.76] 0.02 <0.001 0.10
CTCA c 0.90 [0.88–0.93] 0.01 <0.001 <0.001 <0.001
Duke+CaSc+CTCA c 0.93 [0.91–0.94] 0.01 <0.001 d <0.001 <0.001 <0.001
Duke Duke risk score, CaSc Calcium score, CTCA CT coronary angiography, LM CAD left main coronary artery disease, 3VD three-vessel CAD,
AUC area under the receiver operating characteristic curve, se standard error
a Logistic regression (univariate and multivariate) analyses were used to calculate the probability of high-risk CAD
bComparison of discrimination of high-risk CAD using the different models with the DeLong method
c CTCA model: LM CAD and 3VD were inserted as separate variables into the logistic regression model
d CaSc did not contribute (P=0.23) to the prediction of high-risk CAD
Fig. 1 Receiver operating characteristic curves in the discrimination of
high-risk CAD using different models. Logistic regression (univariate
and multivariate) analyses were used to calculate the probability of
high-risk CAD. Duke Duke risk score, CaSc calcium score, CTCA CT
coronary angiography, LM CAD left main coronary artery disease, 3VD
three-vessel CAD, AUC area under the receiver operating characteristic
curve. *CTCA model: LM CAD and 3VD were inserted as separate
variables into the logistic regression model
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severity of a given obstruction is because the CT reader is
careful not to “miss” an obstructive stenosis (in the case of
breathing, motion or artefacts due to the calcifications), thus to
avoid “under-diagnosis” and delay of appropriate treatment,
which could negatively affect the prognosis. We found false-
positive observations to be associated with a higher heart rate
(Table 6). The substantial rate of CAD overestimation and the
inability of CTCA to assess the functional significance of
lesions [14, 44] require referral of these symptomatic patients
with CT-determined high-risk CAD for ICA combined with
measurement of the fractional flow reserve (FFR). The FAME
study (n=1,005) demonstrated that FFR-guided
revascularisation of multi-vessel CAD by ICAwas associated
with lower adverse event rates, use of fewer stents and lower
healthcare costs [45].
To overcome the high rates of referral to ICA, the integration
of anatomical and functional testing is required. Currently this
can be achieved by combining PETor SPECTwith CT, but more
recently by the fusion of CTCA anatomy and CT-derived FFR
using computational fluid dynamics during simulated maximal
hyperaemia [46]. Another CT-derived method is to compare
myocardial enhancement at rest and during adenosine-induced
stress CT perfusion to assess the impedance of coronary stenosis
on myocardial blood flow [47, 48]. However, these novel ap-
proaches are only in their infancy, and further investigation is
needed to confirm their applicability in the clinical setting.
The study had a number of limitations. Referral bias was
present, because the patients in our population were referred
by their treating physician to undergo ICA on the basis of
their chest-pain presentation with or without an outcome of
stress testing. To account for this referral bias on the diag-
nostic accuracy of CTCA in detecting high-risk CAD we
assessed the ROC AUC [23] for CTCA (0.90) which is
comparable to that of stress echocardiography (0.82) [10].
Table 6 Influence of the variables on the diagnostic performance of CTCA in the detection and exclusion of high-risk CAD
SN % SP % PPV % NPV %
Heart rate P=NS P=NS P=0.007 P=NS
<60 beats/min 97 [91–99] 85 [80–88] 60 [52–68] 99 [97–100]
≥60 beats/min 93 [87–96] 82 [79–85] 49 [43–56] 98 [97–99]
Calcium score P=NS P<0.001 P=NS P<0.001
<400 95 [90–97] 90 [87–92] 48 [39–56] 99 [99–100]
≥400 95 [89–97] 68 [63–73] 56 [49–62] 97 [94–98]
Gender P=NS P=NS P=NS P=NS
Women 98 [88–100] 86 [82–90] 48 [38–59] 100 [98–100]
Men 94 [89–97] 81 [78–84] 54 [48–60] 98 [97–99]
BMI P=NS P=NS P=NS P=NS
<30 96 [91–98] 83 [80–85] 52 [46–58] 99 [98–100]
≥30 92 [81–97] 81 [75–86] 54 [44–65] 98 [94–99]
CT imaging protocol a P=NS P<0.01 b P=NS P=NS
Low-pitch helical 96 [92–98] 84 [81–86] 54 [48–60] 99 [98–100]
Sequential imaging 88 [64–97] 82 [73–89] 48 [31–66] 97 [90–99]
High pitch helical 100 [72–100] 64 [47–78] 45 [27–65] 100 [85–100]
CT device generation c P=NS P=NS P<0.001 d P=NS
SSCT 95 [83–99] 83 [78–86] 38 [28–47] 99 [97–100]
DSCT 1st generation 96 [90–98] 85 [81–88] 65 [57–71] 99 [97–99]
DSCT 2nd generation 93 [81–97] 78 [72–83] 46 [35–56] 98 [95–99]
P values were determined for heart rate, calcium score and BMI as continuous variables and for gender, CT imaging protocol and CT device
generation as categorical variables in the multivariate logistic regression. The diagnostic performance of CTCA is shown at arbitrary thresholds of
heart rate, calcium score and BMI
SN sensitivity, SP specificity, PPV positive predictive value, NPV negative predictive value, NS not significant (P≥0.05), BMI body mass index,
SSCT single-source CT, DSCT dual-source CT
a CT-imaging protocol was inserted as a dummy variable into the multivariate logistic regression. Low-pitch helical imaging protocol was taken as a
reference and was compared with a sequential imaging protocol and a high-pitch helical imaging protocol
b Sequential imaging protocol (P=0.007) and high-pitch helical imaging protocol (P=0.005) were significantly different from the low-pitch helical
imaging protocol
c CT generation was inserted as a dummy variable into the multivariate logistic regression. SSCTwas taken as the reference and was compared with
1st and 2nd generation DSCT
d 1st generation DSCT (P=0.56) and 2nd generation DSCT (P=0.17) were not significantly different from the SSCT
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Our study population only consisted of symptomatic pa-
tients with stable angina, and our results may not apply to the
wider spectrum of patients with suspected CAD, who have
unstable symptoms or did not undergo ICA. Of concern was
the rather high radiation exposure of CTCA (11 mSv) owing
to the most frequently used low-pitch helical imaging proto-
col, which was standard in the first-generation CT systems
[19, 49]. Currently with the newer generation systems and
optimal imaging protocols radiation exposure can be kept
within much lower levels (<3 mSv) in patients with low heart
rates (<65 beats/min) [20].
In conclusion, CTCA accurately excludes high-risk CAD
in patients with suggestive symptoms. However, the perfor-
mance of CTCA in detecting high-risk CAD is suboptimal,
owing to the high number of false-positive observations made
by overestimating the severity of stenosis. CTCA provides
incremental value in the discrimination of high-risk CAD
compared with the Duke risk score and the calcium score.
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Abstract
Objectives To investigate the diagnostic accuracy of CT
coronary angiography (CTCA) in women at low to interme-
diate pre-test probability of coronary artery disease (CAD)
compared with men.
Methods In this retrospective study we included symptom-
atic patients with low to intermediate risk who underwent
both invasive coronary angiography and CTCA. Exclusion
criteria were previous revascularisation or myocardial in-
farction. The pre-test probability of CAD was estimated
using the Duke risk score. Thresholds of less than 30 %
and 30–90 % were used for determining low and interme-
diate risk, respectively. The diagnostic accuracy of CTCA in
detecting obstructive CAD (≥50 % lumen diameter narrow-
ing) was calculated on patient level. P<0.05 was considered
significant.
Results A total of 570 patients (46 % women [262/570])
were included and stratified as low (women 73 % [80/109])
and intermediate risk (women 39 % [182/461]). Sensitivity,
specificity, PPV and NPV were not significantly different in
and between women and men at low and intermediate risk.
For women vs. men at low risk they were 97 % vs. 100 %,
79 % vs. 90 %, 80 % vs. 80 % and 97 % vs. 100 %,
respectively. For intermediate risk they were 99 % vs.
99 %, 72 % vs. 83 %, 88 % vs. 93 % and 98 % vs. 99 %,
respectively.
Conclusion CTCA has similar diagnostic accuracy in wom-
en and men at low and intermediate risk.
Key Points
• Coronary artery disease (CAD) is increasingly investigat-
ed by computed tomography angiography (CTCA).
• CAD detection or exclusion by CTCA is not different
between sexes.
• CTCA diagnostic accuracy was similar between low and
intermediate risk sex-specific-groups.
• CTCA rarely misses obstructive CAD in low–intermediate
risk women and men.
• CAD yield by invasive coronary angiography after positive
CTCA is similar between sex-risk-specific groups.
Keywords Diagnostic accuracy .CTcoronary angiography .
Multidetector computed tomography . Coronary artery
disease . Duke pre-test probability . Sex, women and men
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SP specificity
SPECT single photon emission computed tomography
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Introduction
Cardiovascular disease is the leading cause of death in the
western world [1]. For several years awareness has been
growing that cardiovascular disease is also the primary
cause of death in women not only in the western world but
also in economic developing countries [2]. Part of this high
mortality is related to under-recognition, underdiagnosis and
undertreatment of coronary artery disease (CAD) in women
[3–7].
The interpretation of chest pain in women caused by
CAD is often difficult because of the “less typical” symp-
toms in women compared with the classical “typical” symp-
toms in men [3, 4, 8]. This may cause a delay or lead to
incorrect diagnosis [3, 4]. Additionally first-line non-inva-
sive diagnostic tests such as exercise electrocardiography
and single photon emission computed tomography (SPECT)
imaging in women are less sensitive and specific [5, 6].
Paradoxically, because of the diagnostic uncertainty there
appears to be an overuse of invasive coronary angiography
(ICA) in women, with a rather low diagnostic yield of
obstructive CAD [9, 10]. This prompted a “red alert call”
for the promotion of advanced non-invasive imaging tech-
niques in women including CT coronary angiography
(CTCA) [11]. CTCA has evolved as a reliable gatekeeper
of ICA because negative CT findings virtually rule out the
presence of obstructive CAD [12–14]. Whether this also
applies to women remains unresolved because women have
been under-represented in studies assessing the diagnostic
accuracy of CTCA [12–17]. The pre-test probability (PTP)
of obstructive CAD plays a significant role in the assess-
ment of the clinical utility of CTCA. This PTP of obstruc-
tive CAD can be derived from reported clinical prediction
rules [18] and may influence the post-CTCA probability of
obstructive CAD and thus the need for further testing and
management.
The purpose of our study was to assess the diagnostic
accuracy and clinical utility of CTCA to detect or exclude
obstructive CAD in women with low to intermediate PTP of
obstructive CAD in comparison to men.
Methods and materials
Study population
Patients referred by their treating physician for ICA between
July 2004 and June 2009 on the basis of chest pain
presentation (typical, atypical and non-anginal complaints)
with or without outcome of stress testing were invited to
undergo CTCAwithin 2 weeks of ICA. The CTCA outcome
did not affect referral to ICA. We excluded patients with
known iodine allergy, impaired renal function and patients
with previous revascularisation. A total of 907 patients gave
consent for CT accuracy studies and were entered in our
single-centre registry. Out of these 907 patients we excluded
patients with previous myocardial infarct (n054) as well as
patients with a high PTP (>90 %) of having obstructive
CAD (n0283). The final study sample comprised a total
of 570 symptomatic patients. The study was approved by
the institutional review board of our medical hospital.
Computed tomography imaging protocol and image
reconstruction
Patients underwent single-source CT (Somatom Sensation,
Siemens Healthcare, Forchheim, Germany) between 2004
and 2006 and subsequently underwent dual-source CT
(Somatom Definition, Siemens Healthcare). The imaging
settings are described in Table 1. Heart-rate-lowering med-
ication (Metoprolol, Seloken, Astra Zeneca, Zoetermeer,
Netherlands) was administered when the heart rate was
above 65 beats per minute before the single-source CT in
the absence of contraindications to achieve better quality
images. To achieve better visualisation of the small coronary
arteries the vasodilating agent Nitrolingual (Nitroglycerin
Pumpspray, G.Pohl-boskamp, Itohenlockstedt, Germany)
was administered before imaging in the absence of
contraindications.
All patients initially underwent unenhanced CT to calcu-
late the calcium score using the Agatston method [19].
Subsequently a bolus tracking technique was used to syn-
chronise the start of image acquisition with the arrival of the
iodinated contrast agent [Iomeprol, iomeron (400 milligram
iodine per millilitre), Bracco, Milan, Italy; Ultravist, iopro-
mide (370 milligram iodine per millilitre), Schering Berlin,
Germany] in the coronary arteries followed by a saline chaser.
Between 2004 and 2006 a full-dose ECG-synchronised
spiral imaging technique was used. After the introduction of
ECG-triggered tube current modulation, the spiral imaging
technique with ECG pulsing was used in the subsequent
years to reduce the effective radiation dose. Data sets were
reconstructed retrospectively according to the heart rate to
obtain motion-free images. For heart rates of at least 80
beats per minute the data sets were reconstructed in 31–
47 % of the R–R interval (systolic phases). For heart rates of
no greater than 65 beats per minute this value was 60–76 %
of the R–R interval (diastolic phases). For heart rates be-
tween 66 and 79 beats per minute reconstructions were
needed in both systolic and diastolic phases, 30–77 % of
the R–R interval. Images were analysed using medium-to-
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smooth convolution kernels for non-calcified lesions and
sharp convolution kernels for calcified lesions.
Computed tomography image evaluation
All data sets were transferred for analyses to an offline
proprietary workstation (Leonardo, Siemens, Erlangen, Ger-
many); the total calcium score was calculated using dedi-
cated proprietary software (CaScoring). Two experienced
observers with more than 2 years of experience in cardiac
CT, blinded to the ICA results, independently evaluated all
CTCAs for the presence of CAD, using axial source images,
multiplanar, curved reformatted reconstructions, and thin-
slab maximum intensity projections using “Circulation”
software on the proprietary workstation. Interobserver dis-
agreements were resolved by a joint consensus reading.
The modified 17-segment American Heart Association
model was used to classify each segment [20]. Each seg-
ment was visually scored as obstructive in the presence of at
least 50 % lumen diameter narrowing and non-obstructive
when the lumen diameter narrowing was less than 50 % in
comparison with the proximal and distal lumen. All anatom-
ically available coronary segments with a diameter of at
least 1.5 mm, irrespective of image quality or calcification,
were included and scored with the intention to diagnose.
Un-evaluable segments of poor quality due to calcification,
stack, motion artefacts, or low contrast enhancement were
scored as obstructive. Coronary segments distal to a total
occlusion could not be optimally visualised by ICA and thus
were excluded from the analyses. The image quality was
scored on a segment level as diagnostic and non-diagnostic.
The average of this score per patient was compared between
women and men.
Invasive coronary angiogram image evaluation
One experienced cardiologist, blinded to the CT results,
visually assessed each coronary segment (American Heart
Association model) for the presence of luminal narrowing in
two orthogonal planes. Stenoses scored as having more than
20 % narrowing on visual assessment were quantified using
the validated quantitative coronary angiography (QCA) al-
gorithm (CAASII [Cardiovascular Angiography Analysis
System II]; Pie Medical Imaging Maastricht, the Nether-
lands). The segments were considered obstructive when
the quantified lumen diameter narrowing in one of the two
planes was at least 50 %. Obstructive lesions on a segment
level were used to determine obstructive CAD on a patient
level as having one or more obstructive stenoses (≥50 %
lumen diameter stenosis) irrespective of the segment in
which they were located.
PTP of obstructive CAD
We used the Duke risk score [18] to estimate the PTP of
obstructive CAD due to the presence of multiple risk factors
such as age, gender, symptoms, history of myocardial in-
farction, ECG, smoking, hypercholesterolaemia and diabe-
tes mellitus. We used less than 30 %, 30–90 %, and greater
than 90 % as thresholds for the low, intermediate and high
risk group, respectively. As patients with a high risk are
directly referred for ICAwe did not include these patients in
our analyses [21, 22].
The observed PTP of obstructive CAD is the prevalence
of obstructive CAD defined as having at least one lesion
with at least 50 % lumen diameter stenosis per patient
detected by ICA.
Statistical analyses
The statistical analysis was performed using a dedicated
statistical software program (SPSS, version 16.0, IMB, Chi-
cago, IL, USA). Categorical variables were expressed as
percentages and continuous variables were expressed as
means ± standard deviation. Continuous variables with a
Table 1 Imaging protocol
SSCTb DSCTc
β-blockera Yes No
Nitroglycerina No Yes
X-ray tube 1 2
Collimation 32×0.6 (Z-FFS) 32×0.6 (Z-FFS)
Gantry rotation time (ms) 330 330
Temporal resolution (ms) 165 83
Spatial resolution (mm) 0.4×0.4×0.4 0.4×0.4×0.4
Pitch 0.2 0.2–0.53
Rotation time (ms) 330 330
Unenhanced imaging
Tube voltage (kV) 120 120
Tube current 200–150 effective
mAs
75 mAs/rotation
ECG-triggered tube current
modulation
Yes Yes
Contrast-enhanced imaging
Tube voltage (kV) 120 120
Tube current 850–960
effective mAs
320–412 mAs/
rotation
ECG-triggered tube current
modulation
No Yes
SSCT single-source CT, DSCT dual-source CT, Z-FFS Z-flying focal
spot, ECG electrocardiogram, mAs/rotation total mA × rotation time
a Administration before imaging when no contraindication was present
b Somatom Sensation, Siemens Healthcare, Forchheim, Germany
c Somatom Definition, Siemens Healthcare, Forchheim, Germany
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skewed distribution were expressed as median with inter-
quartile range.
The estimated PTP was compared in women, men and in
the different risk groups with the observed PTP (observed
prevalence) using the paired t test.
The patients’ characteristics were compared between
women and men and between different risk groups using
the independent t test; otherwise the Mann-Whitney U test
was used (skewed distribution of continuous data). The
interobserver variability was tested between the two CT
readers on segment and patient level using the κ statistic.
The CTCA results were compared with the reference stan-
dard ICA on a patient level to calculate the sensitivity (SN),
specificity (SP), positive predictive value (PPV) and negative
predictive value (NPV) [23]. The Wilson score [24] was used
to calculate the confidence intervals for small groups. The
diagnostic accuracy and utility were compared across the
different risk groups, between women and men using the
chi-squared test or the Fisher’s exact test in the presence of
less than five observations in a cell of the 2×2 table. A P value
of less than 0.05 was considered statistically significant.
The receiver-operating characteristic (ROC) curve was
used for visual analyses of the trade-offs between the sensi-
tivity and the specificity of CTCA. The area under the ROC
curve (AUC) was calculated to account for the influence of
referral bias and prevalence of disease on the diagnostic
accuracy of CTCA in our population [25, 26].
The clinical utility of CTCAwas a measure of diagnostic
certainty or remaining uncertainty of absence or presence of
CAD that is derived from the post-test probability of CAD.
In case of diagnostic certainty no further testing is required,
whereas remaining uncertainty requires further diagnostic
testing. It was assumed that a post-test probability of ob-
structive CAD of less than 5% indicated high certainty with
no further requirement for diagnostic testing; probabilities
between 5 and 90 % represented uncertainty and indicated a
requirement for further diagnostic testing; and probabilities
of greater than 90 % indicated high certainty with direct
referral to ICA, as proposed by previous studies [27].
This study was performed according to the criteria set forth
in the Standard for Reporting of Diagnostic Accuracy Initiative
[28].
Results
In total, 570 patients at low to intermediate risk were in-
cluded of which 46 % were women (n0262). The patients’
characteristics are provided according to sex and risk group
in Table 2. Women overall had a significantly higher heart
rate (HR) than men (P00.03). The HR was similar in the
different risk groups (Table 2). The prevalence of CAD (at
least one obstructive lesion) in women was 61 % and in men
this was 64 % (P00.42). The PTP of obstructive CAD
determined by the Duke risk score (estimated PTP) was
significantly lower than the observed prevalence of obstruc-
tive CAD determined by ICA in women in the overall group
(45 % vs. 61 %, P<0.01) as well as in the low (17 % vs.
48 %, P<0.01) and intermediate risk groups (60 % vs. 66 %,
P00.02) separately. In men there was no difference between
the estimated PTP and observed prevalence (overall 65 %
vs. 64 %, P00.56; low 21 % vs. 28 %, P00.43; intermediate
risk group (70 % vs. 68 %, P00.38).
In this population the prevalence of obstructive CAD and
extent of CAD in terms of multi-vessel disease and calcium
score were similar between women and men (Table 2).
The interobserver variability for detection of obstructive
stenosis showed a good agreement on segment (κ00.94 [95%
CI 0.93–0.95]) and patient levels (κ00.91 [95 % CI 0.87–
0.95]). The diagnostic image quality was not significantly
different between women and men (0.96 vs. 0.97, P00.06).
Diagnostic accuracy of CTCA
The patient-based diagnostic accuracy of CTCA for detecting
or ruling out obstructive CAD according to ICA revealed an
AUC of 0.895 (95 % CI: 0.862 - 0.928) which was similar
between women and men (0.867 [95 % CI: 0.815 - 0.920] vs.
0.921 [95 % CI: 0.880 - 0.961], P00.06), with similar sensi-
tivity and specificity for women and men when grouped in the
low and intermediate risk groups and across the low and
intermediate risk groups in both women and men (Table 3).
Because different CT systems were used over the years we
also assessed the diagnostic performance for detecting CAD
between these two machines. No significant differences were
found between the single-source and dual-source CT systems
for sensitivity (99 % vs. 99 %, P00.93), specificity (84 % vs.
75 %, P00.10), positive predictive value (85 % vs. 91 %, P0
0.06) and negative predictive value (99 % vs. 97 %, P00.39).
Clinical utility of CTCA
Certainty defined as probabilities for obstructive CAD of no
greater than 5 % after negative CTCA was achieved in both
women (NPV 97 % and 98 % for low and intermediate risk,
respectively) and men (NPV 100 % and 99 % for low and
intermediate risk, respectively) at low to intermediate risk. No
certainty of obstructive CAD after positive CTCA could be
achieved (probability <90%) in women at low (PPV 80%) and
intermediate risk (PPV 88 %), and men at low risk (PPV 80 %)
(Table 3).
Yield of obstructive CAD by ICA after CTCA
A negative CTCAwould prevent 31% (174/570) of the low to
intermediate risk patients proceeding to ICA (30 % (79/262)
152
women; 31 % (95/308) men, P00.86; Fig. 1). This prevention
of ICAwould be more pronounced in patients at low risk (low
49 % (53/109) vs. intermediate 26 % (121/461), P<0.001)
compared to patients at intermediate risk. Obstructive CAD
would be missed in less than 1 % after a negative CTCAwith
no significant differences between women and men (1 % (2/
262) women vs. 0 % (1/308) men, P00.48), or between the
low and intermediate risk groups (1 % (1/109) low vs. 0 % (2/
461) intermediate risk group, P00.52). A positive CTCA
would result in 89 % (353/396) yield of obstructive CAD by
ICAwith no significant differences between women and men
(86 % (157/183) women vs. 92 % (196/213) men, P00.0502)
or between the low and intermediate risk groups (80% (45/56)
low vs. 91 % (308/340) intermediate risk group, P00.06).
Discussion
In our clinical evaluation of CTCA in low to intermediate
risk women and men with suspected CAD who were
Table 2 Patients’ characteristics
All Low Intermediate
Women Men Women Men Women Men
Mean [SD] Mean [SD] Mean [SD] Mean [SD] Mean [SD] Mean [SD]
Number patients 262 308 80 29 182 279
Age (years) 62* [10.96] 55* [9.52] 54* [8.58] 40* [8.15] 66* [9.57] 57* [8.18]
Chest pain complaintsa
Typical 30 %* (78) [0.46] 20 %* (63) [0.40] 1 %* (1) [0.11] 0 %* (0) [0.00] 42 %* (77) [0.50] 23 %* (63) [0.42]
Atypical 38 %* (100) [0.49] 50 %* (155) [0.50] 49 %* (39) [0.50] 41 %* (12) [0.50] 34 %* (61) [0.47] 51 %* (143) [0.50]
Non-anginal 32 % (84) [0.47] 29 % (90) [0.46] 50 % (40) [0.50] 59 % (17) [0.50] 24 % (44) [0.43] 26 % (73) [0.44]
Current smoker 23 % (59) [0.42] 28 % (86) [0.45] 14 % (11) [0.34] 10 % (3) [0.31] 26 % (48) [0.44] 29 % (83) [0.46]
Diabetes mellitusb 16 % (43) [0.37] 12 % (36) [0.33] 4 % (3) [0.19] 0 % (0) [0.00] 22 %* (40) [0.42] 13 %* (36) [0.34]
CAD in familyc 55 %* (143) [0.50] 44 %* (137) [0.50] 59 % (47) [0.50] 41 % (12) [0.50] 53 % (96) [0.50] 45 % (125) [0.50]
Hypercholesterolaemiad 56 %* (147) [0.50] 44 %* (135) [0.50] 41 %* (35) [0.50] 10 %* (3) [0.31] 62 %* (112) [0.49] 47 %* (132) [0.50]
Hypertensione 52 %* (138) [0.50] 40 %* (122) [0.49] 48 %* (38) [0.50] 10 %* (3) [0.31] 54 %* (100) [0.50] 42 %* (119) [0.50]
Body mass index
(kg/m2)
27 [4.45] 27 [3.51] 27 [4.62] 26 [2.56] 27 [4.38] 27 [3.59]
Calcium scoref 139* [5–446] 349* [9–401] 20 [0–194] 2 [0–65] 211 [36–613] 155 [14–444]
Prevalence CAD
segments/patientg
9 % [0.11] 10 % [0.12] 7 %* [0.09] 3 %* [0.06] 10 % [0.11] 11 % [0.13]
One vessel disease 35 % (92) [0.48] 32 % (98) [0.47] 33 % (26) [0.47] 21 % (6) [0.41] 36 % (66) [0.48] 33 % (92) [0.47]
Multi-vessel diseaseh 25 % (65) [0.43] 32 % (99) [0.47] 14 % (11) [0.35] 7 % (2) [0.26] 30 % (54) [0.46] 35 % (97) [0.48]
Estimated PTPi 45 %* [0.25] 65 %* [0.21] 17 %* [0.07] 21 %* [0.08] 60 %* [0.18] 70 %* [0.17]
Observed PTPj 61 % (159) [0.49] 64 % (197) [0.48] 48 % (38) [0.50] 28 % (8) [0.45] 66 % (121) [0.47] 68 % (189) [0.47]
HR (beats per minute) 67* [11.94] 65* [12.64] 67 [11.91] 65 [13.78] 67 [11.98] 65 [12.54]
Radiation exposure
(mSv)k
12 [3.78] 12 [4.05] 12 [3.24] 13 [3.56] 12 [3.92] 12 [4.09]
Data in parentheses are number of patients. Data in brackets are the standard deviations and for the calcium score the 25th and 75th percentiles
*Bold values represent significant values (P<0.05) in the comparison between women and men using Student’s t test or Mann–Whitney U test
(italics)
aWe defined typical angina as substernal discomfort that was precipitated by physical exertion or emotion and relieved by rest or nitroglycerin
within 10 min. We classified chest pain with only 1 or 2 of these 3 symptom characteristics as atypical angina pectoris; if none of the characteristics
was present, we classified it as non-anginal chest pain
b Treatment with oral antidiabetic medication or insulin
c Patient had first- or second-degree relatives with premature CAD
d Total cholesterol >180 mg/dl or treatment for hypercholesterolaemia
e Blood pressure >120/90 mmHg or treatment for hypertension
f Agatston score with median and [interquartile range]
g [(Number diseased segments×100%)/(total of number segments)] per patient
h >1 vessel with obstructive CAD detected by ICA
i Estimated pre-test probability of obstructive CAD [18]: low, <30 % (estimated PTP); intermediate, 30–90 % (estimated PTP)
j Prevalence of obstructive CAD on a patient level: observed probability of obstructive CAD determined by ICA
kmSv (millisievert): dose length product×0.017
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referred for ICA but underwent additional CTCA we found
that:
& The Duke risk score underestimated the prevalence of
angiographically obstructive CAD in women, especially
in those at low risk;
& The sensitivity and specificity of CTCA were similar
across low and intermediate risk groups in and between
women and men;
& The clinical utility of a positive CTCA was moderate,
with remaining diagnostic uncertainty in low to interme-
diate risk women and low risk men requiring additional
functional testing;
& The yield of obstructive CAD by ICA was similar in
women and men with low and intermediate risk;
& CTCAwas highly accurate in excluding the presence of
obstructive CAD in women and men at low and inter-
mediate risk.
In our study the overall predicted probability of having
obstructive CAD using the Duke risk score was underesti-
mated in women (45 % vs. 61 %, P<0.01) compared with
the actual presence of CAD assessed by ICA. This finding
probably reflects the difficulties of evaluating women with
symptoms suspected of CAD and has been described in
previous studies [3, 8]. Physicians may misclassify the
Fig. 1 CAD detection by CTCA and its influence on the yield of CAD by ICA
Table 3 Diagnostic accuracy and clinical utility of CTCA between women and men across different risk groups
Risk groups Women Men Women Men P value
(W–M)
n n SN SP PPV NPV SN SP PPV NPV
All TP 157 196 SN 99 [96–100] 99 [97–100] 0.59*
TN 77 94 SP 77 [66–82] 85 [77–90] 0.07
FP 26 17 PPV 86 [80–90] 92 [88–95] 0.047
FN 2 1 NPV 97 [91–99] 99 [94–100] 0.59*
Low TP 37 8 SN 97 [87–100] 100 [68–100] 1.00*
TN 33 19 SP 79 [64–88] 90 [71–97] 0.31*
FP 9 2 PPV 80 [67–89] 80 [49–94] 1.00*
FN 1 0 NPV 97 [85–99] 100 [83–100] 1.00*
Intermediate TP 120 188 SN 99 [95–100] 99 [97–100] 1.00*
TN 44 75 SP 72 [60–82] 83 [74–90] 0.10
FP 17 15 PPV 88 [81–92] 93 [88–96] 0.12
FN 1 1 NP 98 [88–100] 99 [93–100] 1.00*
P value (L–I) 0.42* 0.46 0.23 1.00* 1.00* 0.52* 0.19* 1.00*
The diagnostic accuracy (SN, SP) and clinical utility (PPV, NPV) values are expressed as percentages with [95 % confidence interval]. Estimated
PTP [18] <30 % was defined as low and 30–90 % as belonging to the intermediate risk group. P value L–I (low vs. intermediate risk group) and W–
M (women vs. men) estimated using chi-squared test and (*) Fisher’s exact test
TP true positive, TN true negative, FP false positive, FN false negative, SN sensitivity, SP specificity, PPV positive predictive value, NPV negative
predictive value
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symptoms as non-anginal or atypical angina in women,
which consequently affects the Duke risk score where symp-
tom presentation plays a significant role in the calculation of
the PTP. Underestimation of the Duke risk score may also be
related to the referral bias of our study population, in par-
ticular in women who were referred by their treating physi-
cians for ICA.
It is noteworthy that the diagnostic accuracy of CTCA in
detecting obstructive CAD was similar in women and men
(Table 3; sensitivity 99 % vs. 99 %; specificity 77 % vs. 85 %
for women and men, respectively). Similar findings were
shown by Meijboom et al. in a multicentre study (sensitivity
100 % vs. 99 %; specificity 63 % vs. 66 %) [14] and by
Pundziute et al. in a single-centre study (sensitivity 95 %
vs.100 %; specificity 93 % vs. 89 % for women and men,
respectively) [29]. This is in contrast to the reported technical
limitations and diminished accuracy in women of other non-
invasive ischaemia tests [6, 30] and underscores the gender
neutrality (equality) of the diagnostic accuracy of CTCA.
The clinical utility of CTCA, i.e. reflecting the remaining
diagnostic certainty of the presence or absence of significant
CAD, is an important criterion in the overall clinical assess-
ment of CTCA. The clinical utility is derived from the post-
test probability of CAD and even with the same diagnostic
accuracy of a test (sensitivity/specificity) it is different in
patients with low or intermediate PTP of CAD. We arbi-
trarily assumed that in patients with a post-test probability of
less than 5 % or greater than 90 % sufficient diagnostic
certainty was achieved and no further diagnostic testing was
required. In patients with a post-test probability between
5 % and 90 % diagnostic certainty was not sufficient and
in these patients further diagnostic testing was deemed nec-
essary. In our population we found that the clinical utility of
a positive CTCA was high (>90 %) in men at intermediate
PTP of CAD and further diagnostic testing was not neces-
sary. These patients may then be referred to ICA. The
clinical utility of a positive CTCA was moderate in women
at low to intermediate PTP and in men of low PTP of CAD.
In these patients diagnostic certainty was insufficient and
further diagnostic testing may be needed. Higher certainty
may be then achieved by functional testing for ischaemia
e.g. by SPECT or by stress echocardiography [31, 32].
The clinical utility of a negative CTCA was high in
women and men at low or intermediate PTP of CAD pro-
viding high certainty (<5 %) of absence of obstructive CAD,
and no further testing would be necessary. It has been shown
in numerous studies that the absence of CAD detected by
CTCA is associated with an excellent prognosis [33, 34],
which further lends support that these patients may be safely
discharged. It should be noted that in patients with persistent
chest complaints due to microvascular dysfunction, normal
CT findings with no obstructive epicardial CAD may be
seen [35]. In these patients, who are often women, further
diagnostic testing for ischaemia to detect microvascular
dysfunction will be needed to adjust clinical management
and survival [36].
Recent studies reported that the yield of elective ICA to
demonstrate the presence of obstructive CAD in women and
men is 27–49 % and 47–67 %, respectively, in patients
referred for ICA [9, 10], whereas by performing CTCA
before diagnostic ICA the yield may improve to 86 % for
women and 92 % for men (Fig. 1) and may decrease the
number of unnecessary ICA in women and men by 30 %
and 31 %, respectively, as suggested by our study.
Our study has limitations. Referral bias was present, be-
cause the patients in our population were referred by their
treating physicians to undergo invasive coronary imaging on
the basis of their chest pain presentation with or without
outcome of stress testing. This may explain the relatively high
prevalence of obstructive CAD, in particular in women. To
account for the influence of referral bias on the diagnostic
accuracy [25, 26] of CTCAwe also reported the AUC which
was not different between women and men (0.87 vs. 0.92, P0
0.056). Our study population only consisted of stable patients
and our results may not apply to the wider spectrum of patients
with suspected CAD who did not undergo ICA or who have
unstable symptoms. Of concern was the rather high radiation
exposure of CTCA (12 mSv) due to the use of a retrospective
imaging protocol, which was standard in first-generation CT
[14, 37]. Currently with the newer-generation systems and
optimal imaging protocols much lower levels of radiation
exposure (<3 mSv) can be achieved in patients with low heart
rates (<65 beats per minute) [38].
In conclusion, computed tomography coronary angiogra-
phy has similar diagnostic accuracy in women and men with
low and intermediate risk, and may function as an efficient
gatekeeper for ICA in women as well as in men.
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Is there a difference in the diagnostic accuracy of computed
tomography coronary angiography between women
and men?
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Objective To assess the influence of sex on the diagnostic
performance of computed tomography coronary
angiography (CTCA).
Methods A total of 916 symptomatic patients (30.5%
women) without earlier history of coronary artery
intervention underwent both CTCA and invasive coronary
angiography. Descriptive diagnostic parameters, to detect
obstructive coronary artery disease (CAD; Z50%
lumen diameter narrowing) on CTCA, were compared
between women and men on a per-patient, per-vessel,
and per-segment level. Adjusted values were calculated
for clustered segments and differences in sex variables
using logistic multivariate regression models in general
estimated equations.
Results Women were older, had less typical chest
complaints, and had a lower prevalence, extent, and
severity of CAD compared with men. Multivariate analysis
on a per-patient level revealed no difference in sensitivity
(98 vs. 99%, P=0.15), specificity (78 vs. 82%, P=0.65),
positive predictive value (PPV; 87 vs. 95%, P=0.10),
negative predictive value (NPV; 97 vs. 98%, P=0.63), and
diagnostic odds ratio (DOR; 198 vs. 721, P=0.07). No
difference was found on per-vessel level analysis
(sensitivity 95 vs. 97%, P=0.14; specificity 89 vs. 87%,
P=0.93; PPV 73 vs. 79%, P=0.06; NPV 98 vs. 98%, P=0.72;
and DOR 143 vs. 240, P=0.08). Per-segment analysis
revealed a lower sensitivity (88 vs. 94%, P<0.001) and
DOR (163 vs. 302, P=0.002) in women compared with men,
without a difference in specificity (96 vs. 95%, P=0.19),
PPV (64 vs. 69%, P=0.07), and NPV (99 vs. 99%, P=0.08).
Conclusion CTCA can accurately rule out obstructive CAD
in both women and men. CTCA is less accurate in women
to detect individual obstructive disease. Coron Artery Dis
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Introduction
Coronary artery disease (CAD) remains one of the leading
causes of death in the western world in both women and
men. A larger number of cardiac deaths are reported in
women compared with men [1,2]. The cardiovascular
mortality was 55% in women compared with 43% in men
in Europe (2007) [3]. In women, the identification of CAD
is challenged by the fact that perception and reporting of
symptoms is different compared with men, with poorer
correlation between symptoms and angiographic coronary
obstruction. In addition, diagnostic performance of many
commonly used noninvasive tests, such as electrocardio-
graphic (ECG) exercise testing, myocardial perfusion imag-
ing, or stress echocardiography seems to be lower in women
compared with men [4–6].
Direct visualization of obstructive CAD by multislice CT
(MSCT) has been shown very accurate in comparison
with invasive coronary angiography [7–9], although
concerns have been raised regarding its diagnostic
performance in women [10]. The few published MSCT
diagnostic performance studies presented conflicting data
for women [10,11]. These data, regarding the diagnostic
accuracy in women, have not been detailed in recently
reported multicenter studies [7–9,12].
The purpose of this study was to compare, within a large
population, the diagnostic performance of MSCT cor-
onary angiography between women and men, using
invasive coronary angiography as reference.
Methods
General study design
The study is a continuation of the research reported
in 2007 by Meijboom et al. [10]. It is designed as a
comparison between women and men with regard to the
diagnostic performance of MSCT for the detection of
obstructive CAD, using invasive quantitative coronary161
angiography as reference [13–15]. Patients were enrolled
in previously published study protocols [15,16], which
were approved by our institutional review board. The
study is performed according to the criteria as set forth in
the Standards for Reporting of Diagnostic Accuracy
initiative [17].
Patient selection
Between July 2004 and June 2009, 1575 symptomatic
patients underwent computed tomography coronary
angiography (CTCA) and invasive coronary angiography
(ICA) within 2 weeks. Patients with a history of per-
cutaneous coronary intervention or coronary artery bypass
grafting (n=659) were excluded. The final study sample
comprised a total of 916 symptomatic patients.
Scan protocol and image reconstruction
A total of 385 patients were scanned using a single-source
CT (SSCT) from July 2004 to March 2006. The following
531 patients were scanned using a dual-source CT
(DSCT) from April 2006 to April 2009.
Beta-adrenergic blocking agents (Metoprolol, Selokeen,
Astra Zeneca, Zoetermeer, The Netherlands) were admi-
nistered in the absence of contraindications to patients
with high heart rates (>65/min) before the SSCTscan, but
not to the patients scanned by the DSCT. For vasodilation
of the coronary arteries, sublingual nitroglycerin (Nitrolin-
gual, Nitroglycerin Pumpspray, G. Pohl-Boskamp, Itohen-
lockstedt, Germany) was administered before the scan
when no contraindications were present.
The scan settings are described in Table 1. All patients
received an unenhanced CTscan to calculate the calcium
score using the Agatston method [18]. Subsequently a
bolus tracking technique was used to synchronize the
start of image acquisition with the arrival of the iodinated
contrast agent [Iomeprol, iomeron (400mgI/ml), Bracco,
Milan, Italy; and Ultravist, iopromide (370mgI/ml),
Schering, Berlin, Germany] in the coronary arteries.
The SSCT used a full-dose spiral scan technique with
retrospective ECG-gated image reconstruction. In the
DSCT, the tube current modulation was introduced to
reduce the effective radiation dose. Datasets with
motion-free images were reconstructed in the systolic
and diastolic phases for the analysis of high and low heart
rates, respectively. Both systolic and diastolic phases were
used in medium heart rates. Images were analyzed using
medium-to-smooth and sharp convolution kernels as
described in previous studies [14,16].
Computed tomography image evaluation
The total calcium score was calculated using a multi-
modality workstation with dedicated software (Siemens,
Erlangen, Germany). Experienced observers, blinded for
the ICA result, independently evaluated all CT coronary
angiograms for the presence of CAD, using axial source
images, multiplanar, curved reformatted reconstructions,
and thin-slab maximum-intensity projections on a multi-
modality workstation. Interobserver disagreements were
resolved by a joint consensus reading. The k statistic for
interobserver–intraobserver agreement in SSCTand DSCT
were 0.70, 0.72 [10] and 0.73, 0.81 [14], respectively.
The 17-segment American Heart Association model was
used to classify each segment [19]. Each segment was
visually scored as obstructive in the presence of 50%
or more lumen diameter narrowing and nonobstructive
when the lumen diameter narrowing was less than 50% in
comparison with the proximal and distal lumen. All
anatomically available segments, irrespective of image
quality or calcification, were included and scored. Poor
quality segments that were not evaluable due to calcific-
ation, stack, or movement artifacts were classified as
obstructive. Coronary segments distal to a chronic total
occlusion were excluded from the analysis.
Quantitative coronary angiography
Experienced cardiologists, blinded toward the CTresults,
visually assessed each coronary segment (American Heart
Association model) for the presence of luminal narrowing
in two orthogonal planes. Stenoses scored as having more
than 20% narrowing on visual assessment were quantified
using a validated quantitative coronary artery algorithm
(Cardiovascular Angiography Analysis System II; Pie
Medical Imaging, Maastricht, The Netherlands). The
segments were considered obstructed when the quanti-
fied lumen diameter narrowing in the two planes was
more than or equal to 50%.
Statistical analyses
The statistical analysis was performed using a dedicated
statistical software program (SPSS, version 16.0, IMB,
Table 1 Computed tomography coronary angiography protocol
SSCT DSCT
b-blockera Yes No
Nitroglycerinea No Yes
Slices 64 64
Collimation 320.6 (Z-FFS) 320.6 (Z-FFS)
Gantry rotation time (ms) 330 330
Temporal resolution (ms) 165 83
Spatial resolution (mm) 0.4 0.4 0.4 0.4 0.4 0.4
Pitch 0.20 0.2–0.53
Unenhanced scan
Tube voltage (kV) 120 120
Tube current 200–150effective
mAs
75mAs/rot
Contrast enhanced scan
Tube voltage (kV) 120 120
Tube current 850–960 effective
mAs
320–412mAs/
rot
ECG-triggered tube current
modulation
No Yes
Effective radiation dose (mSv) 16.3 14.9
DSCT, dual-source CT; ECG, electrocardiogram; mAs/rot (mAs per rotation) =
total mA rotation time; mSv (millisievert) = dose length product0.017; SSCT,
single-source CT; Z-FFS, Z-flying focal spot.
aWhen no contraindication was present.
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Chicago, Illinois, USA). Categorical variables are ex-
pressed as percentages and numbers. Continuous vari-
ables are expressed as mean values± standard deviation
and continuous variables with a skewed distribution as
median with 25th and 75th percentiles.
The clinical characteristics between women and men
were compared using the two-sided independent Student
t-test. The w2-test was used for independent nonpara-
metric comparison of categorical variables.
Lesions on CTCA and ICA were compared on a per-
segment level (Fig. 1). Obstructive lesions on both CTCA
and ICA were classified as true-positive results. Non-
obstructive lesions on both CTCA and ICA were classified
as true-negative results. Obstructive lesions on CTCA that
were nonobstructive on ICA were classified as false-positive
results. Nonobstructive lesions on CTCA that were
obstructive on ICA were classified as false negative.
The sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV), and diagnostic
odds ratio (DOR) were calculated with 95% confidence
intervals on a per-patient, per-vessel, and per-segment
level for women and men using a 2 2 table. The DOR
is used as a measure of the discriminatory power of the
CTCA and represents the odds of an obstructive result
among diseased persons relative to the odds of an
obstructive result among nondiseased persons.
To investigate whether sex had an influence on sensitivity,
specificity, PPV, NPV, and DOR, analyses were performed
on a per-patient, per-vessel, and per-segment level through
a binary logistic regression. Subanalysis of the segments was
performed dividing the segments into proximal, mid, distal,
and branches. In the awareness that multiple segments
from one patient cannot be considered as independent
values, the binary logistic regression in Generalized
Estimation Equation was used to fit model parameters.
Sex, smoking, diabetes, family history of cardiovascular
disease, age, hypertension, hypercholesterolemia, clinical
presentation of chest complaints, BMI, average heart rate
during enhanced scan, calcium score, and the type of
scanner were imported as variables in the multivariate
model. The backward elimination technique was used to
remove variables from the model based on the probability
of the Wald statistics. Variables were reentered in the
model when a significant influence on sex was seen in
terms of significant change in b-coefficient and/or a P value.
Sex was kept in the multivariate model even when the
b-coefficient did not show a significant additive value to
the model. Adjusted sensitivity, specificity, positive pre-
dictive, and NPVs were calculated using multivariate
models. The adjusted DOR was calculated using the
adjusted sensitivity and specificity. The adjusted values
were reported along with the sex-associated b-coefficients
and corresponding P value for their influence on the
multivariate model. A P value of less than 0.05 was
considered significant.
Results
A total of 280 (30.6%) women and 636 (69.4%) men with
symptoms suspected or known CAD were evaluated. The
sex-specific population characteristics and CT findings
are described in Table 2. The women in our population
presented more often with non-anginal chest complaints
(30 vs. 18%, P<0.001). They were slightly older (63±
11.1 vs. 60± 10.4 years, P<0.001) and had higher heart
rates during image acquisition in comparison with men
(67/min vs. 63/min, P<0.001). The prevalence of
obstructive disease was higher in men (60 vs. 76%,
P<0.001) accompanied by a higher calcium score (143
Fig. 1
MO1
(a) (c) (d)
(b)
MO2
MO3 ∗∗
∗∗
∗∗∗
PL
MO1 MO1
LAD
MO2 MO2
MO3 MO3
PL PL∗∗∗
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∗
A male patient (50 years) with typical complaints had computed tomography coronary angiography (CTCA; a–c) and invasive coronary angiography
(ICA; d). There was a total occlusion of the left anterior descending and an obstructive lesion at the origin of the first obtuse marginal branch (MO1),
which can be observed in the volume-rendering image (c). The distal circumflex (CX) demonstrates a missed lesion (*) on CTCA demonstrated with
the curved multiplanar reconstruction (a) and detailed in the axial images (b). (**) Proximal to the lesion (distal CX); (*) missed lesion; and (***) in the
posterolateral branch, distal to the lesion. The lesion was missed by CTCA but was acknowledged by ICA (d).
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vs. 268, P<0.001) and higher prevalence of total
occlusions (13 vs. 22%, P<0.001; Table 2).
Unadjusted diagnostic accuracy analyses
The unadjusted diagnostic performances of CTCA for the
detection of obstructive lesions on a per-patient, per-
vessel, and per-segment level are detailed in Table 3. On
a per-patient level, there was a lower PPV in women com-
pared with men (87 vs. 95%, P=0.005). This difference
was also present on a per-vessel level (PPV, 74 vs. 79%,
P= 0.031). On a per-segment level, the PPV was not
significantly different; however, there was a lower
sensitivity (88 vs. 94%, P<0.001) in women accompa-
nied by a higher specificity (96 vs. 95%, P<0.001) and
lower DOR (171 vs. 298, P<0.001).
Adjusted diagnostic accuracy analyses
After adjusting for clustering of segments and clinical
variables that were different between women and men,
the adjusted and unadjusted values were similar on each
level.
Adjusted analyses on a per-patient and per-vessel levels
did no longer show significant differences in terms of
sensitivity, specificity, PPV, NPV, and DOR between
women and men (Table 4).
On a per-segment level, the lower sensitivity (88 vs. 94%,
P<0.001) and DOR (163 vs. 302 P= 0.002) in women
remained present in the adjusted analysis, whereas the
adjusted specificity no longer showed a difference (96 vs.
95%, P= 0.43).
In the subanalysis on a per-segment level (proximal, mid,
distal segments, and branches), the sensitivity remained
significantly different between women and men. The
sensitivity for women versus men in the proximal and mid
segments was 91 versus 96% (P<0.05) and 93 versus
98% (P<0.01), respectively. A decline in the sensitivity
was observed for both women and men in distal segments
(76 vs. 89%, P 0.03) and branches (77 vs. 90%, P= 0.09).
Discussion
This study demonstrated that the diagnostic performance
of CTCA was equally reliable to exclude obstructive CAD
Table 2 Patient characteristics and computed tomography coronary angiography findings
Women Men P
Total patients (%)a,f 30.6 (280/916) 69.4 (636/916)
Age (years)e 63 (11.1) 60 (10.4) <0.001
BMI (kg/m2)e 26.8 (4.4) 26.9 (3.6) 0.84
Clinical presentation (%)a,f
Typical angina 34 (93/277) 52 (319/616) <0.001
Atypical angina 36 (101/277) 30 (187/620) 0.06
Non-anginal chest pain 30 (83/277) 18 (112/617) <0.001
Risk factor (%)a,f
Current smoker 23 (65/277) 31 (195/626) 0.019
Diabetesg 17 (46/277) 16 (103/625) 0.96
Family history of cardiovascular disease 54 (150/277) 44 (278/626) 0.007
Hypercholesterolemia (%)h 57 (159/277) 55 (344/627) 0.50
Hypertension (%)i 52 (145/277) 47 (294/617) 0.13
Average heart rate (/min)b,e 67 (11.7) 63 (11.8) <0.001
Effective radiation dose (mSv)
SSCT 16.0 (1.3) 16.4 (1.1) 0.002
DSCT 14.4 (4.6) 15.2 (4.8) 0.10
Calcium scored,e 143 (5–446) 268 (61–689) <0.001
Prevalence of disease on ICA (%)
Patientsa,f 60 (169/280) 76 (485/636) <0.001
Vesselc,e 24 (0.24) 34 (0.25) <0.001
Segmentc,e 8 (0.10) 13 (0.12) <0.001
Prevalence of total obstructions 13 (35/280) 22 (141/636) <0.001
Single-vessel disease (%) 33 (77/280) 32 (206/636) 0.81
Multivessel disease (%) 28 (77/280) 44 (280/636) <0.001
BMI, body mass index; CX, circumflex; DSCT, dual-source CT; ICA, invasive coronary angiography; LAD, left anterior descending; LM, left main; RCA, right coronary
artery; SSCT, single-source CT.
mSv (millisievert) = dose length product0.0017.
Prevalence of disease was calculated per patient as:
[(Patients with disease100%)/(total number of patients)] on patient level.
{[Diseased vessels100%]/[4 vessels(LM, RCA, LAD, CX)]} per patient on vessel level.
[(Number diseased segments100%)/(total of number segments)] per patient on segment level.
aPercentage (number/total number).
bMean (standard deviation).
cPercentage (standard deviation).
dMedian with (25th–75th percentile).
eIndependent Student t-test.
fChi-square test.
gTreatment with oral antidiabetic medication of insulin.
hTotal cholesterol > 180mg/dl or treatment for hypercholesterolemia.
iBlood pressure Z140/90mmHg or treatment for hypertension.
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both in women and men. The diagnostic performance of
CTCA to detect individual coronary obstructions was good,
but lower in women compared with men. This is in line
with other noninvasive diagnostic studies, demonstrating
lower accuracy in women in exercise-ECG testing, stress-
echocardiography, and myocardial perfusion imaging (single
photon emission computed tomography) [2,4,20]. This
may be related to sex-varying factors such as the presence
of risk factors, presentation of symptoms, prevalence,
extent and severity of CAD all of which may influence
noninvasive CAD ischemia test outcomes [2,4].
Previous comparisons of the diagnostic performance of
CTCA between men and women were in disagreement.
Meijboom et al. [10] reported a lower diagnostic accuracy on
a per-segment level in women, which was not confirmed in
an another study by Pundziute et al. [11]. In contrast with
the two former studies in our diagnostic accuracy study we
were able to collect a large number of women, which
allowed adjustment of sex-varying factors that could have an
influence on CT-diagnostic performance. After adjusting for
the sex-varying factors by multivariate analyses, we found
similar results in women and men except for the sensitivity
on a per-segment level. This difference in sensitivity can be
explained by the presence of more severe and extensive
CAD in men. In addition, the prevalence of total occlusions
(13 vs. 22%, P<0.001) was higher in men, which may have
positively affected the sensitivity in men because these
lesions are detected with an almost 100% sensitivity.
Traditionally, exercise ECG testing, stress echocardiography,
or single photon emission computed tomography have been
used as a first-line diagnostic test in patients with suspected
CAD to serve as gatekeeper for ICA [21]. The rather
modest diagnostic performance of these tests and relative
under use particularly in women may have contributed to
the high percent of nonobstructive CAD by ICA. The
absence of obstructive CAD in women undergoing elective
diagnostic ICA was approximately 51.2–72.6%, which was
much higher than the 33.3–52.8% in men [22,23].
Table 3 Unadjusted diagnostic performance of computed tomography coronary angiography for women and men
Women Men
(95% CI) (95% CI) P
Patient level TP TN FP FN TP TN FP FN
166 87 24 3 482 124 27 3
Sensitivity 98 (96–100) 99 (99–100) 0.28
Specificity 78 (71–86) 82 (76–88) 0.34
PPV 87 (83–92) 95 (93–97) 0.005
NPV 97 (93–100) 98 (95–100) 0.68
DOR 201 (59–685) 738 (220–2472) 0.07
Vessel level TP TN FP FN TP TN FP FN
262 752 94 14 840 1464 219 27
Sensitivity 95 (92–98) 97 (96–98) 0.18
Specificity 89 (87–91) 87 (85–89) 0.08
PPV 74 (69–78) 79 (77–82) 0.031
NPV 98 (97–99) 98 (98–99) 0.98
DOR 150 (84–267) 208 (138–313) 0.18
Segment level TP TN FP FN TP TN FP FN
319 4221 175 45 1134 9117 510 68
Sensitivity 88 (84–91) 94 (93–96) <0.001
Specificity 96 (95–97) 95 (94–95) <0.001
PPV 65 (60–69) 69 (67–71) 0.07
NPV 99 (99–99) 99 (99–100) 0.08
DOR 171 (121–242) 298 (230–387) 0.006
Sensitivity = TP/(TP+FN), Specificity = TN/(FP+TN), PPV=TP/(TP+FP), NPV=TN/(TN+FN), are presented as %. DOR= (TP TN)/(FN FP). Numbers in square
brackets are the 95% confidence intervals. P values are calculated using the independent Student t-test.
CI, confidence interval; DOR, diagnostic odds ratio; FN, false negative; FP, false positive; NPV, negative predictive value; PPV, positive predictive value; TN, true negative;
TP, true positive.
Table 4 Adjusted diagnostic performance of computed tomogra-
phy coronary angiography on patient, vessel, and segment level
Women Men b-coefficient P
Patient level
Sensitivity (%) 98 99 –1.32 0.15
Specificity (%) 78 82 0.16 0.65
PPV (%) 87 95 –0.50 0.10
NPV (%) 97 98 –0.52 0.63
DOR 198 721 0.07
Vessel level
Sensitivity (%) 95 97 –0.52 0.14
Specificity (%) 89 87 0.14 0.93
PPV (%) 73 79 –0.28 0.06
NPV (%) 98 98 –0.12 0.72
DOR 143 240 0.08
Segment level
Sensitivity (%) 88 94 –0.84 <0.001
Specificity (%) 96 95 0.16 0.19
PPV (%) 64 69 –0.24 0.07
NPV (%) 99 99 –0.41 0.08
DOR 163 302 0.002
Adjusted sensitivity, specificity, PPV, and NPV calculated using binary logistic
regression analyses (generalized estimation equation). Clustering for 17
segments. Input variables: sex, smoking, diabetes, family history of cardiovascular
disease, age, hypertension and hypercholesterolemia, type of chest complaints,
BMI, heart rate, and calcium score. Backward elimination technique removed
nonpredicting variables from the model. Sex influence on this model is
demonstrated as b-coefficient with corresponding P value.
DOR calculated with adjusted sensitivity and specificity: [(sensitivity/(1–sensitivity))/
((1–specificity)/specificity)].
DOR, diagnostic odds ratio; NPV, negative predictive value; PPV, positive predictive
value.
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Although the sensitivity to detect individual obstructions
was lower in women (88 vs. 94%, P<0.001), this did not
affect the ability to exclude CAD because the NPV on a
per-patient level was similar between women and men
(97 vs. 98%, P= 0.63). This suggests that CTCA in
women can be used as a first-line noninvasive diagnostic
test to serve as an effective gatekeeper for ICA, which
may result in significant reduction in normal ICAs
compared with other first-line noninvasive tests.
Study limitations
The ionizing radiation inherent to CTCA remains of
concern. Especially, women have higher lifetime that was
attributable for breast and lung cancer at all ages compared
with men. This risk decreases with age because of decrease
of radiosensitivity of involved organs at an increasing age.
Women with symptoms suggestive of CAD are generally
older and thereby fall in a relatively favorable range. Our
reported radiation exposure was rather high, which was due
to the fact that this study was initiated in 2004 when we
had access to CT scanners, which then used a full-dose
spiral scan protocol, resulting in a relatively high effective
radiation dose. Since then gradually, by introducing radi-
ation exposure reduction techniques, the radiation expo-
sure has decreased first after use of wide window tube
current modulation and subsequently further decreased by
use of a narrow window tube current modulation (Table 2).
The estimated risk of cancer has been decreased by
approximately 60% by the introduction of radiation
reduction techniques [24,25]. With the current optimized
scan protocols this radiation dose has decreased even more,
to less than 5mSv [26–28].
The study group consisted of patients with stable angina
pectoris referred for ICA who have a high prevalence
of CAD. Therefore, the results may not be extrapolated
to patients with unstable CAD or patients with low
prevalence of CAD.
Furthermore, the retrospective study design and the
inclusion of patients referred for ICA may have caused
selection and verification bias, which may have resulted in a
relative higher sensitivity and lower specificity of CTCA.
However, this would be similar for women and men.
Conclusion
CTCA can accurately rule out obstructive CAD in both
women and men. CTCA is less accurate in women to
detect individual obstructive disease.
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CT coronary angiography for the assessment of 
atherosclerotic plaque 
 
Chapter 2      We evaluated the ability of 64-slice CT coronary angiography (CTCA)-derived plaque parameters to detect and quantify coronary atherosclerosis, using intravascular ultrasound (IVUS) as the reference standard. We analyzed 1364 co-registered 1-mm coronary cross-sections and 255 segments of 5-mm length. Compared with IVUS, CTCA demonstrated 86% sensitivity and 71% specificity for the detection of plaque on cross-sectional level; on a per segment basis we observed 96% sensitivity and 88% specificity. The sensitivity of CTCA to detect plaque decreased with smaller plaque size and with the distance from the coronary ostium. Correlation for vessel plaque volumes measured by CTCA and IVUS was high. Bland–Altman analysis showed a slight underestimation of any plaque volume by CTCA, with a trend to underestimate non-calcified and overestimate mixed/calcified plaque volumes. In conclusion, CTCA is able to detect and quantify atherosclerotic plaque, but further improvement in CT resolution is necessary for more reliable assessment of very small and distal coronary plaques.  
Chapter 3       Reproducibility of the quantitative assessment of atherosclerosis by CTCA is paramount for the design of longitudinal studies. We assessed the inter- and intra-observer reproducibility using semiautomated CT plaque analysis software in symptomatic patients who underwent CTCA at baseline and after 3 years. The plaque quantitative analysis was performed in untreated vessels with mild-to-moderate atherosclerosis and included geometrical and compositional characteristics. Our results suggest that the geometrical assessment of coronary atherosclerosis by CTCA is highly reproducible using semiautomated quantification software and that serial plaque changes can be detected beyond observer variability. The compositional measurements are more variable between observers than geometrical measurements.  
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Chapter 4       We assessed the serial changes in coronary plaque burden, lumen dimensions and arterial remodeling in patients with acute coronary syndromes who underwent 64-slice CTCA after percutaneous coronary intervention at baseline and after a median of 39 months. All patients received contemporary medical treatment. Clinical events at follow-up were documented. Our findings showed that despite standard-of-care treatment, the atheroma size in untreated non-culprit lesions increased over 3 years, compensated for by an increase in the vessel size (positive expansive remodeling) and without compromising the lumen. Patients with clinical events had a larger plaque volume at baseline. We concluded that CTCA can assess the progression of coronary atherosclerosis and may be used for noninvasive monitoring of pharmacologic interventions in coronary artery disease.  
Chapter 5 We compared the diagnostic performance of quantitative CTCA with visual CTCA for the detection of flow-limiting coronary lesions using fractional flow reserve (FFR) as reference standard. CTCA and FFR measurements were obtained in 99 symptomatic patients. In total, 144 coronary lesions detected on CTCA were visually graded for stenosis severity. Quantitative CTCA measurements included lesion length, minimal area diameter, % area stenosis, minimal lumen diameter, % diameter stenosis, and plaque burden [(vessel area−lumen area)/vessel area×100]. Optimal cutoff values of CTCA-derived parameters were determined, and their diagnostic accuracy for the detection of flow-limiting coronary lesions (FFR ≤0.80) was compared with visual CTCA. Our findings demonstrated that CTCA cross-sectional quantitative parameters improve the prediction of flow-limiting lesions, compared to visual assessment, but remain insufficient and functional assessment is still needed for lesions of moderate severity to guide patient's management.   
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CT coronary angiography for the assessment of coronary 
bifurcations  
Chapter 6       We evaluated the distribution and composition of atherosclerotic plaques at bifurcations with intravascular ultrasound-virtual histology (IVUS-VH) and CTCA in relation to the bifurcation angle (BA). Thirty-three bifurcations were matched and studied with both modalities; the analyzed main vessel was divided into a 5-mm proximal segment, the in-bifurcation segment, and a 5-mm distal segment. Our findings demonstrated that the proximal segment has a more extensive plaque burden with more lipid content. The plaques with high-risk features on IVUS-VH and the non-calcified plaques on CTCA both show a differential distribution along the bifurcation being more frequent in the proximal segment, and are associated with higher BA values.  
Chapter 7       We evaluated the distribution of atherosclerosis at bifurcations with CTCA and proposed a novel CT-Medina classification for bifurcation lesions. We quantified plaque in 39 bifurcations; the analysis included the proximal main vessel, the distal main vessel and the side branch (SB). The carina cross-sections were divided into four equal parts according to the expected wall shear stress (WSS) to assess circumferential plaque distribution. All the bifurcation lesions were classified using the Medina classification and a novel CT-Medina classification combining lumen narrowing and plaque burden 
≥70%. Our investigation demonstrated that atherosclerotic plaque is widely present in all bifurcation segments, even in the absence of coronary lumen stenosis. The plaque is more often located opposite to the flow divider, whereas the carina is rarely affected. Characterization of bifurcation lesions using the new CT-Medina classification provided additional information in 18% of cases compared to the Medina classification, indicating that a CT-Medina classification scheme combining lumen stenosis and plaque severity is more informative than angiographic classification of bifurcation lesions.  
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CT coronary angiography for risk stratification of coronary 
atherosclerotic disease  
Chapter 8       The invasive coronary angiography SYNTAX score (ICA SXscore) is an important prognostic tool in risk stratifying patients undergoing revascularisation, as well as an independent predictor of adverse cardiac events.  We investigated the feasibility and reproducibility of the CTCA-derived SYNTAX score. The SXscore of 80 symptomatic patients who underwent ICA and CTCA was retrospectively calculated for both modalities by 2 independent teams of experienced reviewers. The CTCA SXscore was re-
calculated after two months in 40 random patients to assess intra-observer variability. We found a good correlation between the ICA SXscore and the CTCA SXscore (rs=0.76, p<0.001), whereas the median CTCA SXscore was higher compared to the median ICA SXscore. Kappa statistics indicated a substantial intra-observer agreement for CTCA SXscore tertiles and the correlation between the two rounds of analyses was high 
(r=0.95, p<0.001). We concluded that the calculation of the SXscore by CTCA in symptomatic patients appeared feasible and reproducible. The long-term prognostic role of this scoring methodology should be further investigated.  
Chapter 9       Detection of patients with LM and/or 3VD (so-called “high risk CAD”) is important because optimal medical treatment combined with revascularization has shown to improve prognosis in these patients. We investigated the diagnostic performance of CTCA to rule in/out “high risk CAD” in 1136 symptomatic patients using invasive coronary angiography (ICA) as the reference standard. Vessels were considered obstructive in the presence of ≥50% lumen diameter stenosis. We compared the discriminatory value of CTCA to detect “high risk CAD” to the Duke risk score and calcium score. The sensitivity of CTCA to detect these patients was 95%; the specificity was 83%; the positive predictive value was 54% and the negative predictive value was 99%. CTCA provided incremental value in the discrimination of “high risk CAD” with an 
area under the receiver operating characteristic curve of 0.90 for CTCA separately. We 
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concluded that CTCA accurately rules out “high risk CAD” in patients with suggestive symptoms. However, the performance of CTCA to rule in “high risk CAD” is suboptimal, due to the high number of false positive observations by overestimating severity of stenosis. CTCA provides incremental value in the discrimination of “high risk CAD” compared to the Duke risk score and calcium score.  
Chapter 10      We investigated the diagnostic accuracy of CTCA in women at low to intermediate pre-test probability of coronary artery disease (CAD) compared with men. We included 570 symptomatic patients who underwent both invasive coronary angiography (reference standard) and CTCA and were stratified as low (women 73%) and intermediate risk (women 39%). The pre-test probability of CAD was estimated using the Duke risk score. 
Thresholds of less than 30% and 30–90% were used for determining low and intermediate risk, respectively. We found that sensitivity, specificity, positive predictive value and negative predictive value were not significantly different in and between women and men at low and intermediate risk.   
Chapter 11       We assessed the influence of gender on the diagnostic performance of CTCA. A total of 
916 symptomatic patients (30.5% women) without earlier history of coronary artery intervention underwent both CTCA and invasive coronary angiography. Descriptive diagnostic parameters, to detect obstructive CAD (≥50% lumen diameter narrowing) on CTCA, were compared between women and men on a per-patient, per-vessel, and per-segment level. Our analysis showed that women were older, had less typical chest complaints, and had a lower prevalence, extent, and severity of CAD compared with men. Multivariate analysis on a per-patient level revealed no difference in sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic odds ratio (DOR). No difference was found on per-vessel level analysis. Per-segment analysis revealed a lower sensitivity (88% vs. 94%) and DOR (163 vs. 302) in women compared with men, without a difference in specificity (96% vs. 95%), PPV (64% vs. 69%), and NPV (99% vs. 99%). We concluded that CTCA can accurately rule out obstructive CAD in 
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both women and men. CTCA is less accurate in women to detect individual obstructive disease.                       
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   Samenvatting en conclusies                    
CT coronaire angiografie voor de beoordeling van coronaire 
atherosclerose 
 
Hoofdstuk 2 We hebben de mogelijkheid onderzocht om met  64-slice CT coronaire angiografie (CTCA)-afgeleide plaque parameters coronaire atherosclerose op te sporen en te kwantificeren, met intravasculair ultrageluid (IVUS) als referentiestandaard. We analyseerden 1364 gecorreleerde 1-mm coronaire doorsneden en 255 segmenten met een lengte van 5 mm. Vergeleken met IVUS, CTCA toonde 86% sensitiviteit en 71% specificiteit voor de detectie van plaque op transversaal niveau; per segment zagen we 96% sensitiviteit en 88% specificiteit. De sensitiviteit van CTCA voor de detectie van plaque nam af naarmate de plaque kleiner werd en de afstand van het coronaire ostium langer werd. De correlatie voor het coronaire plaque volume gemeten met CTCA en IVUS was hoog. Bland-Altman-analyse toonde een lichte onderschatting van elk plaque volume door CTCA, met een trend voor onderschatting van niet-verkalkte en overschatting van gemengde/verkalkte plaque volumes. Concluderend, CTCA is geschikt voor het detecteren en kwantificeren van atherosclerotische plaque, maar verdere verbetering van de CT resolutie is noodzakelijk voor een meer betrouwbare beoordeling van zeer kleine en distale coronaire plaques.   
Hoofdstuk 3 Reproduceerbaarheid van de kwantitatieve beoordeling van atherosclerose door CTCA is van groot belang voor het ontwerpen van longitudinale studies. Wij hebben daarom de inter- en intra-observer reproduceerbaarheid beoordeeld met behulp van semi-automatische CT plaque analyse software bij symptomatische patiënten die CTCA ondergingen op baseline en na 3 jaar. De kwantitatieve plaque analyse werd uitgevoerd in onbehandelde coronairen met milde tot matige atherosclerose, en bestond uit geometrische en compositorische kenmerken. Onze resultaten suggereren dat de geometrische beoordeling van coronaire atherosclerose door CTCA zeer reproduceerbaar is middels semi-automatische kwantificering software, en dat seriële 
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plaque veranderingen nauwkeuriger kunnen worden gedetecteerd ondanks observer variabiliteit. De compositorische metingen zijn meer variabel tussen observers dan geometrische metingen.  
Hoofdstuk 4 Wij hebben de seriële veranderingen onderzocht in coronaire plaque burden, lumen afmetingen en arteriële remodeling bij patiënten met acuut coronair syndroom die 64-slice CTCA ondergingen na percutane coronaire interventie op baseline en na een mediaan van 39 maanden. Alle patiënten kregen de hedendaagse medische behandeling. Klinische events bij follow-up werden gedocumenteerd. Onze bevindingen toonden aan dat ondanks de standard-of-care behandeling de atheroma grootte in onbehandelde non-culprit laesies was gestegen na 3 jaar, gecompenseerd voor een toename van de grootte van het vat (positive expansive remodeling) en zonder afbreuk te doen aan het lumen. Patiënten met klinische events hadden een groter plaque volume op baseline. Wij concludeerden dat CTCA de progressie van coronaire atherosclerose kan beoordelen en kan worden gebruikt voor non-invasieve bewaking van farmacologische interventies bij coronaire hartziekte.  
Hoofdstuk 5 We vergeleken de diagnostische waarde van kwantitatieve CTCA in vergelijking met visuele CTCA voor de detectie van flow-limiting coronaire laesies middels fractionele flow reserve (FFR) als referentiestandaard. CTCA en FFR metingen werden verzameld bij 99 symptomatische patiënten. In totaal werden 144 coronaire laesies gevonden op CTCA visueel beoordeeld op ernst van de stenose. Kwantitatieve CTCA metingen bestonden uit  laesie lengte, minimale oppervlakte diameter, percentage oppervlakte stenose, minimale lumen diameter, percentage diameter stenose, en plaque burden [(vessel area-lumen area) / vessel area × 100]. Optimale cutoff waarden van CTCA-afgeleide parameters werden bepaald, en de diagnostische nauwkeurigheid voor het detecteren van flow-limiting coronaire laesies (FFR ≤0.80) werd vergeleken met visuele CTCA. Onze bevindingen laten zien dat CTCA cross-sectionele kwantitatieve parameters de voorspelling van flow-limiting laesies verbeteren, vergeleken met visuele 
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beoordeling, maar onvoldoende blijven en dat daarom een functionele beoordeling nog steeds nodig is voor laesies van matige ernst om de behandeling van patiënten te ondersteunen.  
CT coronaire angiografie voor de beoordeling van coronaire 
bifurcaties  
Hoofdstuk 6 We evalueerden de distributie en samenstelling van atherosclerotische plaques bij vertakkingen met intravascular ultrasound-virtual histology (IVUS-VH) en CTCA met betrekking tot de hoek van de bifurcatie (BA). Drieëndertig vertakkingen werden gevonden en bestudeerd met beide modaliteiten; de geanalyseerde main vessel werd verdeeld in een 5-mm proximaal segment, een segment in de aftakking, en een 5-mm distaal segment. Onze bevindingen laten zien dat het proximale segment een uitgebreidere plaque burden heeft  met een hoger lipidegehalte. De plaques met hoog-risico eigenschappen op IVUS-VH en de niet-gecalcificeerde plaques op CTCA tonen een verschillende verdeling over de vertakking, met name vaker in het proximale segment, en worden geassocieerd met hogere BA waarden.  
Hoofdstuk 7 We hebben de verdeling van atherosclerose bij vertakkingen met CTCA beoordeeld en stellen een nieuwe CT-Medina classificatie bij bifurcatie laesies voor. We kwantificeerden plaque in 39 vertakkingen; de analyse omvatte de proximale main vessel, de distale main vessel en de zijtak (SB). De carina doorsneden werden verdeeld in vier gelijke delen volgens de verwachte wand shear stress (WSS) om zo de circumferentiële plaque distributie te beoordelen. Alle bifurcatie laesies werden ingedeeld aan de hand van de Medina classificatie en een nieuwe CT-Medina classificatie die lumen vernauwing en plaque burden ≥70% combineert. Ons onderzoek heeft aangetoond dat atherosclerotische plaque wijdverspreid is in elke segment van de bifurcatie, zelfs bij afwezigheid van vernauwingen in het coronaire lumen. De plaque is 
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vaker tegenover de stroomverdeler gelokaliseerd, terwijl de carina zelden is aangedaan. Karakterisering van bifurcatie laesies met behulp van de nieuwe CT-Medina classificatie leverde aanvullende informatie op in 18% van de gevallen in vergelijking met de Medina classificatie, wat aangeeft dat een CT-Medina classificatieschema die lumen vernauwing en plaque ernst combineert informatiever is dan een angiografische classificatie van bifurcatie laesies.   
CT coronaire angiografie voor risicostratificatie van 
coronaire atherosclerose  
Hoofdstuk 8 De invasieve coronaire angiografie SYNTAX score (ICA SXscore) is een belangrijk prognostisch instrument voor het stratificeren van patiënten die revascularisatie ondergaan, alsook een onafhankelijke voorspeller van ongewenste cardiale events. We onderzochten de haalbaarheid en de reproduceerbaarheid van de CTCA-afgeleide 
SYNTAX score. De SXscore van 80 symptomatische patiënten die ICA en CTCA ondergingen werd retrospectief berekend voor beide modaliteiten door 2 onafhankelijke teams van ervaren beoordelaars. De CTCA SXscore werd opnieuw 
berekend na twee maanden bij 40 willekeurig gekozen patiënten om de intra-observer variabiliteit te evalueren. We vonden een goede correlatie tussen de ICA SXscore en de CTCA SXscore (rs=0,76, p <0.001), terwijl de mediane CTCA SXscore hoger was in vergelijking met de mediane ICA SXscore. De Kappa waarden lieten een aanzienlijke intra-observer overeenkomst zien voor CTCA SXscore tertiles en de correlatie tussen de twee analyserondes was hoog (r=0.95, p<0.001). We concludeerden dat de berekening van de SXscore met CTCA bij symptomatische patiënten  zowel haalbaar als reproduceerbaar bleek. De lange termijn prognostische rol van deze scoring methode moet verder worden onderzocht.    
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Hoofdstuk 9 Detectie van patiënten met LM en/of 3VD (zogenaamde "hoog-risico CAD") is belangrijk omdat optimale medische behandeling in combinatie met revascularisatie de prognose bij deze patiënten blijkt te verbeteren. We onderzochten de diagnostische waarde van CTCA om "hoog-risico CAD" in- of uit te sluiten in 1136 symptomatische patiënten met behulp van invasieve coronaire angiografie (ICA) als referentie standaard. Coronairen werden als vernauwd gezien bij aanwezigheid van ≥50% lumen  diameter stenose. We vergeleken de discriminerende waarde van CTCA om "hoog-risico CAD" te detecteren ten opzichte van de Duke risk score en calcium score. De sensitiviteit van CTCA om deze patiënten te detecteren was 95%; de specificiteit was 83%; de positief voorspellende waarde was 54% en de negatieve voorspellende waarde was 99%. CTCA levert een zeer belangrijke meerwaarde bij het identificeren van "hoog-risico CAD" patiënten, met een 
receiver operating characteristic curve van 0.90 voor CTCA afzonderlijk. We concludeerden dat CTCA nauwkeurig "hoog-risico CAD" kan uitsluiten bij patiënten met suggestieve symptomen. Echter, de mogelijkheid van CTCA om 'hoog-risico CAD" aan te tonen is suboptimaal, met name door het grote aantal vals-positieve bevindingen door overschatting van de ernst van de stenose. CTCA biedt een belangrijke meerwaarde in het maken van onderscheid in "hoog-risico CAD" in vergelijking met de Duke risico score en calcium score.  
Hoofdstuk 10 We onderzochten de diagnostische nauwkeurigheid van CTCA bij vrouwen met een laag tot intermediaire a priori kans op coronaire hartziekte (CAD) in vergelijking met mannen. We includeerden 570 symptomatische patiënten die zowel invasieve coronaire angiografie (referentie standaard) als CTCA ondergingen, en die werden gestratificeerd als laag (vrouwen 73%) en intermediair risico (vrouwen 39%). De pre-test probability van CAD werd geschat met behulp van de Duke risico score. Drempels van minder dan 
30% en 30-90% werden gebruikt voor het bepalen van respectievelijk laag en gemiddeld risico. We vonden dat de sensitiviteit, specificiteit, positief voorspellende waarde en negatief voorspellende waarde niet significant verschillend waren bij en tussen mannen en vrouwen met een laag en gemiddeld risico. 
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Hoofdstuk 11 We onderzochten de invloed van geslacht op de diagnostische prestaties van CTCA. Een totaal aantal van 916 symptomatische patiënten (30.5% vrouwen) zonder een voorgeschiedenis van coronaire interventie ondergingen zowel CTCA als invasieve coronaire angiografie. Beschrijvende diagnostische parameters, om obstructieve CAD (≥50% lumen diameter vernauwing) te detecteren op CTCA, werden vergeleken tussen vrouwen en mannen op patiënt-, coronair- en segment niveau. Onze analyse toonde aan dat vrouwen ouder waren, minder typische angina klachten hadden alsook een lagere prevalentie, mate en ernst van CAD in vergelijking met mannen. Multivariate analyse op een per-patiënt niveau toonde geen verschil in sensitiviteit, specificiteit, positief voorspellende waarde, negatief voorspellende waarde en diagnostische odds ratio (DOR). Er werd geen verschil gevonden op per-coronair niveau analyse. Per-segment analyse toonde een lagere sensitiviteit (88% vs. 94%) en DOR (163 versus 302) bij vrouwen in vergelijking met mannen, zonder een verschil in specificiteit (96% vs. 95%), PPV (64% vs. 69%) en NPV (99% vs. 99%). We concludeerden dat CTCA nauwkeurig obstructieve CAD kan uitsluiten bij zowel vrouwen als mannen. CTCA is bij vrouwen minder nauwkeurig om individuele obstructieve ziekte op te sporen.            
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   General discussion and future directions   
 
            
In the final part of this thesis book we will discuss the results of our main studies regarding the ability of CTCA to detect, assess and monitor coronary atherosclerotic plaque.  
CT coronary angiography for the assessment of 
atherosclerotic plaque 
CTCA vs. IVUS for plaque detection and quantification: are they 
comparable? Computed Tomography Coronary Angiography (CTCA) has the potential to become a non-invasive alternative to IVUS for plaque quantification and to be used for risk stratification of asymptomatic individuals or the assessment of atherosclerosis progression/regression. Previous studies (1-4) have focused on the comparison of CTCA- and IVUS-derived quantitative parameters, such as plaque area or plaque burden, showing moderate to good correlation. In our study (Chapter 2), we used a CTCA-derived quantitative parameter (wall thickness) to assess diagnostic accuracy on a slice-by-slice and segmental basis. Our data demonstrated that the detection of atherosclerotic plaque based on CTCA-derived quantitative parameters in a similar fashion to IVUS was feasible. Plaques located within the proximal 40mm were detected with very high sensitivity (88–100%) and as invasive imaging studies have shown, the most clinically relevant lesions are highly clustered within the proximal sections of the coronaries (5-7). Moreover, the very good diagnostic accuracy obtained at segmental level is promising for the potential development of prediction models based on plaque presence on a per-segment basis. Nevertheless, it is important to keep in mind that the clinical use of CTCA for detection of early atherosclerosis is still limited by the current spatial and temporal resolution of the technique. Further technical improvements of the acquisition and reconstruction techniques will enable more reliable visualisation of the coronary arteries with better signal-to-noise ratio and decrease of partial voluming and motion artifacts. Regarding the quantification of plaque volume by CTCA, our results add to the existing literature which only deals with stable angina patients. Several researchers compared 
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plaque volumes derived from CTCA with corresponding IVUS data and reported strong correlation and moderate agreement (8-13). The differences between CTCA and IVUS volumetric measurements, which were also observed in our analysis, could be attributed to several technical and methodological factors. The spatial resolution of 64-slice CT may still be inadequate for accurate edge discrimination of CTCA images. The smaller coronary plaques, in particular non-calcified plaques, cannot be well defined and may occasionally not be detected, resulting in underestimation of plaque volume. Moreover, the real size of calcified plaque is overestimated by CTCA due to the blooming effects. Quantification of calcified plaque by IVUS can also be imprecise, because the acoustic shadowing in areas of calcification blocks the view of the outer vessel borders. In addition, on IVUS the outer boundaries were defined by the external elastic membrane (EEM), whereas on CTCA the outer vessel border was annotated at the adventitia-fat boundary, which may also have accounted for the discrepancies in the measurements. Furthermore, the IVUS images are not strictly perpendicular to the centerline, depending on the catheter position and vessel tortuosity. In the real life of clinical practice, there is no imaging technique without limitations.  
Assessment of atherosclerotic plaque by CTCA: what about 
reproducibility? Over the recent few years, CTCA has been more commonly used as a tool to non-invasively assess the temporal effect of medical therapies on coronary plaque size in longitudinal studies (14-20). Moreover, this method has the potential to assess plaque composition and therefore to assess the effect of drug therapies on the phenotype of coronary atherosclerosis. As the impact of medical treatment on the atherosclerotic plaque size and composition over time is relatively small, highly reproducible CTCA quantitative measurements are pivotal. In our investigation (Chapter 3), using semiautomated plaque quantification software, the CTCA geometrical measurements were highly reproducible in both intra- and inter-observer comparisons. Furthermore, in comparison with IVUS studies, the CTCA reproducibility appeared to be comparable or better. This observation could be partly attributed to the methodology for the actual analysis, since in CTCA all frames were analyzed in a stepwise approach; first the lumen 
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and vessel wall borders were delineated as continuous lines in the longitudinal view (L-view). These contour positions functioned as landmarks for the automated contour detection in the individual cross sections; a visual inspection was performed in every cross-section and a manual correction was applied if necessary. In contrast, in IVUS only the individual cross-sections are drawn without the first step (i.e. longitudinal drawing).  Regarding the plaque composition, overall the differences of the average plaque attenuation between observers were very small on the cross-sectional and segment level analyses. Despite this finding, the presumably lipid-rich content [the % Low Attenuation Plaque – LAP (<30 HU)] showed a relatively high inter-observer variability of 12%, which is of major significance since the temporal change of such component could potentially become an imaging endpoint of longitudinal studies. The LAP is probably the most clinically relevant component of coronary plaques as it has been shown to correlate closely with plaques of low echogenicity (presumably lipid-rich) on IVUS (21) and to have prognostic value for the development of acute coronary syndromes (22). On the other hand, the intra-observer variability for %LAP was low (median 3% approximately), which underlines the fact that the position of the plaque contours can play a detrimental role in the distribution of attenuation values. Small differences in the lumen or vessel wall delineation would not dramatically influence the geometrical measurements, but they could result in much bigger differences in the compositional measurements due to partial volume, i.e. in case part of the lumen or the pericoronary fat is incorrectly included in the plaque area.  
Implications for the design of longitudinal studies In our study (Chapter 3), the observer variability was lower than the temporal changes in plaque burden - the most common endpoint in IVUS progression/regression studies. This finding suggests that CTCA data analysis using semiautomated software can detect changes in atherosclerotic plaque size beyond the observer bias. Certainly, the best approach is that the same analyst analyzes in a blind fashion both the baseline and follow-up CTCA images, since the difference is much lower in the intra-observer comparison for both the cross-sectional and segment based analyses than in the inter-observer comparison; more importantly, for the compositional measurements only the 
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intra-observer variability was below the generally acceptable threshold of 10%. It should be noted that our study was conducted on a population with mild-to-moderately diseased arteries receiving contemporary medical therapy. This was driven by the intention to study the reproducibility of this quantitative method on patients that would be the most suitable candidates for serial assessment of atherosclerosis in the ‘‘real life’’; since the severe lesions would have been treated with percutaneous coronary intervention, the efficacy of the statin therapy would be monitored mainly in the untreated, mild-to-moderately diseased atherosclerotic arteries.  
CTCA for the serial assessment of atherosclerosis: is it possible in 
“real world”?  Previous IVUS studies (23) have demonstrated that there is a direct association between the burden of coronary atherosclerosis, its progression, and the presence of clinical events at follow-up. Similarly, in the main PROSPECT study, lesions with plaque burden >70% were shown to be strongly associated with future clinical events (24). Our data (Chapter 4) are in accordance with these findings, because the patients presenting with clinical events had greater amount of plaque at baseline. This observation could contribute to the potential development of prediction models based on atherosclerotic plaque burden. Motoyama et al. (22) and Hoffmann et al. (25) described that the plaques in patients with ACS have positive remodeling and are associated with events. Consistent with the original description by Glagov et al. (26), our investigation showed that arteries enlarge as atherosclerosis progresses. Previous serial IVUS reports have demonstrated that atheroma burden does not limit compensatory remodeling (27), whereas there is a broad spectrum of serial remodeling responses in coronary atherosclerosis (28,29). Importantly, arterial remodeling changes closely relate to changes in Percent Atheroma Volume (PAV), which is the most common primary IVUS endpoint. In the absence of actual change in plaque volume, positive remodeling could reduce PAV, whereas negative remodeling would increase PAV.  Eventually, the greatest strength of CTCA is that it can assess coronary atherosclerosis by combining the 2 “worlds” of QCA-like and IVUS-like parameters. Previous papers 
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have shown that CTCA is comparable to QCA angiography regarding lumen stenosis assessment (30,31); similarly, IVUS and CTCA comparative studies (4,25) have shown that the CTCA can reasonably evaluate atherosclerotic plaque size, remodeling, eccentricity, and composition, despite the acknowledged limitations of the technique. Voros et al. (4) suggested that quantitative CTCA could be acceptably used in population-based approaches, given the small mean differences between CTCA and IVUS-virtual histology measurements. Interestingly, our results closely fit the regression line in the classical graph depicting the relation between mean LDL levels and median change in PAV for several previous IVUS progression/regression studies. Most prior IVUS studies have used PAV as the primary endpoint; however, the percentage change in TAV may be more suitable for CTCA studies, because not only 1 coronary segment can be imaged, but the full coronary tree can be assessed. Conversely, considering the resolution and reproducibility of CTCA, the minute changes in PAV observed in IVUS studies may be more difficult to detect.   
CT coronary angiography for the assessment of coronary 
bifurcations  
Comprehensive assessment of coronary bifurcations by CTCA: what 
is the role of anatomy? The complex three-dimensional (3D) geometry of coronary artery bifurcations can affect the local haemodynamic conditions and thereby the plaque distribution and composition. This plausible effect mediated by the bifurcation angle (BA) can only be studied in vivo by means of imaging modalities that provide a 3D reconstruction of the bifurcation, such as multidetector computed tomography (MDCT).  Our study (Chapter 6) corroborates earlier findings on plaque volumetric and compositional characteristics at bifurcation sites: the plaque burden and the percentage of the NC were significantly larger in the proximal segment of the non-left main bifurcations. The differential distribution of the NC and the high-risk plaques along the 
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coronary tree could be attributed to the influence of local haemodynamic factors altered at bifurcation sites. Our data also demonstrated that predominantly non-calcified plaque type by MDCT corresponded to the IVUS-VH high-risk phenotype. This finding is in agreement with histopathology studies (32) and with previous greyscale IVUS studies showing that plaques with low echogenicity (presumably lipid rich) are mainly soft (noncalcified) by MDCT (10,33,34).  Notably, the present study (Chapter 6) emphasizes the added value of MDCT as 3D imaging modality by integrating the MDCT-based BA measurements to the bifurcation assessment. Our in vivo data showed that the presence and phenotype of atherosclerotic plaque in the proximal bifurcation segment is related to the BA size. This finding could be supported by computational fluid dynamics (35-37) and histopathology (38) studies demonstrating that the haemodynamic phenomena important in atherogenesis are more pronounced in widely angulated bifurcations. Moreover, the BA size has been described as a determinant of treatment strategy in bifurcation lesions (39). In numerous bench and clinical studies (40-44) a wide BA has been associated with a greater risk for suboptimal post-procedural result and long-term adverse clinical events. Additionally, our data demonstrated that a wide BA is associated with a greater plaque burden and a high-risk phenotype of bifurcation lesions, which make us speculate that NC-rich plaques could be related to the higher restenosis and thrombosis rates (45-47). Eventually, a comprehensive assessment of bifurcation lesions including plaque characterization and BA measurements could lead to optimized interventional strategies and improved long-term clinical outcomes.  
A CT-based Medina classification in coronary bifurcations: does the 
lumen assessment provide sufficient information? 
Currently, angiographic classification of bifurcations is widely accepted in clinical practice; nevertheless conventional angiography is an imperfect tool, which considerably underestimates the extent of atherosclerotic lesions when compensatory positive remodeling is present (48-50). In addition, the angiographic assessment of coronary bifurcations is limited by vessel foreshortening and overlap. In a previous 
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IVUS study, Oviedo et al. (51) reported the distribution of plaque at the LM bifurcation, and proposed an IVUS classification of plaque morphology which was compared with the commonly used Medina system. The authors concluded that there was no relation between the Medina angiographic classification and IVUS plaque distribution. Similarly to IVUS, imaging by CTCA goes beyond lumenography and enables the assessment of atherosclerotic lesions that are angiographically “silent”. In our investigation (Chapter 7), we propose a simple modification of the Medina classification to incorporate plaque severity, by adding an asterisk (*) as a superscript to the existing segments’ score for 
≥70% plaque burden; this CT-Medina classification scheme combining lumen stenosis and plaque severity is more informative than angiographic classification of bifurcation lesions and could potentially facilitate the decision-making on the treatment of these lesions. As CTCA is becoming widely available and its value in detecting significant lumen narrowing has been robustly established, many patients are being brought into the cathlab based on the CTCA findings. Percutaneous treatment of coronary bifurcation lesions has been associated with worse acute and late outcomes due to higher restenosis and stent thrombosis rates (52-54). Comprehensive pre-interventional assessment of both lumen stenosis and plaque severity of a diseased coronary bifurcation may be important to better plan a percutaneous strategy. Although carina shift is suggested to be the predominant mechanism of side branch (SB) lumen loss after main vessel (MV) stent implantation, plaque shift from the MV also contributes to the aggravation of an SB ostial lesion and was more frequently observed in hemodynamically significant SB lesions (55,56). Therefore, we envision that a CT-based Medina classification of bifurcation lesions may assist the preparation for the bifurcation stent implantation, regarding for example the location of the stent or even the need for a second stent, whereas the prevailing technique is the provisional 
stenting. Especially the presence of 0* at the side branch ostium in a case of 1, 0, 0* classification, could herald acute SB occlusion after provisional stenting, which could necessitate a 2-stent strategy from the beginning or the use of dedicated bifurcation stent. Although novel, this classification was based on an analysis of a small number of patients, thus it must be considered work in progress. Larger studies with procedural and clinical outcomes are warranted to examine the value of the newly introduced CT-Medina classification. 
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CT coronary angiography for risk stratification of coronary 
atherosclerotic disease 
 
The CTCA-derived SYNTAX Score: is it feasible and reproducible? Our report (Chapter 8) investigates for the first time the feasibility of the MSCT SXscore and shows that it is comparable to the conventional ICA SXscore. For the purpose of this study, we reviewed all the definitions from the ICA SXscore and adapted them to the MSCT capabilities. Of note, in our study the absolute difference between MSCT and ICA SXscores per patient did not correlate with the Ca Score. Although it can be hypothesized that extreme calcification, which is making the assessment of the coronary lumen more difficult, is responsible for the overestimation of SXscore by MSCT, it appears that the presence of high amount of calcium does not account for the difference between the SXscore calculation with the 2 modalities. Not unexpectedly, the median Ca score in each MSCT SXscore tertile increased gradually and proportionally with the increase of the MSCT SXscore value; conversely, this was not the case with the ICA SXscore, as in the two lower tertiles, the median Ca score was similar. This finding suggests that the stratification based on the MSCT SXscore tertiles reflects better the overall burden of the disease. It is important for a diagnostic tool to be easy to perform and to analyze, accessible and reproducible. Generally speaking, both SXscores share the first qualities, but the MSCT SXscore as investigated by our group appears to have better reproducibility considering historical data (57-61). The general correlation of MSCT SXscore values between the first and second rounds of analysis was high, and so was the intra-observer agreement 
of the MSCT SXscore tertiles (weighted kappa 0.80). The latter has been reported to be lower in all previous studies using conventional angiography (57,59-61), except for a study by Genereux et al. (58) reporting a kappa value of 0.88 for one of the reviewers. One important consideration is the fact that these reports have mean ICA SXcores ranging from 16.2 to 34.1 while our overall ICA SXscore was much lower (median 10.5, 
mean 13.05). We acknowledge that the extent and complexity of the disease may affect the reproducibility. Nevertheless, the ICA SXscores of the cases included in our study 
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are in the same range of values reported in the SIRTAX (SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization) (62) and the LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) (63) all-comers trials; to put our results in perspective, we envision that the MSCT SXscore could be used in the future in such populations since it has a better precision. Finally, it could be assumed that the MSCT SXscore is in part more reproducible than the ICA SXscore because the coronary bifurcations can be better visualized by MSCT, without the limitations of the vessel foreshortening and overlap that exist in conventional angiography. Indeed the reproducibility of the number of bifurcation/trifurcation lesions in MSCT SXscore is much better than the one reported in the studies using conventional angiography (3,26-29).  
The CTCA-derived SYNTAX Score: where do we go from here? The development of an online algorithm customized for the MSCT SXscore calculation (i.e. incorporating the Ca score values), as is currently available for the conventional SXscore, could be of great interest. Furthermore, the “functional SYNTAX score” – a fractional flow reserve guided SYNTAX score – has been shown to improve the diagnostic accuracy of the SXscore (64). Recently, the feasibility of non-invasive fractional flow measurements has been demonstrated, by applying computational fluid dynamics to MSCT angiography (65); thus the application of this promising technology to the MSCT SXscore may improve its diagnostic accuracy and reproducibility.  In addition, the angiographic SYNTAX score is lacking the information related to clinical factors which are known to have prognostic value, such as a patients’ age, left ventricular ejection fraction and renal function (66). Integrating the aforementioned variables to the SYNTAX score resulted in the development of the Clinical SYNTAX score, which has shown improved predictive value for adverse clinical events after revascularization (62,67,68). Under this perspective, the ability of MSCT to comprehensively assess the heart can have great potential. Apart from the evaluation of the coronary vessels, MSCT can be used for the evaluation of the left ventricular ejection fraction, the valves and the ischemic myocardium; adding the information from all these 
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parameters may serve to add incremental value to the prognostic utility of the MSCT SXscore.   
Conclusion CT coronary angiography allows detection of coronary atherosclerosis, as well as characterization of different coronary plaque patterns. The accurate and reproducible assessment of atherosclerotic plaque noninvasively is paramount to monitor the progression of disease and the response to pharmacological therapy and quantitative measurements are more reliable when semiautomated software is used. Moreover, the ability of the technique to appreciate the whole coronary tree and the complex 3D geometry of coronary arteries can facilitate the decision-making on the treatment of coronary bifurcation lesions and the risk stratification of patients. The integration of information such as functional significance to the anatomic evaluation of atherosclerosis may serve to add incremental value to the prognostic utility of CTCA. 
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